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Foreword
Knowledge of the behavioral, environmental, and pharmacological
correlates of substance use and abuse is central to the interests
of the National Institute on Drug Abuse. Thus, NIDA has
contributed to the expansion and dissemination of such knowledge
by supporting research and sponsoring major reviews to examine the
mechanisms that determine substance abuse and other habitual
behaviors, with particular emphasis on the common explanatory
elements. The publications that resulted from these reviews have
explored what we know about the specific behavioral
pharmacological processes which underlie the observed effects of
drug use and abuse.
Several volumes in the NIDA Research Monograph series have
embodied the perspective of behavioral pharmacology.* With
varying emphasis, each has examined broad theoretical issues,
sought to expand on and contribute to a sound conceptual
framework, and applied its findings to improving the science and
techniques of treatment--in which basic research ultimately comes
to fruition. Behavioral Intervention Techniques in Drug Abuse
Treatment, the ninth of these monographs, focuses directly on
treatment applications as well as broader issues in the treatment
domain.
Behavioral intervention techniques are based on the premise that
behavior is controlled by its positive and negative consequences
and can be modified by making changes in selected aspects of the
environment so as to reinforce desired behaviors. They encompass
numerous related procedures, variously labeled as behavior
modification, behavior therapy, contingency contracting,
contingency management, or token economy. These interventions are
increasingly being used, integratively with other more traditional
forms of therapy, in treating the diverse disorders associated
with drug dependency. They can enhance the effectiveness of
essentially all available treatment components, including
pharmacological adjuncts, psychotherapy, family therapy, and job
training. Through such a spectrum of uses, behavioral
intervention techniques, thoughtfully planned and applied, promise
increasing levels of success in the treatment of drug abusers.
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The contributors to this monograph all are actively involved in
various aspects of drug abuse research and treatment in which
behavioral techniques are used. Representing a broad range of
areas of expertise, their presentations will be of interest to
those who are engaged in clinical research, treatment, and
analysis of drug abuse treatment systems.
William Pollin. M.D.
Director
National Institute on Drug Abuse
*Behavioral Tolerance: Research and Treatment Implications
(No. 18)
Self-Administration of Abused Substances: Methods for Studv
(No. 20)
Behavioral Analysis and Treatment of Substance Abuse (No. 25)
Behavioral Pharmacology of Human Drug Dependence (No. 37)
Research on Smoking Behavior (No. 17)
Cigarette Smoking as a Dependence Process (No. 23)
The Behavioral Aspects of Smoking (No. 26)
Measurement in the Analysis and Treatment of Smoking Behavior
(No. 48)
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Therapeutic Application of Behav-
ioral Techniques: An Overview
John Grabowski, Ph.D., Maxine L. Stitzer, Ph.D., and
Jack E. Henningfield, Ph.D.
Observations on the History of Treatment
History is replete with examples and reports of drug abuse despite
the current popular perspective that drug abuse is a relatively
recent behavioral anomaly. References to maladaptive patterns of
drug use are prevalent in the treatment literature of the past
century, and, on even casual examination, the characteristic
efforts to eliminate the problems are not unfamiliar.
The techniques have ranged from essentially entirely pharmaco-
logical to completely behavioral-psychological. An early example
of treatment in the realm of pharmacological manipulations was
that of Bentley (1880; see Byck 1974, p. 15), who, among others,
treated heroin use by administering cocaine. Later, some
clinicians, researchers, and observers of the discipline did
recognize or acknowledge the importance of environmental factors.
As was noted by Bernfeld (1953), "Neither cocaine nor any other
chemical, in itself, produces addiction. It is a psychological
[behavioral] phenomenon. In the '80s [188Os] the problem of
addiction was approached, if at all, as one of toxicity
to certain habit-forming drugs" (see Byck 1974, p. 3473.
specific
Nevertheless, despite a century of documented treatment experi-
ence, intensive research, and repetition of comments  paralleling
those of Bernfeld, continued belief in the singular importance of
the substance is frequent, and failure to acknowledge the
importance of behavioral and environmental factors in the
development, maintenance, and elimination of drug use is not
uncommon. Thus, for example, methadone maintenance, when
introduced 20 years ago, constituted a pharmacological inter-
vention which was commonly administered as a primary therapy
rather than as a pharmacological adjunct to other therapy.
Furthermore, this practice is not altogether unusual today.
Early reports of treatment illustrated the general inadequacy of
approaches not explicitly attending to the interactive nature of
drug use. In the United States, "drug addiction," i.e.,
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maladaptive drug use, was for many years essentially synonymous
with use of narcotic analgesics. "Treatment" for the stereotypic
user was equated, at one extreme, with inpatient drug withdrawal
and discharge, and, at the other, with long-term incarceration at
the United States Public Health Service hospitals. In this case,
seeming attention to the environmental factors, i.e., through
removal from the drug-taking environment, was in fact founded in a
pharmacological perspective. Later, Wikler (1965) and others
pointed to the difficulties in the model and developed a
theoretical position delineating the role of some environmental
factors in the maintenance of opiate use (e.g., Stitzer et al.
1983; Grabowski and Cherek 1983). As Stitzer et al. (1983) have
noted concerning treatment based on the incarceration strategy,
"the therapeutic success...was not impressive." It was, however,
consistent with a general societal view which dictated that
removal of an individual with behavioral disorders to a separate
environment would contribute to a return to health or provide an
opportunity for rehabilitation. As with the mentally ill and
mentally retarded individuals of an earlier era (e.g., see
Thompson and Grabowski 1977; Deutsch 1949). it has since become
clear that temporary, or even prolonged, removal from the natural
environment in which the behavior occurs does not, in and of
itself, have any particular utility unless it is intended that the
individual will never return to that environment. Overall it
became evident that treatment by simple isolation from drugs is
neither a necessary nor sufficient condition to eliminate drug
use. As is indicated elsewhere in this volume, there still exists
some tendency, if not to remove the users from society, at least
to segregate them from other components of the behavioral health
care system.
Interestingly, the reverse condition, of increased likelihood of
drug use under novel environmental conditions, has also been
described. Robins et al. (1974) observed that individuals whose
first exposure to, and repeated use of, heroin occurred in Vietnam
did not in the main continue use of the drug after returning to
the United States. Thus, it may be argued that availability of
the drug in a different environment devoid of other reinforcers
may greatly increase the likelihood of use. In turn, return to
the original environment where drug use may be less acceptable and
where the drug is less available may result in discontinuation of
use. This further illustrates that-diverse environmental stimuli
serve to control and determine the probability of both use and
nonuse. This phenomenon has been adequately documented in the
behavioral pharmacology laboratory (e.g., Thompson and Ostlund
1965).
It is clear that the treatment issues as well as the drugs of
current concern (e.g., heroin, cocaine) are the same as those
about which much has been written in the last century. And yet
there now exists a substantial data base focusing attention on the
importance of nonpharmacological, in addition to pharmacological,
factors in treatment. Numerous reviews delineate the potential or
demonstrated importance of the interactions between behavioral and
environmental factors (e.g., Grabowski and Cherek 1983; Stitzer
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et al. 1983; Griffiths et al,. 1980). Nevertheless, only slowly is
acceptance emerging at a more general level of the importance of
drug-behavior-environment interactions and the need to attend to
the problems principally from this perspective,
Treatment Strategies and Brief Overview
Both pharmacological and environmental factors must be considered
in treating the specific problems of drug abuse and the plethora
of correlated disorders. However, in fact there are several basic
strategies to "treatment" of drug use and in the main they "treat"
rather different phenomena (e. g, see Grabowski and O'Brien
1981). Approaches include: (1 pharmacological treatment of4
cessation (i.e., withdrawal and rebound symptoms); (2) pharmaco-
logical maintenance treatment; (3) rehabilitation and treatment of
collateral problems; and (4) behavioral intervention techniques.
It is clear that the first strategy, drug withdrawal, is unlikely
to have any long-term utility. The second strategy,
administration of opiate partial agonists (e.g., methadone),
antagonists (e.g., naltrexone), or drugs intended for treatment of
extant psychopathology such as depression (e.g., tricyclic
antidepressants) or anxiety (e.g., benzodiazepines) has potential
benefits. It must be recalled, however, that these drugs are
rarely of utility alone and should, indeed, be viewed as adjuncts
to other treatment. The third strategy, which involves major
efforts to treat psychological problems and to develop social
skills and educational or vocational opportunities is important
but should not take precedence over all other foci of
intervention. Further, this strategy is often applied in an
unintegrated and unsystematic fashion. The fourth strategy is
integrative; it takes in essence a longitudinal perspective
encompassing and using the other techniques as adjuncts and
components. A behavioral analysis is undertaken for the
individual. Current behaviors are examined, goals are developed,
and techniques for achieving these goals are delineated.
Depending on the needs of the individual, the resultant
individualized program may be narrow or broad and rather, all
inclusive, dealing with diverse aspects of the individual's
behavioral repertoire. The program is best implemented in the
context of a clinical milieu based on behavioral management
techniques. It should be evident in this regard that this does
not refer to those systems of punitive consequences which on
occasion are purported to be the foundation of a clinic-wide
behaviorally. based program.
It is important to note that "behavioral intervention techniques"
has been used here as a generic phrase that encompasses the
numerous related specific procedures which are discussed under the
rubrics of behavior modification, behavior therapy, contingency
contracting, contingency management, token economy, and other
labels. In addition it is intended that the phrase indicate the
use of specific behavioral principles in the application or
introduction of other more traditional therapy forms. Thus, for
example, behavioral analysis and procedures can well be used to
enhance the effectiveness of pharmacological adjuncts, therapy
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involving families, job training, and essentially all other
components of treatment. While pharmacotherapy, family therapy,
and other elements are components focusing on specific loci of
intervention, behavioral intervention constitutes and refers to a
scientific analysis and treatment superstructure.
When a procedure of potential clinical utility is identified, it
should, ideally, proceed through a series of investigations and
evaluations through which its usefulness and limitations are
defined. It should be understood, however, that the development
of more precise techniques does not imply that their application
has always progressed smoothly. Early reports tended to describe
the application of fairly circumscribed techniques to equally
limited problems. These are often thought to have followed
preliminary laboratory efforts in a logical and systematic
fashion, but as Tharp and Wetzel (1969) noted, this logical
progression from laboratory to clinical setting, from simple to
more complex, is not as much in evidence as the historian of a
discipline might wish.
Nevertheless a systematic approach to analysis has developed.
Most important is the recognition that behavioral research and
clinical application are conducted with emphasis on "operationism
and observable anchors" (Craighead et al. 1976). This is
essential to, and indicative of, precise and effective implemen-
tation of behavioral techniques. The requirement for use of
measureable intermediate goals and endpoints does not, as some
suggest, limit one to simple interventions, and this is reflected
throughout the present volume. Rather it simply requires and
assures that any therapeutic procedure has been demonstrated with
some rigor to be efficacious.
In the present volume diverse applications of behavioral
interventions are discussed, ranging from the pharmacological,
through the broad rehabilitative efforts involved in socialization
and training, to possible alternative treatment systems based on
integration into the community at large. In addition, background
is provided in the form of a behaviorally based "ethological"
classification system delineating some of the behavioral reper-
toires in the natural environment of opiate users' who are not in
treatment and treatment clients who are not using opiates.
Hunt et al. have provided an interesting first step in identi-
fication of behavioral patterns characterizing methadone clients
in their natural environment and provide insight into both
adaptive and maladaptive patterns of behavior which emerge not
only in the clinic but away from it. Perhaps most important from
the perspective of behavioral analysis is that Hunt and her
coworkers used a procedure explicitly involving in vivo
observation rather than simply relying on the self-reports of the
patients, who are necessarily compromised in their ability to
report objectively on some aspects of their own behavior or the
behavior of others in treatment. These data assist in under-
standing the problems and issues raised by Woody et al. Woody's
paper describes the structure and the functioning of a clinic
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which is representative, although it is perhaps more elaborate and
sophisticated in its resources than many, since it is invested in
extensive research activities. This suggests that some of the
problems which emerge reside in basic aspects of the system of
treatment rather than the presence or absence of extensive
resources. Further it is clear that some of the prototypic
problems inherent in the extant treatment system are represented
in the problems described by both Hunt et al. and Woody et al.
Bigelow et al., Pickens and Thompson, Stitzer et al., and Crowley
provide detailed analyses of various aspects of application of
behavioral intervention techniques in a variety of settings with
widely differing populations. Paramount in appreciating this
series of papers is the diversity in the populations and
specificity of the procedures considered. In addition it should
be noted that Bigelow's overview provides a substantive review and
background for considering approaches to behaviorally based
treatment of drug abuse and the development of interventions in
numerous facets of the patient's life. Stitzer et al; attend in
detail to a common problem in the treatment of drug-using
patients: that is, control of ongoing opiate use as well as use
of other drugs, an issue that must be addressed if treatment is
ultimately to be successful.
Those unfamiliar with the scope and utility of the philosophy of
behavioral intervention techniques as well as their explicit
application often assume that behavioral strategies may work well
with the stereotypic opiate user but have little relevance to
other groups. In fact, Pickens and Thompson, as well as Crowley,
amply demonstrate the broad utility of the techniques with respect
not only to populations but also to the drugs in question--in one
case, barbiturates and benzodiazepines, and in the other,
cocaine. A critical issue in this area is that the scope of
application is increasing rapidly and techniques are undergoing
development, refinement, and redefinition. Early efforts by
Crowley in dealing with the particularly pernicious problems
related to abuse of cocaine, an especially effective positive
reinforcer, in patients who have numerous alternative reinforcers
emphasized the control and utilization of punitive consequences in
therapy. Although procedures based on avoidance are clearly
effective, alternative techniques based on positive reinforcements
are being explored which may also be effective and have more
desirable characteristics in terms of both patient and community
acceptance. The efforts of Crowley, as well as those of Pickens
and Thompson, are especially important today since they represent
treatment of forms of drug misuse only recently acknowledged as
prevalent in the mainstream of the population.
The clinical research efforts of Todd in delivering family
therapy, as well as those of Hall et al. in job seekers' training,
illustrate extensions into areas not often thought to be amenable
to intervention through behavioral techniques. In this regard it
should be recalled that the conceptual framework and philosophical
underpinnings of behavioral techniques can readily be applied to a
diversity of behavioral-psychological problems. These authors
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indicate that the collateral behavioral problems and rehabili-
tation needs in treatment of drug abuse are amenable to analysis
and resolution using behaviorally based techniques.
As becomes evident throughout the volume, the generality of
behavioral intervention strategies is limited only by the
ingenuity and precision of implementation. Specific behaviors
such as supplemental drug use may be addressed on one hand while
the more global aspects of family interactions may be attended to
on the other. Given the scope of the problems and resources
requisite in many cases of drug use, Thompson et al. address the
more general issues inherent in a "behavioral analysis" of extant
treatment systems for drug abuse problems. The questions are
difficult and answers are not readily achieved. However, it is
apparent that some of the problems related to drug abuse treatment
will not be resolved by patchwork modifications. Given the
increasing diversity and magnitude of drug abuse problems, the
suggestion of Thompson et al. that alternative strategies be
pursued may be especially timely.
Concluding Comments
In considering the techniques described in the present volume a
"word of caution" should perhaps be provided. As has been noted,
there exists an extensive experimental and clinical literature on
the application of behaviorally based intervention techniques to a
wide range of behavioral problems in diverse settings. with equally
diverse populations. Application of therapeutic techniques,
conceptual models, or technological advances to a new problem
outside the mainstream of use may result in disregard of past use
and of experience gained elsewhere. The applications often emerge
de novo in the setting, and as a result the benefits, as well as
errors, of past experience are likely to be overlooked. Thus it
is suggested that attention both to development of specialized
knowledge of behavioral techniques and to experience in
psychopharmacology and behavioral pharmacology will be important
in pursuing the development of new approaches and implementing the
approaches which are currently available. It is hoped that the
present volume will contribute to the wider application of
behavioral techniques in drug abuse treatment by indicating the
scope of applicability of these techniques and that the papers
which follow will serve as a stimulus to the reader to seek
further information from appropriate sources.
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Problems in Methadone Treat-
ment: The Influence of Reference
Groups
Dana E. Hunt, Ph.D., Douglas S. Lipton, Ph.D.,
Douglas S. Goldsmith, M.A., and David L. Strug, Ph.D.
Since its introduction in the late 196Os, methadone treatment has
been evaluated, researched, and reviewed by the scientific
community in innumerable studies focusing on different types of
treatment and treatment strategies: methadone maintenance versus
therapeutic communities, detoxification versus maintenance
(Lowenson et al. 1981; Gearing 1970; Cushman 1972). Others have
described problems in drug treatment such as alcohol abuse among
patients, patterns of criminal activity, or methods for
modification of undesirable patient behavior. Few studies,
however, have left the confines of the treatment facility to
describe the total milieu of methadone treatment.
The Tri-State Ethnographic Project (TRISEP) was a cooperative
effort of researchers and program administrators in New York, New
Jersey, and Connecticut to examine multifaceted aspects of
methadone treatment. By gathering information from patients,
staff, and addicts not in treatment, the project sought to focus
attention on the processes of methadone treatment and the
characteristics of patients which affect those treatment
processes. The purpose was to determine whether informal social
networks among persons in and around a methadone clinic influence
attitudes and opinions about methadone and, consequently, affect
patients' cooperation and compliance. The TRISEP research also
examined problems common to most methadone programs--diversion,
loitering, and polydrug abuse --to gather information which might
be helpful for developing strategies to alleviate these problems.
This paper describes four distinguishable groups identified in and
around the methadone treatment clinic which act as referents for
the behavior of their membership. These groups have important
influences on addicts' decisions regarding whether or not to enter
into and/or to cooperate with methadone treatment. The problems
common to treatment programs can also be better understood in
terms of the social organization of these groups. Therefore, this
paper concentrates on the importance of reference groups and the
normative behavior which characterizes each of them.
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TRISEP METHODS AND SAMPLE
Interviews and extensive field research were conducted at four
methadone maintenance clinics in three States: New York, New
Jersey, and Connecticut. The four programs were comparable in
terms of demographic makeup of the patient population and the
presence of common clinic behavior problems among clients. The
total patient population of all four sites was approximately 2,000
persons. The study sample consisted of 510 people, 368 patients
randomly selected, from the clinic rolls and 142 narcotics users
not currently in treatment. The individuals not in treatment were
identified through both snowball sampling and the use of
indigenous field workers, trained methadone clients working for
TRISEP. Participation was voluntary; subjects were paid for
participation. 'The interviewing and field observations were
conducted in a four- to six-block radius of each clinic. This
territory included the drug-dealing areas and the social areas
commonly used by both patients and current street addicts who
interact with the clinic population.
RESULTS AND DISCUSSION
The methadone patient population is varied in a number of ways,
including drug histories, previous treatment experiences, and
motivations for treatment. These differences influence the
patients' receptivity to treatment. Methadone patients are also
different in terms of their reference groups in the treatment
setting. The reference groups share common values and beliefs,
have established forms of social interaction, definition of
membership, and recognition of membership by nonmembers (Merton
1968). Four clearly delineated groups have been identified
through ethnographic field observation and through cluster
analysis of respondent behaviors and attitudes:
1) street addict group: active narcotics users not
currently in treatment
2) methadone treatment group: a compliant patient group
with a positive attitude toward treatment
3) methadone street group: a noncompliant patient group who
are involved in alcohol and polydrug use
4) self-prescribing group: composed of (a) persons not in
treatment using illegal methadone to avoid withdrawal and
(b) persons in treatment who are systematically adjusting
their own dose to detoxify without the knowledge of the
program
Characteristics of these four groups will be described, followed
by a discussion of their differential contribution to the problem
areas commonly identified with methadone treatment: premature
treatment dropout, polydrug abuse, loitering, and methadone
diversion. Demographic characteristics of each subcultural group
are summarized in table 1.
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TABLE 1. DEMOGRAPHIC INFORMATION ON GROUPS
Age
Mean Age
Race
White
Black
Hispanic
Sex
Male
Female
Employment
Employed
Unemployed
Education
Mean years
N*=
Street Methadone Methadone
Addict Treatment Street
Group Group Group
29 32 31 30
38% 45% 48%
54% 38% 42%
8% 18% 10%
46%
54%
0%
69%
31%
70% 51%
30% 49%
73%
27%
28%
72%
41% 14%
59% 86%
10.2
117
11.5 ll.O
185 177
41%
59%
11.3
22**
Self-
Prescribing
Group
*Nine persons originally interviewed in the study are not included
in this classification system.
**The Self-Prescribing Group size is disproportionately small for
several reasons. First, this group was not anticipated in the
research design and no questions directly related to
self-detoxification were included in the interview. Secondly,
those persons buying methadone in the clinic area, but not wishing
to become patients, are very difficult to gain access to. The
size of this group in our sample should not be taken as reflective
of the size of this group in the larger population.
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Street Addict Group (N=117)
The "street addict" lifestyle has been described by many
researchers (Preble and Casey 1969; Agar 1973; Stephens and
McBride 1976). Members of this group are described as heroin
addicts still "ripping and running," involved in daily or near
daily use of heroin often financed through illegal activities.
When heroin is difficult to obtain, the addict may substitute
other drugs such as morphine, codeine, hydromorphone (Dilaudid),
meperidine (Demerol), methadone, or paregoric (Gould et al. 1974),
but heroin is considered the drug of first preference and highest
status.
Results of the present study support previous findings about the
"street addict." Johnson (1981), in a recent study of the
economic behavior of "street addicts" in East Harlem, found that
drug use in the natural environment has been greatly influenced by
the influx of methadone as an available opiate. Methadone is now
the most attractive substitute for heroin, and the street addict
is rarely a user of heroin alone. However, among the "street
addict" community, methadone is seen as a drug of lower status
than heroin. The "street addict" group member can reel off a list
of side effects of methadone which are part of the basis for its
inferior reputation compared to heroin. Its use is justified by
this group in terms of perceived medical necessity rather than as
a desirable euphoriant.
The "street addict" population is, as would be expected, more
heavily involved in criminal activity than the treatment
population in general. They can be found around methadone
programs as merchants of stolen goods and as dealers of pills and
cocaine, using methadone patients as customers.
A strong antitreatment attitude markedly differentiates the
"street addict" from other groups. Over 50% of this group rated
methadone treatment as "not good with some qualification" to "not
good at all." They express contempt for the idea of treatment,
regard treatment as unnecessary, and are suspicious of treatment
staff. This group of subjects argues that methadone has
deleterious side-effects and that it is simply an inexpensive
alternative to more desirable drugs. They also tend to believe
that treatment is unnecessary and that, if they chose to, they
could readily terminate opiate use without treatment.
Methadone Treatment Group (N=l85)
This group is composed of individuals formally in treatment,
generally acting in compliance with program rules concerning
loitering, polydrug use, and methadone diversion. In addition,
commonly accepted treatment goals such as working for a living,
staying clear of serious criminal activity, and maintaining a
stable family situtation are adhered to by the methadone treatment
Their values and behavior are thus congruent with those of
the treatment staff and of the middle class culture in general.
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The methadone treatment group is somewhat less integrated and less
visible than other groups, primarily because many of its members
work and do not gather for long periods of time at or near the
clinic. They typically come for medication early in the morning
or late in the evening, i.e., before or after work, and remain
only briefly. Because of their. cooperative behavior, they also
contribute disproportionately to the list of patients receiving
"take home" doses of methadone and thus do not show up at the
clinic every day. Members of this group generally know each
other, call greetings, and ask about each others' families. Their
network of friends includes other members of the treatment group
and drug-free people. They make a clear distinction between
themselves and members of the methadone street group, with whom
they choose not to interact.
Although the methadone treatment group members are generally
oriented toward cooperation with the positive goals of methadone
treatment, they nevertheless occasionally engage in
antitherapeutic activities. Although most work at legitimate
jobs, 32% reported income from criminal activities in the week
prior to the interview. Further, some of the jobs cited as
regular employment involve illegal activities, such as policy
writing and bookmaking.
Methadone treatment group members have many complaints about
program policies and even about methadone itself as a treatment
for drug abuse. However, the overall attitude is one of
cooperation with treatment. In contrast with other groups, this
one expresses affirmative and socially valued reasons for entering
treatment, such as avoidance of social, legal, and health hazards
associated with heroin use.
Methadone Street Group (N=177)
There are two clusters within this broad category. The first is
composed of individuals in treatment, taking their methadone dose
as well as any extra doses they are able to purchase, who are
involved in low-level dealing or criminal activity,. abusing other
substances such as tranquilizers, drinking to excess, and
unemployed. These are considered to be the lowest status
individuals in the clinic community, referred to by the street
addicts and the compliant patient group as "pillheads" and
"lowlife." They are also the patients who are most disruptive to
methadone programs. The second cluster is in treatment but using
the methadone dose only as an adjunct to continued active heroin
use. Members of this second group routinely sell their medication
to obtain money for heroin or cocaine purchase.
Methadone is viewed as a drug of pleasure as well as a medication
by the methadone street group. At times, it is used as an
inexpensive euphoriant in combination with other drugs, including
alcohol. When a euphoriant drug effect is sought with methadone,
these patients will ingest extra quantities. For example, if they
have take-home dose, they will commonly "double dose," taking
twice the usual daily dose.
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Criminal activity in this group is confined to small-scale
operations such as shoplifting, dealing in stolen merchandise or
dealing drugs, primarily pills such as diazepam or amitriptyline.
Stolen merchandise is sold openly among members of this group.
They deal in pills on a small scale, rarely having more than $15
or $20 in operating capital.
Of all the groups, the methadone street group reports the highest
level of ambivalence about methadone as a treatment. Side effects
such as lethargy, muscle and bone aches, and edema are widely
discussed and home remedies exchanged. However, even as they
complain about the methadone and its effects, returning to the
street to shoot heroin or to kick the habit without methadone is
not viewed as a desirable alternative. Methadone is a source of
problems but it is also a source of stability, because of its
relative safety in comparison with the less reliable street heroin.
Self-Prescribing Group (N=22)
The sample size of self-prescribers in the present study is
considerably smaller than that for any of the other groups. This
is primarily due to the difficulty of reaching persons not in
treatment rather than to their scarcity in the population.
Reports of clinic patients and trained patient field workers
indicate that these individuals are an integral part of the clinic
setting. The self-prescriber group also consists of two
subgroups, one existing in the clinic population and one outside
the clinic population. The behavior common to both is the
self-manipulation of methadone dosage, usually in the direction of
detoxification. Both subgroups view methadone as a therapeutic
medication rather than a euphoriant.
Self-prescribers who are not clinic patients are people either
attempting to maintain themselves on methadone as if they were
regular maintenance patients or attempting to detoxify themselves
from heroin, but who do not wish or are unable to become clinic
patients. These individuals regularly buy street methadone
(usually from only a limited number of sellers) and titrate their
dosage to maintain a steady state and preclude withdrawal. These
people appear to self-administer illicit methadone as if they were
compliant patients. They are similar to the methadone treatment
group in terms of stability and appear to be "good patients" who
are simply not enrolled in a program.In some cases they are on
waiting lists, while in others they are avoiding program
regulations and schedules, and in still others they are avoiding
the perceived possibility of disclosing their drug use to friends
or employers.
The other half of this group consists of patients who engage in
self-regulated dose reduction and withdrawal without the knowledge
or permission of program staff. Unused methadone is sold or given
away. Thus, this portion of the self-prescribing group operates
symbiotically with the other self-meditators. The reasons given
for self-regulated dose reduction fall into two broad categories:
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dissatisfaction with the physician-prescribed rate of dose
reduction and concern over either acute or long-term side-effects
of methadone.
The self-prescribing group is the most difficult to characterize
empirically. Many of the behaviors and characteristics of its
members overlap with the methadone treatment group in terms of
attitudes toward methadone, criminal involvement, and extra drug
use. Further research is needed on this difficult to contact but
important element in the treatment milieu.
PROBLEMS IN TREATMENT AND THE INFLUENCE OF REFERENCE GROUPS
A variety of problems is generally acknowledged to exist in
methadone maintenance programs. Three problem areas have been
selected for discussion in the present paper: (1) early exit from
treatment, (2) the somewhat related problems of loitering and
methadone diversion, and (3) polydrug use. These will be
considered in relation to the attitudes and behaviors of the
reference groups which have been described in the first part of
the paper.
1. Early Exit From Treatment
Recent data indicate that there is a trend towards shorter periods
of enrollment in methadone maintenance treatment. Senay et al.
(1977) found a 27% dropout rate within the first 8 weeks of
methadone treatment, while Brown et al. (1975) reported an 18%
termination rate from three different New York clinics during 44
clinic-months of treatment delivery. Other researchers report
premature exit rates from 7% - 64% (DuPont 1971; Gearing 1971;
Perkins and Richman 1972). Drug-free programs fare even more
poorly, with dropout rates as high as 82% (Kaufman 1972).
The problem of early exit is a serious one, since data indicate
that individuals leaving treatment suffer a higher incidence of
problems than those remaining. Des Jarlais et al. (1978) reported
that 72% of patients who left methadone maintenance treatment
returned either to daily narcotic use or to methadone treatment
programs. The type of discharge was important in predicting
return to narcotics. Those who had completed a full course of
treatment were less likely to return either to treatment or to
narcotics use.
In addition to renewed narcotics use, methadone patients who leave
treatment early appear to have high mortality rates. A recent
report by Des Jarlais (in press) indicates that the death rate of
persons leaving methadone treatment was more than double the rate
of those still in treatment. These deaths were most often related
to drugs, alcohol, accidents, or violence. Compared to the
general population, there are more deaths in both the methadone
treatment and post-treatment populations. Among persons 25 - 44
years of age, those in treatment have death rates five times
higher than the general population, while persons no longer in
treatment have death rates twelve times higher than the comparable
group in the general population. Methadone patients who leave
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treatment appear to be more susceptible to overdose or other
drug-related calamities. Keeping patients in treatment until they
have a reasonable chance of remaining drug free appears to be not
only an important measure of success, but a life-preserving action.
One goal of the TRISEP study was to examine patient views
concerning treatment termination. Sixty-two percent of the
patients reported that they had given serious consideration to
leaving the program without the sanction of the staff. Reasons
given included the desire to be drug free, fear of the long-term
side effects of methadone, and anger at program rules, schedules,
or policies. Most patients who considered leaving, however, did
not follow through. When asked why they stayed if dissatisfied,
patients cited a sense of uncertainty about the future, fear of a
return to the street, or the monetary advantages of methadone
compared to street hustling.
It is interesting that although the safety of long-term methadone
administration has been demonstrated, many of the self-reported
reasons for leaving early or considering doing so are related to
fears about methadone's side effects. The perception that
methadone produces many serious side effects compared to heroin is
an important belief extant among both street addicts and current
methadone patients. The list of side effects reported is long and
often contradictory. Misinformation or lack of staff attention to
the perceived seriousness of these complaints appear to be factors
in early exit from methadone treatment, especially among the
compliant methadone treatment group.
Members of the methadone street group are more likely to leave
treatment due to disciplinary action by the program than
self-selection. These individuals may commit repeated infractions
of program rules concerning loitering, diversion of methadone, and
polydrug use and thus may have histories of disciplinary actions.
They may also leave programs due to incarceration for recent,
criminal activities. When disciplinary dismissals occurred, the
methadone street group members became agitated, and discussion
increased among the group about the program abuses and unfairness
of program policies. Such behavior within the group may
contribute to perpetuating the chronic lack of treatment
cooperation evidenced by this group. Released from treatment into
the community, methadone street patients are likely to escalate
polydrug use while adding street methadone and/or heroin to their
list of abused drugs.
The self-prescribing group members who are in treatment commonly
depart prematurely. These individuals report that the
physician-prescribed rate of dose reduction is not sufficiently
rapid and that they must therefore establish a self-determined
dose reduction regimen. In some cases patients may have saved or
hoarded methadone to continue their detoxification after the
planned departure. Because the self-prescribers have a rational
reason for leaving treatment, they are likely to be amenable to.
retention through thoughtful distribution of information and
policy changes such as self-regulated detoxification
opportunities.
15
Members of each reference group may leave treatment early for
different reasons. Consequently, intervention in premature exits
should be approached differently for each group. However, the
serious consequences of return to heroin use and increased risk of
death exist for all groups.
2. Loitering and Diversion
Loitering is often mentioned by program administrators as an
annoying clinic problem. Though often seen as synonymous with the
diversion problem, loitering is not necessarily related to drug
In the present study, loitering was found to be
predominantly a social activity, with only a small group of
elements routinely using the loitering site as a place to sell
their medication.
Methadone street group members are most involved in loitering in
the clinic area. These people congregate in areas close to the
programs, often in a snack bar or other eating establishment.
Members of the methadone street group will typically go into the
program about midmorning for medication, then go to the loitering
area and remain there for one to several hours afterward.
Individuals who loiter in the clinic area before and after
receiving medication are usually unemployed and often female.
This daily meeting is often the chief social contact for the
methadone street group members. They stay to socialize, to sell
methadone and other drugs. This group is a highly visible crowd
in the clinic vicinity and frequently the target of community
concern.
Some of the people in the loitering group are not patients in the
nearby clinic. Sociometric analyses of the loitering areas
indicated that a number of people in the loitering group are
ex-methadone patients and "street addicts" using the clinic
population as buyers of stolen merchandise or drugs and as sellers
of methadone. The core of the group, however, tends to be current
patients meeting daily who consider each other to be friends.
Related to the loitering problem is diversion of methadone by
clinic patients (Martin et al. 1973; Stephens and Weppner 1973)
often in the immediate vicinity of the clinic. "Street addicts:'
appear to be the most frequent customers for diverted methadone.
This was reported to be the case by the majority of patients
interviewed in the present study. Further, 50% of the street
addicts interviewed reported using illegally obtained methadone in
the week prior to the interview. Other sales are made to
self-prescribers and methadone street group members who are double
dosing.
A large percentage of patients in the TRISEP sample reported
selling medication while in their current treatment program,
although only a small portion appeared to be regular sellers. The
reasons for selling, however, vary with the group to which the
seller belongs. A methadone street group member may use money
from the sale of methadone to purchase other drugs of abuse
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(including extra methadone). A few methadone street group members
reported selling all their methadone to support heroin habits or
as a regular income source. It was also members of this group
with limited take-home privileges who sold "spitback" doses, i.e.,
doses held in the mouth at the medication dispensary and spit back
into a cup for resale.
In the compliant methadone treatment group, selling a portion of
one's take-home medication was considered legitimate under some
circumstances. These patients will sell or share their medication
with persons not in treatment if the buyer is using medication
either to avoid withdrawal sickness or to maintain a
self-regulated withdrawal regimen. The buyer may be a friend or a
relative and will almost invariably be known to the seller, while
the seller may be the only source of methadone for that particular
buyer. Interestingly, an occasional sale for financial gain is
also defined by this group as legitimate when the money is to be
used for family-related needs rather than for drug purchases.
In summary, the function and the circumstances of sales are quite
different in different reference groups. The methadone treatment
group may sell to regular customers, often to friends or relatives
not in treatment. The self-prescribing group members manipulating
their dosage on the program may also sell to self-prescribers not
in treatment or to the street addict buying methadone to alleviate
withdrawal rather than to get high. Overall, ethics prevail, and
it appears that sales of methadone are neither random nor
indiscriminate.
3. Polydrug Use
Earlier reports have suggested that methadone maintenance patients
exhibit substantial levels of polydrug use (Stephens and Weppner
1973; Cohen and Stimmel, 1978). Benzodiazepines and cocaine have
been identified as popular drugs of abuse in this population,
while alcohol abuse has long been reported in the treatment
literature (Carroll et al. 1977). The present study was designed
both to investigate the prevalence of polydrug use and to
delineate attitudes toward drug use among the reference groups.
Table 2 indicates the drug use of each group in the week prior to
interview. Use of heroin is generally limited to the "street
addict" group; over half of the street addict subjects reported
heroin use in the previous week. Although some patients in
treatment may also use heroin, in general, patients agreed that it
is neither safe nor cost effective to try to override methadone's
blocking properties by injecting high doses of heroin. Use of
cocaine, marijuana, and methadone is also frequently reported by
members of the "street addict" group. Occasionally, members of
this group report using other drugs such as diazepam or
amitriptyline. This usage is justified as medicinal, e.g., as a
sleeping aid. In general, these drugs are disdained as drugs of
pleasure.
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TABLE 2. ILLICIT DRUG USE IN WEEK PRIOR TO INTERVIEW
Heroin, Cocaine Metha- Barbitu- Ampheta- Benzodia-
done rates mines zepines*
Methadone Street Group (N=l77)
none 71%
once 16%
2-6 Xs 2%
7 Xs 4%
or daily
47% 83% 91%
23% 12% 4%
22% 2% 2%
7% 1% 2%
Methadone Treatment Group (N=185)
none 94% 81% 95%
once 5% 14% 5%
2-6 Xs ** 5% 0
7 Xs 0 ** 0
or daily
Street Addict Group (N=ll7)
none 48% 34% 50%
once 19% 28% 28%
2-6 Xs 22% 27% 19%
7 Xs 11% 9% 2%
or daily
Self-Prescribing Group (N=22)
none 77%
once 23%
2-6 Xs 0
7 Xs 0
or daily
73% 46%
9% 27%
13% 18%
5% 9%
96%
3%
**
**
90%
4%
4%
2%
91%
9%
0
0
95%
2%
2%
0
98%
1%
**
**
99%
1%
0
0
90%
0
5%
5%
52%
16%
23%
9%
83%
7%
11%
3%
75%
9%
12%
3%
73%
14%
5%
9%
Cannabis
45%
9%
14%
32%
41%
11%
28%
20%
45%
4%
21%
28%
27%
9%
28%
36%
* This category also includes reports of the use of amitriptyline
(Elavil), a drug popular in the New York area.
** less than 1%
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The methadone treatment group is characterized by the absence of
reported drug use except for marijuana and some cocaine. Both
marijuana and cocaine may be used recreationally and support of
this drug use does not usually require substantial criminal
activity. About 20% reported recent use of cocaine. Cocaine is
viewed as a highly desirable drug whose use connotes high status
and upward mobility of the user. Concurrently, this group views
methadone only as a medication rather than a euphoriant and
disdains the use of pills.
Members of the methadone street group typically use tranquilizers
and other pills as euphoriants. This can be seen in table 2 in
the high rates of reported recent benzodiazepine use. These pills
are readily available in the illicit drug market and relatively
inexpensive. Heroin may also be used as a supplemental drug of
abuse. Their use of drugs and attitude toward methadone as a drug
of pleasure clearly distinguish this group from the others and
are, in part, the basis for their negative status among the
groups. Benzodiazepines and alcohol may be used in combination
with methadone; patients report that such combinations can enhance
the effects of the methadone. On the other hand, prevailing lore
also indicates that heavy alcohol use increases the rate of
metabolism of methadone and thereby exacerbates withdrawal signs
prior to the next daily dose. Discomfort after heavy drinking may
also be due to alcohol hangover effects. The sheer quantity of
alcohol, sedatives, and tranquilizers which may be consumed by
this group explains much of the sedated appearance they often
display on the street.
SUMMARY AND CONCLUSIONS
Methadone patients can be distinguished into unique but
overlapping groups both quantitatively and through qualitative,
ethnographic data analysis. These groups operate in the setting
of treatment and dramatically affect patient behavior and
consequently, treatment outcome. Members are known to each other,
distinct norms govern interaction within and between groups, and
the behavior of group members is affected in the degree to which
the individual identifies with the group.
All groups are in contact with each other and the effect of that
contact appears to be mediated through commmon values and
behaviors and complementary needs. The street addict group serves
the methadone street group as dealers of illegal goods and in turn
uses them for income to support heroin habits. The
self-prescribing group members who are patients and the nonpatient
self-prescribing group members operate symbiotically: the
nonclinic member requires accurate, reliable supplies of methadone
which are best obtained from the methadone treatment or
self-prescribing group seller. The buyer and the seller often
share the same definition of drug use in those transactions in
viewing methadone as a therapeutic agent, thus perhaps diffusing a
sense of deviance in making sales. This is in contrast to the
street addict who often sells to the methadone street buyer and
views drugs as a way either of getting high or of making money, a
view the methadone street group member shares.
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Common goals and behavior such as these are important keys to
recruitment into or passages between each of the groups. Groups
which share the same definitions of drugs and similar use patterns
have important common ground, and it is the areas where values and
behaviors overlap which seem the most sensitive to membership
recruitment. The self-prescribing group member not in treatment
shares all of the characteristics of the methadone treatment
group, except participation in treatment program. Program
policies which can identify and reach the self-prescriber can
bring into treatment a potentially compliant patient. The
methadone street group member may begin to divorce himself or
herself from that group through an assumption of some of the
methadone treatment groups' behaviors and attitudes and perhaps
gain membership in the latter group. Potential members of each
group take on the characteristics and behaviors of the group in
anticipation of membership. Once a person becomes a member of the
group, the group norms and values become powerful referents for
behavior. In addition, the group members themselves become
powerful reinforcers of individual members' behavior.
While a fascinating study in reference group behavior, this study
has far more significant ramifications. The problems facing
methadone treatment programs are inextricably linked to these
groups and their interactions. The problem of loitering will not
be adequately dealt with by simply prohibiting loitering in the
clinic area because of the important social function loitering
serves for the methadone street group. The loiterers will
continue their behavior in a different place. The problem of
diversion may be alleviated somewhat by a 7-day pickup of
medication schedule for all patients. Unfortunately, however, the
methadone treatment group member and the self-prescribing group
member, the very patients clinics are most eager to keep, may
leave treatment prematurely because of such a policy. Similarly,
program activities or policies which put the methadone treatment
patients and the methadone street patients together may fail
because of the status antagonisms of these groups; participants
remaining in such activities will undoubtedly be the more idle
methadone street group members.
In short, problems in the setting of methadone treatment can not
be adequately addressed without a recognition of the impact of the
unique reference groups on individual behavior. Each group is
both an adaptation to methadone and to each of the other groups.
The delicate interfaces between groups, while affected by program
policy, are also maintained in a complex pattern of their own.
Intervention in the form of individual treatment contracting or
group intervention must consider the social organization of the
methadone setting in the development of successful contingency
planning.
20
REFERENCES
Agar, M. Ripping and Running: A Formal Ethnography of Urban
Heroin Addicts. New York: Seminar Press, 1973.
Brown, E.M.; Benante, J.; Greenberg, M.; and MacArthur, M. Study
of methadone terminations. Brit J Addict, 70:83-88, 1975.
Carroll, J.; Malloy T.; and Kendrich, R. Alcohol abuse by drug
dependent persons: A literature review. Am J Drug Alc Abuse,
4(81:293-315, 1977.
Cohen; M.J., and Stimmel, B. Amitriptyline (Elavill abuse in
persons on chronic methadone maintenance. In: Lowinson J., ed.
Critical Concerns in the Field of Drug Abuse. New York: Marcel
Dekker, 1978. pp. 403-404.
Cushman. P. Arrests before and during methadone maintenance. In:
Proceedings of the Fourth National Conference on Methadone
Treatment. New York: NAPAN 1972. pp. 487-488,
Des Jarlais, 0.; Dole, V.; Joseph, H.; and Smeidler, J.
Predicting Post-treatment Narcotics Use Among Patients
Terminating From Methadone Maintenance. Report to the New
State Division of Substance Abuse Services, 1978.
York
Des Jarlais, D. Research Design, Drug Use and Death: A Cross-
Study Comparison. In press.
DuPont, R.L. Profile of a heroin addiction epidemic. New Eng J
Med, 285:320-324, 1971.
Gearing. F.R. Successes and failures in methadone maintenance
treatment of heroin addiction in New York City. In: Proceedings
of the Third National Conference on Methadone Treatment.
Washington, D.C.: Public Health Publication No. 2172: 2-16,
1 9 7 0 .
Gearing, F.R. Evaluation of methadone maintenance treatment
programs. In: Einstein S., ed. Methadone, Maintenance.
New York: Marcel Dekker, 1971.
Gould, L.D.; Walker, A.L.; Crane, L.E.; and Ledz, C.W.
Connections: Notes from the Heroin World. New Haven: Yale
University, 1974
Johnson, B.D. "The Criminal Behavior of Street Heroin and Cocaine
Users." Presentations at International Institute on the
Prevention and Treatment of Drug Dependence, Austria, June, 1981.
Kaufman, E.A. A psychiatrist's views on addict self help
programs. Am J Psychiatry, 128:846-851, 1972.
Lowenson, J.; Ruiz, P.;  Langrod, J.; and Martinez, M. Consumer
input in the evaluation of drug addiction services. Int J
Addict, 16(1):165-171.
Martin,.R.; Jasinski, D.R.; Haertzin, C.A.; Kay, D.C.; Jones,
B.E.; Mansky, P.A.; and Carpenter, R.W. Methadone: A
re-evaluation. Arch Gen Psychiatry, 28:286-295, 1973.
Merton, R. Social Theory and Social Structures. New York: Free
Press, 1968.
Perkins, M.E., and Richman, A. Prevalence of participation in
methadone programs, Am J Psychiatry, 128:846-851, 1972.
Preble, E., and Casey, J.H.  Taking care of business--The heroin
user's life in the street. Int J Addict, 4:1-24, 1969.
21
Senay, E.C.; Dorus, W.; Goldberg, F.; and Thornton, W. Withdrawal
from methadone maintenance: Rate of withdrawal and expectation,
Arch Gen Psychiatry, 34 (March):361-367, 1977.
Stephens, R.C., and McBride, D. Becoming a street addict.
Human Organization, 35(l), 1976.
Stephens, R.C., and Weppner, R. Legal and illegal use of
methadone: One year later. Am J Psychiatry, 130(12):1391-4,
1973.
ACKNOWLEDGMENT
This research was supported by a grant from the National Institute
on Drug Abuse (1 H8l DA 02300-01) to Narcotics and Drug Research,
Inc., New York, and by the New York State Division of Substance
Abuse Services.
22
Treatment of Behavioral and
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With Opiate Dependence
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INTRODUCTION
Diverse problems and challenges confront the staff members of
programs/clinics intended to treat individuals with histories of
opiate use and associated problems. The clinic sponsored and
staffed by the Philadelphia Veterans Administration Medical Center
and University of Pennsylvania provides numerous examples of the
merits and problems of such treatment programs. The clinic's
patient population over the past decade has varied from two to
four hundred patients. A range of services is provided along with
pharmacological interventions including opiate-specific treatments
such as methadone, LAAM, naltrexone, and a variety of psycho-
therapeutic agents administered in treatment of diverse presenting
disorders. It should be noted that the clinic differs in some
respects from "standard" clinics insofar as it includes numerous
associated ongoing basic and applied research projects. There may
therefore be more options and staff available from time to time
but there may also be considerable variability uncharacteristic of
other clinics. In any case the clinic appears to have many of the
problems reported to prevail in other nonresearch clinics. It can
therefore be used as a reference in the sorts of issues which do
arise.
Patients entering standard treatment programs for opiate use often
display serious behavioral and psychiatric problems both within
and outside treatment programs. The successful management of
these problems is of great importance for both the patient and the
community. Failure on the part of a treatment program
successfully to control behavioral problems of its patients has
sometimes resulted in community pressure to close the program, and
in some cases this pressure has achieved its intended result.
Inadequate treatment of the psychological disorders of the opiate
user/patient has contributed to poor treatment response and
sometimes to premature termination from therapy.
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BEHAVIORAL AND PSYCHIATRIC PROBLEMS
Many of the behavioral problems demonstrated by these patients
originate from drug-seeking behavior which is, of course, a normal
part of the drug-using cycle. Patients may fabricate elaborate
stories to obtain prescriptions for a variety of controlled
substances, buy or sell illicit drugs, attempt to falsify urine
samples to avoid loss of take-home methadone doses, or attempt to
divert methadone at the pharmacy window.
A common problem viewed as serious by most program staff members
is loitering. Its origins and rewards are diverse. The most
common motive for loitering appears to be social contact (see Hunt
et al., this volume), but a considerable amount of drug dealing
also takes place when patients loiter. Persistent loitering can
serve as a nidus for the development of other behavioral problems
such as arguments or fights. The loitering and associated
behaviors can also be frightening to people who happen to be in
the vicinity and who are not familiar with the personalities and
lifestyles of the opiate-using patient population. Threats and
disruptive behavior including fighting may occur, and when clients
carry weapons, special problems are encountered.
These patients also bring with them to the clinic the full range
of social and family problems. Many are unemployed, have few
skills, and could likely benefit from training programs, although
questions as to how best to achieve the training are numerous
(e.g., see Hall et al. and Thompson et al., present volume). In
addition, problems with both family of origin and current family
may exist (e.g., see Todd, this volume). All of these problems
may or may not be related to the addiction or to other factors
such as personality disorders, psychiatric problems, or
socio-environmental circumstances.
As might be expected, the range of psychiatric disorders reported
in the general population has been observed in opiate-using
patients. Table 1 summarizes the Research Diagnostic Criteria
(RDC) diagnoses reported in a sample of 533 opiate users who were
given a thorough and careful psychiatric evaluation as part of a
study recently completed by Rounsaville et al. (1982). Depression
was the most common diagnosis, with about 60% of the sample having
had some form of depression at least once. The next most common,
problem was alcoholism, followed by antisocial personality and
anxiety disorders. Occurring with a much lower frequency were
schizophrenia, other types of personality disorders, mania, and
hypomania. Not included in this table but also seen regularly are
acute situational reactions which involve intense but transient
feelings of anger, anxiety, or depression; psychiatric disorders
complicated by medical conditions such as hepatitis; and illnesses
or injuries which produce chronic pain, such as pancreatitis,
sickle cell anemia, or trauma resulting in nerve root irritation.
The diverse medical, behavioral, and psychiatric problems observed
may be closely related to one another and interact to produce
constellations of complex disorders. For example, either
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Table 1
Lifetime Rates of Psychiatric Diagnoses
per 100 for Opiate Addicts*
Type of Disorder (n=4O3)
AFFECTIVE DISORDERS
Major depression
Minor depression
Intermittent depression
Cyclothymic personality
Labile personality
Manic disorders
Hypomanic disorder
Bipolar 1 or 2
Any Affective Disorder
SCHIZOPHRENIC DISORDERS
48.9
9.4
18.1
2.5
17.1
0:5
5.5
3.7
70.7
Schizophrenia
Schizoaffective, depressed
Schizoaffective, manic
0.7
2.2
0.5
ANXIETY DISORDERS
Panic 0.5
Obsessive-Compulsive 1.7
Generalized anxiety 4.7
Phobic 8.2
Any anxiety disorder 13.2
ALCOHOLISM
PERSONALITY DISORDERS
Antisocial personality
Briouet's syndrome
Schizotypal feaures
Other psychiatric disorders
37.0
29.5
0 . 0
8.7
5.7
SEX
(n=130)
69.2
5.4
20.8
6.9
14.6
0 . 8
10.0
10.8
85.4
0.8
0.0
0.0
3.9
2.3
7.7
13.9
25.4
26.9
16.9
0.7
7.7
10.0
*From: Rounsaville, B.J., et al. Heterogeneity of Psychiatric
Diagnosis in Treated Opiate Addicts. Arch. Gen. Psych.
(39):161-166, 1982. Copyright 1982, American Medical
Association. Reprinted with permission.
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antisocial personality disorder or addiction itself can lead a
patient to fabricate stories about psychiatric or other medical
problems in attempts to obtain prescriptions for controlled
substances; depression can result in chronic anger and hostile
behavior; and paranoia secondary to schizophrenia or amphetamine
psychosis can lead the patient to carry a weapon for "protection."
In other cases the behavioral and psychiatric problems appear to
be unrelated. Examples include anxiety attacks or schizophrenic
hallucinations which result in psychiatrically correlated
behavioral problems which are not characteristic of the typical
opiate user.
As seen from this brief overview, many combinations of behavioral
and psychiatric problems can occur in a methadone treatment
program. Comments throughout the remainder of the paper review
some thoughts on management and treatment of these problems. They
derive from the perspective of persons who are responsible for
directing a clinic very much invested in methadone maintenance but
with the adjuncts previously mentioned. In any case the comments
have a strong practical orientation,
GENERAL APPROACHES
The staff members of the treatment clinic have spent many hours
deliberating about and experimenting with various general and
specific approaches to management and treatment of patients'
behavioral and psychiatric problems. The strategy that has
emerged is one which uses external environmental controls combined
with procedures designed to change internal processes and
affective states. The external measures are primarily
behavioral-psychological, while the internal ones are mainly
pharmacological. The external interventions aim primarily to
punish certain behaviors and to reinforce others. These in turn
affect attitudes, or reduce the intensity of the affects and
impulses which are part of the problematic behaviors and
psychiatric disturbances demonstrated by the patients.
Clinic patients are similar in many ways, but dissimilar in
others. In this combined approach it is essential to diagnose the
problem correctly in order to make the appropriate response. For
example, a primary focus on behavioral controls and limit-setting
can be destructive for patients who are primarily depressed, but
it can be constructive for patients who are displaying only
sociopathic behavior. Thus the needed strategies and arrangements
to maximize reinforcement must be individualized as well as being
established for the clinic as a whole.
The first treatment priority is often control of the behavioral
problems because they can be detrimental to the entire program,
including staff. The techniques used focus on three potentially
problematic target behaviors: (1) loitering, (2) drug dealing or
other forms of drug-seeking behavior, and (3) disruptive or
aggressive behavior. Many drug treatment programs implement
specific techniques that are aimed to modify these behaviors, and
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the techniques are usually implemented from specific behavioral
guidelines presented in the form of general program rules.
Treatment occurs within the program milieu, and it is necessary to
consider certain aspects of it that contribute importantly to the
success or failure of the specific techniques used. The milieu
includes the physical location, appearance, and design of the
program facilities, as well as the attitudes, hierarchies, and
power structures that exist within the staff.
The physical layout of programs can vary tremendously and may
include storefront clinics, medical offices in separate buildings,
and offices in both general and psychiatric hospitals. Drug
treatment programs can be located in urban or rural areas and
their level of maintenance can vary from exceptionally clean to
extremely insanitary. The formal and informal power structures
within the staff, and the way patients and staff interact, form
another important part of the milieu. In combination, these
factors determine the success of treatment.
A VIEW OF CLINIC ADMINISTRATION
From the onset, the administrative structure that will be used to
run the program must be clearly established and made known.
This step may sound trivial, but it is extremely important. Drug
abuse programs typically have both professional and
paraprofessional staff who work together to solve many complicated
problems, and competition or role diffusion often occurs.
Similarly, the contributions to general policies and to program
rules that can appropriately be made by patients and staff members
are sometimes unclear, especially concerning issues of the degree
of authority and administrative latitude accorded to the group.
The administrative structure that has been found to be effective
in the Philadelphia VA Medical Center clinic is fairly standard.
It is a hierarchical organization which involves differing levels
of power and responsibility for various categories of people
within the program. Examples of these levels are a service chief,
senior program staff member, nurse, counselor, and patient.
Patients should have input into the formation of rules and
policies, but the program staff must retain the authority to-make
final decisions. The hierarchy of responsibility and authority
should begin with one person who is clearly identified as being in
charge and given the authority to act accordingly and is also the
one held responsible if problems occur. Job descriptions and
delegations of authority must be clearly specified. Regular staff
meetings must be held in which management and clinical issues are
discussed and comment from all staff members can be used in making
decisions and in setting policies. These meetings serve to unify
and coordinate program activities.
Patients often request a democracy, or accuse the administration
of being dictatorial when administrative decisions are made
unilaterally. However, a "democracy" can pose very difficult
problems in a methadone program. One of these is that the
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drug-seeking behaviors among the patients are often so intense
that there is a strong tendency to attempt to use "democracy" to
manipulate the system in order to obtain extra supplies of drugs
or whatever other tangible rewards are be available in a manner
that subverts the prevailing rules or contingencies. Other
serious problems can occur in situations where rules must be
enforced and patients disciplined. Attempts to implement
democratic forms of government within this population have been
numerous. For example, a committee (the "Judicial Committee") was
established that consisted of patients and staff members whose
purpose was to hear the comments of all interested parties in
situations where program rules had allegedly been violated. It
was never clear that the committee was very effective. Rarely did
the committee agree on whether rule infractions had occurred. The
deliberations often took hours and required large amounts of staff
time, and meaninful punishment (such as suspension from the
program) almost never occurred. After trying very hard to make
this committee work for almost 2 years, it was disbanded and a
much more authoritarian approach to problems was taken. It
resulted in more penalties and more success in controlling
behavioral problems.
There must be written program rules which consist of explicit
guidelines for conduct with specific penalties for violations.
The rules should be carefully formulated by the combined efforts
of staff with comment from patients. Penalties should, of course,
be graduated according to the severity of the offense. The rules
are helpful to both patients and staff, because they provide a
consistency and uniformity of consequences for behavioral
problems. The rules should be explained to all patients when they
are admitted to the program, and patients should sign a copy which
is then placed in their chart. The rules should also be conspicu-
ously posted in the clinic. Program rules can be modified if
necessary, but only after a similar throughtful and deliberate
process.
Many of the specific rules used by programs will vary depending on
the local situation. For example, the program discussed herein is
in a separate building remote from the main hospital. One of the
results of reducing loitering in the clinic and in the immediate
vicinity was that patients spent considerable time and caused some
difficulty in the cafeteria of the main hospital. Therefore
specific rules were developed governing appropriate and inappro-
priate use of the cafeteria. Many programs such as those located
in storefront clinics rather than general medical centers have no
need for such rules.
As noted earlier there must be a clear line of authority that is
consistent and readily understandable to both patients and staff
if the established rules and policies of the clinic are to be
meaningful. It must be expected that patients will "test the
limits" of the system and this will result in "going to the top,"
especially when serious problems develop, including cases
involving suspension. Good communication among staff members and
clear policies for review of patient requests to speak with people
at higher levels of authority are necessary in these situations.
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As in any treatment setting, all aspects of activity including
infractions of rules that occur must be documented clearly. In
publicly funded facilities, legislative or congressional inquiries
about response to specific incidents may occur and accurate
documentation is essential. In addition some patients in drug
treatment programs are expert "jailhouse lawyers," experienced at
casting a reasonable doubt upon any evidence of illicit behavior
on their part. In some cases they may have been through similar
procedures on repeated occasions during appearances in court.
Thus, it is not uncommon for patients frankly and adamantly to
deny engaging in a problematic behavior that has been witnessed by
reliable staff people. On the other hand, many patients have been
subjected to arbitrary, discriminatory, and unfair treatment by
people in authority, and it is essential that this pattern not be
repeated by the program. Thus, all alleged infractions of program
rules must be examined thoroughly so that a fair and appropriate
decision concerning consequences may be made.
The chief administrator and the administrative system must, of
course, maintain staff morale. Actions that successfully deal
with problematic patient behaviors build and maintain morale,
while lack of control of behavioral problems has the opposite
effect. Morale is strengthened by providing staff regular
opportunities to contribute to decisions, by encouraging
discussion at the regular staff meetings where clinic policies,
rules, and management problems are reviewed.
Inservice training sessions can make an important contribution to
morale by providing the staff members with opportunities to
develop professionally. This can be done in a variety of ways,
the most direct one being a weekly presentation of topics related
to the problems that are treated by the program. These can
include sessions about family therapy, high- vs. low-dose
methadone treatment, jobs programs, how to use psychotropic
medicines, current issues in the criminal justice system, and many
other topics.
It is essential that the administrators spend time working on the
procedures that are necessary for program operations, such as
scheduling hours, secretarial coverage, treatment manuals, and
directives that the staff use in their daily work. These measures
can be very helpful to staff morale via their organizing and
supporting effects.
Finally, it is helpful to develop a clinic manual that defines and
describes counseling duties. This manual should include
guidelines for making treatment plans, making clinical notes,
procedures for using ancillary medicines and for implementing
clinic take-home policies. These written guidelines provide a
framework that the counseling staff can use in formulating a
unified approach to patient management.
Ideally the physical setting should be one that permits reliable
provision of treatment and makes it easy to enforce rules. For
example, it is sometimes difficult to have a methadone treatment
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program located in the main traffic area of a general hospital.
This may, depending on the characteristics of the drug patient
population, lead to difficult interactions between addicts and
other patients or hospital staff. Some feel that the ideal
location for a drug treatment program is in a separate building
which patients can enter without having to pass through other
office or clinic areas. If this situation does exist, the
building should have a waiting area that is comfortable yet highly
visible. Patient access to treatment areas should be easily
controlled by a clinic secretary or other staff via locks with
buzzers or other appropriate traffic control devices. This type
of physical design will facilitate control of patient traffic
within the building, and this decreases the chances for behavioral
problems within the clinic. On the other hand, it must be
recognized that while a separate facility may have fewer Obvious
problems, it may simply be the case that the problems such as
loitering are being displaced to other locations. It is most
helpful to have a staffing pattern which includes people trained
to manage the different behavioral and psychiatric problems that
may occur. This includes counselors, medical personnel,
secretaries, and depending again on the nature of the facility and
patients, police. In general the important issue is that the
clinic have well trained personnel for all the services it
provides. If, for example, the clinic does not have professional
job counselors, it should refer clients elsewhere for this
service. Excellence in available services rather then diversity
of services is probably important in reassuring patients
concerning treatment.
Finally, it may at times be necessary to use legal sanctions, in
addition to the program rules, for the more serious problems such
as threats, weapons offenses, thefts, or fights. Since methadone
programs are under Federal control, it can be valuable to work out
an informal liaison with the Federal criminal justice system so
that formal charges can be filed in situations where serious
behavioral problems have occurred. Thus, in addition to
suspension from the program, patients can be fined or may actually
go to jail for certain offenses. When patients know that this
process exists and that it will be used, problems occur less often.
Implementation of these clear guidelines has decreased problems in
the vicinity of the clinic, although success in eliminating some
problems is not as clear. In some instances, the behaviors are
suppressed in the clinic area but transferred to another
location. For example, some of the patients stopped loitering
around the hospital but moved to a fast food restaurant located
nearby. This shift of problems from one locale to another may
limit their occurrence, but it indicates that these measures are
far short of being curative. Nevertheless, they can have the
positive effect of maintaining a therapeutic milieu within the
immediate vicinity of the treatment program, and in developing
positive regard for the program in the community.
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APPLYING BEHAVIORAL CONTROLS TO SPECIFIC INDIVIDUALS
Careful thought should be given to application of behavioral
control techniques, especially when dealing with "problem
behaviors" as opposed to development of adaptive behaviors leading
to positive consequences. Patients who are often angry must be
approached in ways that will maximize the chances of their
benefitting from the sanctions to be applied, and minimize the
chances for destructive acting out of their anger. Some of the
patients are truly dangerous, and their potential for aggressive
acting out should always be kept in mind. HOW the patient is
approached is an extremely important factor for the safe and
effective management of these situations. Several therapeutic
guidelines may be helpful in these cases.
First, it is important to be open and nonjudgmental when
discussing the specific infraction with the patient/violator.
This should be done in a matter-of-fact, nonhostile manner, and he
should be given the opportunity to express his point of view about
the situation. This approach will minimize the chances for
aggressive acting out by the patient. The patient may complain,
but the complaints should not cause serious problems when things
are consistent, open, and direct, and when he feels that sincere
and honest efforts have been made to assess the situation
accurately and to treat him fairly and in accordance with the
program rules. .
Thus one communicates a sense of firm and consistent limits,
combined with the feeling of underlying support and some degree of
flexibility about the exact timing of his expulsion from the
program. The message that seems important to communicate when
problem behaviors arise is, "We are very concerned with you and
your treatment, but you must understand that certain behaviors are
unacceptable and cannot be tolerated." Support is very important
for this population. Many people have written about the necessity
to provide support for drug-dependent individuals, and this
clinic's experience is consistent with these observations.
Many details have been omitted in the above discussion, such, as
comments about collecting urine specimens, pharmacy dispensing
procedures, and specific techniques for control of patient traffic
flow in the clinic area. Guidelines for these aspects of program
management are also important, and many of them are specified in
FDA or DEA regulations or are found in clinic treatment manuals or
regulations used by the hospital police force.
TREATMENT OF PSYCHIATRIC PROBLEMS
The psychiatric problems experienced by addicts are important
contributors to overall treatment outcome; thus psychiatric
treatments can make important contributions to a program's
effectiveness. Some psychiatric problems appear closely related
to drug dependence, and in these cases one problem cannot be
brought under good control without effective treatment of the
other (McLellan et al. 1979). In general, the psychiatric
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problems of drug-dependent patients are treated in the same way
similar problems are treated in non-drug-using psychiatric
patients. This view and approach are empirical and do not derive
from experimental evidence but do seem reasonable. Commonly
observed psychiatric conditions are considered below.
Anxiety is one problem commonly observed, particularly in patients
who have recently undergone withdrawal. The condition may have a
different physiological basis from that observed in other patients
with an anxiety disorder. However, post-detoxification anxiety is
usually treated with a combination of supportive counseling or
psychotherapy and psychotropic medications, much as it is treated
in general psychiatric patients. Anxiety may also occur during
the course of maintenance treatment and can be treated with
psychotherapy, counseling, family therapy, biofeedback or relaxa-
tion exercises, or with anti-anxiety medications. These
treatments can be used separately or in combination. Anti-anxiety
medications are usually monitored very closely with these patients
because there is a much higher risk of improper use or abuse than
is seen among general psychiatric patients. The anti-anxiety
medications that appear to be most effective are the
benzodiazepines. Diazepam (Valium), however, appears to have high
abuse potential in this population, and thus it is used under very
specific conditions or not used at all. Examples might be
patients being maintained on very low doses of methadone who are
in regular contact with their counselors and who have consistently
drug-free urines; or patients who are detoxified and keeping
regular clinic appointments; or patients who are being treated
with a narcotic antagonist such as naltrexone. Oxazepam (Serax)
is a frequently used benzodiazepine  which appears to be effective
and which does not seem to be abused or misused to any significant
degree.
Depression in its various forms appears to be even more common
than anxiety disorder in drug-dependent and post-drug-dependent
patients. These include major, minor, and intermittent depressive
disorders. Depressive illnesses seen in drug-dependent patients
are often precipitated by disruptive life events, and they
commonly have a significant anxiety component. Depression in
these patients is usually not as severe as that seen on general
psychiatric inpatient units, and it appears to respond to
counseling, psychotherapy, or antidepressant medications.
Favorable results have been obtained with administration of
doxepin, a sedative type antidepressant, when used in combination
with counseling and psychotherapy (Woody, 1982). Doxepin appears
to help control the symptoms of anxiety and depression that are so
often found in these patients, and it also appears not to have any
significant abuse potential. It is unclear whether the apparent
positive effect of doxepin with this population is due primarily
to its anti-anxiety or to its antidepressant effects; however, it
seems to be a useful drug.
Sociopathic behavior is another common and serious problem, and
our best treatment for it is to control and structure the milieu
via clear and consistent rules. Treatment contracts emphasizing
aversive control are sometimes used for patients demonstrating
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sociopathic behavior or for selected patients without sociopathy
who appear to be doing poorly in spite of our best efforts to help
them through traditional psychotherapeutic strategies. These
contracts call for the patient to engage in certain behaviors
within a specific time period or face suspension. Patients who
fail to comply with the conditions of the negative reinforcement-
based treatment contracts have the option of detoxification or
transfer to another program. About 50% of patients given a
treatment contract fulfill its conditions.
Alcoholism is another common problem in this population, and it is
one which we have not been able to treat very effectively.
Counseling combined with regular verification of nondrinking,
using breath testing and sometimes disulfiram (Antabuse) is
typically used with these patients. Treatment contracts are also
used with alcoholics, and those patients who fail their contracts
are usually advised to enter an inpatient alcohol treatment
facility. These patients are also encouraged to attend meetings
of Alcoholics Anonymous or engage in other therapeutic activities.
Schizophrenia is observed only infrequently in this population but
it can be quite disruptive not only for the patient but for other
patients and staff members' efforts to maintain the clinic as a
therapeutic environment for others. Almost every case of
schizophrenia we have seen has been of the paranoid type.
Patients with this disorder are usually treated with
phenothiazines, often in the liquid form which can be mixed with .
the daily dose of methadone. It is important to mention that
methadone itself has some antipsychotic effects; it appears to
have a sufficiently positive psychotropic effect in some
schizophrenic patients to make other medications unnecessary.
Patients with manic depressive illness (Bipolar I or II) are seen
infrequently. They are usually treated with lithium or with
combinations of phenothiazines and antidepressants, as are
nonaddicted manic-depressives (Kleber et al. 1983). Special
attention must be given to monitoring compliance if the patient is
treated with lithium because of the narrow margin between the
therapeutic and toxic dose. Patients taking it must thoroughly
understand its dangers and how important it is to take it exactly
as prescribed. Compliance with the regimen is probably encouraged
if patients know that lithium cannot produce euphoria and that
extra doses will only lead to severe adverse reactions.
Drug dependence generated by administration of analgesics for
medical problems involving pain is seen occasionally. Patients
with chronic pain often have significant depression and can be
treated with an antidepressant plus psychotherapy and relaxation.
Amitriptyline HCl (Elavil) may be especially helpful for these
patients, since it appears to have a mild analgesic effect;
however, it has some degree of abuse potential, and compliance
should be monitored carefully.
One serious problem seen occasionally is persistent opiate drug
use in patients who appear to be maintained on doses of methadone
that are more than sufficient to suppress withdrawal symptoms and
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which also provide some degree of narcotic blockade. In these
cases we will often raise the dose to the highest allowable levels
(80-100 mg/day). Sometimes this process is also combined with a
treatment contract.
RESEARCH IN CLINICAL SETTINGS
An important situation that is worthy of comment is the interface
between research and clinical work when both are performed in the
same setting. The coordination of research projects with the
clinical work is extremely important in these situations.
Competition between clinical and research staff can occur if this
interface is not monitored and cultivated. Lack of coordination
between research and clinical programs can cause treatment or
research staff to feel resentful, and both programs can suffer. A
problem from the therapeutic perspective is that clinicians may
have trouble dealing with the unknowns, e.g., placebos, that are
part of many research projects. Clinical staff feel most
comfortable doing something that will provide known, direct and
tangible benefits. They may also feel uncomfortable with the
basic supposition of research, which is that the most effective
treatment is not known, that several therapeutic approaches will
be examined and that these results will then be evaluated to
delineate an improved treatment. These problems can usually be
managed by explaining to clinical staff placebo effects, the
purposes of research, how there is always a degree of experi-
mentation in medical practice, what the purposes of the specific
study in question are, and especially how it may improve
treatment. Conversely, research staff may have trouble under-
standing or appreciating the interpersonal and unpredictable
aspects of clinical practice which in fact arise from the same
source; that is that diverse aspects of traditional therapeutic
strategies are poorly understood. Regular meetings of the
research and the clinical staffs will usually resolve problems
that arise in this clinical/research interface. The benefits that
may result from integrating research into a busy clinical program
are considerable, and careful attention to these potential
problems is well worth the effort.
SUMMARY
Many difficult and complex behavioral and psychiatric problems can
occur in a methadone treatment program. Some behavioral problems
are very serious, and it is essential that the program place a
high priority on controlling them. This is best done by
structuring the treatment milieu via program rules. Careful
attention must be paid to consistent, fair, and accurate
enforcement of these rules. A proper staffing pattern is
essential; this should include counselors along with medical,
administrative, and pharmacy personnel, and police. Written
policies explaining clinic procedures such as treatment plans, use
of ancillary medications, and take-home policies are most
helpful. They provide structure for the staff and increase the
chances that work will be done in an organized and consistent
manner. The physical facility may have features which either
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enhance or interfere with treatment and must be taken into account
when planning. Attention should be paid to accurate diagnosis and
treatment of the patients' psychiatric, behavioral, and social
problems, and staff morale must be maintained. The best general
ingredients for good patient management appear to be a combination
of structure and support, applied in a systematic and coordinated
way by a well-trained staff.
clinical efforts may present
benefit in most programs.
Finally, integration of research and
unique problems but has considerable
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The Role of Behavioral. Contin-
gency Management in Drug
Abuse Treatment
George E. Bigelow, Ph.D., Maxine L. Stitzer, Ph.D., and
Ira A. Liebson, M.D.
The purpose of the present paper is to provide an overview of the
role of behavioral contingency management procedures in drug abuse
treatment contexts. The paper is organized so as to provide
initially a discussion of the nature of a behavioral conceptuali-
zation of drug abuse, then to provide a brief review of some ap-
plications of contingent behavioral procedures to drug abuse prob-
lems, and finally to provide a discussion of some of the practi-
cal problems faced in implementing these procedures and of some
of the potential future directions for work in this area.
AN OPERANT BEHAVIORAL CONCEPTUALIZATION OF DRUG ABUSE
The value of any conceptualization of drug abuse lies in its
ability to guide us to a valid scientific understanding of the
determinants and controlling variables of the disorder and there-
by to enable us to intervene effectively in either preventive or
treatment modalities. The operant behavioral conceptualization
of drug abuse is of value both in a definitional sense of speci-
fying what drug abuse is -- i.e., what is the appropriate target
of drug abuse treatment -- and also in the functional sense of
specifying a range or domain of controlling variables which can
be expected to influence this target. As will be described more
fully below and elsewhere in this volume, this focusing upon ob-
jectively specified target behaviors and upon functionally defined
classes of controlling variables has made the operant behavioral
approach to drug abuse a productive one, both in terms of advances
in scientific understanding and in terms of practical therapeutic
applications.
Operant behavior is behavior which is controlled by its conse-
quences. when drug abuse is viewed as operant behavior we are
forced to specify precisely what behavior constitutes drug abuse
and we are forced to look for maintaining consequences of that
behavior. Examination of the range of substance abuse disorders,
of both the experimental and the clinical data concerning these
disorders and, in particular, of the commonalities within and
between substance abuse disorders (cf. Griffiths et al. 1980)
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leads us to conclude that: (1) drug abuse can be productively
viewed as consisting of the behavior of drug self-administration;
(2) this behavior is maintained by the pharmacological effects of
the drug; and (3) this behavior is influenced in predictable ways
by manipulations of behavioral contingencies in the same fashion
as other classes of operant behavior.
What is the scientific basis for this conceptualization? And,
what are the practical implications for prevention and treatment?
Scientific Basis
The primary scientific basis for this behavioral conceptualization
of drug abuse comes from the experimental! animal drug self-admin-
istration laboratory and from comparisons of these basic labora-
tory data with data concerning human drug self-administration and
drug abuse. These comparative data have been reviewed extensively
elsewhere (Griffiths et al. 1980), and only the conclusions will
be briefly summarized here:
1. The same drugs which are abused by humans tend to be self-
administered by animals in experimental studies . Thus, opioids ,
sedatives, and CNS stimulants all have been shown to sustain
self-administration in a variety of species and have been found
to be abused by humans. Conversely, a variety of compounds (e.g.,
opioid antagonists, certain anorectics) which have molecular
similarities to abused drugs, but which are not self-administered
by experimental animals, are not significantly abused by humans.
This finding of cross-species generality in drug self-administra-
tion suggests that it is the pharmacological characteristics of
the compounds (and not the personal characteristics of the indi-
vidual organisms) which determine the reinforcing efficacy of
drugs.
2. The temporal patterns of drug self-administration tend to be
similar in animals and in humans. While different pharmacological
classes of drugs are characterized by distinctively different
patterns of intake over time there exists a remarkable across-
species generality in the temporal patterns of self-administra-
tion. For example, ethanol self-administration in both animals
and humans is characterized by spontaneous wide fluctuations in
intake, with several-day periods of voluntary abstinence (even
in the presence of objective withdrawal signs) alternating on a
somewhat irregular basis with several-day periods of heavy con-
sumption. On the other hand, opioid self-administration in both
animals and humans is characterized by a relatively steady level
of intake, with a gradual increasing trend presumably due to
tolerance development, but without periods of spontaneous ab-
stinence. These dual findings of between-drug differences but
across-species similarities in the temporal patterns of drug
self-administration serve to emphasize the importance of the
specific pharmacological characteristics of a compound as a
potent determinant of drug self-administration and drug abuse.
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3. The controlling variables of animal drug self-administration
and of human drug abuse are similar. For example, manipulations
of such variables as the drug dose, the response requirement (i.e.,
effort) required to obtain doses, and the scheduled consequences
of drug use versus drug abstinence behaviors all tend to have
similar effects in animal experimental settings, in human experi-
mental settings, and in clinical drug abuse settings. This
across-species generality to humans of relationships observed in
the basic animal operant behavior laboratory argues in favor of
the applicability of this operant behavioral conceptualization to
human drug abuse problems.
4. The influences of many controlling variables upon drug self-
administration are similar-across the different pharmacological
varieties of drug abuse. That is, self-administration of pharma-
cologically dissimilar classes of compounds is often altered in
a similar fashion by a given experimental variable. For example,
variations in the drug dose, the response requirement to obtain
doses, or the scheduled consequences of drug use versus drug ab-
stinence behaviors may exert similar effects upon self-adminis-
tration of opioids, sedatives, stimulants, etc. This across-drug
similarity in the nature of the controlling variables has served
as a basis for arguing for a general construct of substance abuse.
These data can also be used to argue that drug abuse can best be
understood and influenced by viewing it as an instance of an even
more general construct -- that of operantly reinforced behavior
in which the drug functions as the reinforcer, the maintaining
consequence which sustains the behavior. The utility of this
conceptualization is that it ties drug abuse to an extensive
reservoir of scientific knowledge concerning factors which in-
fluence behavior, and it provides guidance to the researcher or
the practitioner concerning the classes of variables to which one
might profitably attend in an effort to modify drug abuse behavior.
Implications
This behavioral conceptualization has implications both for our
specification of therapeutic target behaviors which we wish to
change and for our search for a domain of controlling variables
which we can work with or influence in order to produce these
desired changes.
It is important to recognize that the central and common objective
defining element of all the substance abuse disorders is the be-
havior of substance self-administration. Thus, the central goal
of drug abuse treatment should be the reduction of drug self-
administration. To the extent that the therapeutic focus is upon
the many other collateral problems which are commonly observed in
drug abuse clients, one is not treating drug abuse, but rather
those other problems. It is quite possible that therapeutic ef-
forts which impact upon these other areas will result inchanges
in drug use also. The point being made here is that if one wishes
to evaluate the efficacy of drug abuse treatment, one must assess
drug use outcomes and not rely upon assessment of hypothesized
intermediary processes.
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In essence this behavioral conceptualization holds that drugs of
abuse exert actions which are intrinsically biologically reinforc-
ing to organisms. According to this view drug self-administration
behavior is a biologically normal and orderly process similar (in
a scientific sense) to many ‘other varieties of operant behavior.
To the extent that pharmacological reinforcement by drug actions
is a potent explanatory mechanism for understanding the develop-
ment and maintenance of drug self-administration behavior, then
one need not hypothesize the existence of unique individual or
environmental circumstances as necessary for inducing and main-
taining drug abuse. Once the behavior of drug self-administration
is established, the drug itself can function as an adequate rein-
forcer to sustain continued self-administration. If one views
drug self-administration as being reinforced and sustained by
normal behavioral/biological processes, then it may be appropriate
to ask what characteristics of the non-drug-abuser’s history/en-
vironment have protected against the development of abuse rather
than to search for factors which have produced it in the abuser.
In terms of what this behavioral conceptualization tells us about
the classes of variables which we might expect to be effective in
modifying drug self-administration, several possibilities are
suggested. First, treatment might focus upon modifying the ante-
cedent circumstances -- i.e., the conditions of drug availability.
In general, this domain of influence is more characteristic of
the law enforcement/legal regulation approach to drug abuse con-
trol. Certainly, ease of access to drugs of abuse would appear
to be one very important element influencing the prevalence of
drug abuse problems. Typically, this is not a set of variables
over which a therapist is likely to exert significant control.
However, residential treatment programs which remove the patient
from environmental circumstances of drug availability are utiliz-
ing this approach, and the observation that drug abuse is reduced
by changing the location of a drug abuser’s residence in the
community (Maddux and Desmond 1982) is certainly supportive of
the importance of this class of variables.
Second, treatment could attempt to alter the pharmacological re-
inforcing consequences of drugs of abuse. This is the approach
attempted when one uses pharmacological interventions to block
or alter the drug effect (e.g., narcotic antagonist treatment of
opioid abuse, or disulfiram treatment of alcohol abuse). This
general approach is also attempted, though with much less success,
when one uses behavioral conditioning procedures to establish
conditioned responses to drug administration which reduce the
drug’s reinforcing efficacy.
Third, treatment might focus upon the nonpharmacological conse-
quences of drug self-administration or drug abstinence in an
effort to influence the future probability of those behaviors.
This is an approach which shows considerable efficacy in research
studies and considerable promise for therapeutic application.
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Finally, since the behavioral conceptualization of drug abuse
views drug self-administration as just one element in an individ-
ual’s overall behavioral repertoire which is occurring excessively,
it may be useful to examine the total behavior of the individual
and to attempt to reduce this undesirable behavior in a competi-
tive fashion by intervening to promote or develop other more
desirable behaviors. This is the approach which is taken when
drug abuse treatment attempts to promote education, employment,
social functioning, etc., or otherwise to correct skill deficits
or increase desirable prosocial behaviors.
TREATMENT GOALS
There are two points to be made concerning the goals of applying
this operant behavioral approach to problems of drug abuse -- one
has to do with the selection of specific target behaviors for
modification, and the second has to do with the procedural ele-
ment of positive reinforcement which is characteristic of this
approach.
Target Behaviors
The above discussion, which emphasizes the view that drug abuse
is a problem consisting objectively of excessive and/or inappro-
priate drug self-administration behavior, would certainly suggest
that the goal of drug abuse treatment is to modify that behavior.
This is certainly the case; but therapeutic goals are often not
limited only to this domain. In clinical drug abuse treatment
settings one encounters problems considerably in excess of drug
self-administration. Drug abuse is a disorder with which a very
wide variety of collateral behavioral problems are commonly
associated -- such problems as poor education/employment skills,
impaired social/marital behavior, criminal activity, psychiatric
disturbance , etc. In emphasizing the importance of drug-taking
behavior as the critical aspect of drug abuse we do not wish to
minimize the importance of addressing these collateral problems
when treating drug abuse patients.
We do, however, wish to make a very clear distinction between
treatment of drug abuse and treatment of the drug abuser. We
would argue that in the treatment of drug abuse the critical out-
come variable is drug self-administration behavior. Both on a
diagnostic and on an outcome assessment basis we feel it is
crucially important to gain some measure of this behavior (usually
indirectly via biological sample analysis -- e.g., urinalysis).
On the other hand, drug abuser patients may present with a variety
of collateral problems other than drug abuse itself which are
themselves warranting of treatment. We would emphasize, however,
that treatment of these other problems, while desirable, does not
in itself constitute treatment of the drug abuse problem unless
drug-taking behavior itself is changed. Still, one’s goal in
drug abuse clinics is to treat the drug abusing individual, not
only to treat the drug abuse disorder itself. Thus, depending
upon the characteristics of individual patients, it may be
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appropriate to focus therapeutic attention upon any among a diverse
array of target behaviors -- of which drug abuse itself is just
one.
It should be noted that the functional basis for the relationship
between drug abuse and collateral disorders is not understood at
this time. There is, of course, considerable speculation that
there is a contributing or even causal relationship between these
different problems. However, interestingly, there is not agree-
ment upon the direction of this influence. Some individuals argue
that it is fruitless to attempt to treat the drug abuse problem
without first (or concurrently) correcting collateral disruptive
lifestyle problems -- thus implying that the drug abuse is at
least in part caused by these collateral problems, At other times
it is argued that it is fruitless to attempt to treat the collat-
era1 disruptive lifestyle problems of drug abusers without first
achieving drug abstinence -- thus implying that the collateral
problems are at least in part caused by the drug abuse. Of
course, there may be truth to both positions. At the present
time, however, we are simply able to note the correlation between
drug abuse and other problems and to suggest that treatment pro-
grams must be prepared to address a range of therapeutic problems
among drug abuse patients, including but not limited to drug abuse
itself. Ultimately the therapeutic goals of drug abuse treatment
will be to produce improvements in as many problem areas as
possible for individual patients.
One advantage of the operant view of drug abuse is that this
places the disorder within a broader behavior analytic and thera-
peutic framework which has generality beyond drug abuse per se,
and which is applicable to understanding and treating the diverse
array of disorders with which patients may present. That is,
operant behavioral approaches can provide treatment programs with
both a conceptual basis for understanding and a practical pro-
cedural basis for influencing a wide range of target behaviors
which are of concern in the drug abuse clinic and among drug
abusing patients. Thus, this is an approach which is fully com-
patible with the practical clinical necessity of individualizing
the selection of specific treatment goals to be pursued with
individual patients.
Positive Reinforcement
Positive reinforcement, in its technical definition, is the pre-
sentation of some consequence to a behavior which increases the
probability of recurrence of that behavior; in informal, nontech-
nical language it is a reward procedure. An emphasis upon posi-
tive reinforcement procedures is characteristic of operant be-
havioral approaches: This is an emphasis which, in general,
distinguishes the operant behavioral approach from other thera-
peutic modalities. It is one of the therapeutic goals of the
operant approach to develop and implement positively reinforcing
procedures for encouraging and promoting desired behavior change.
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The implementation of positive reinforcement procedures can have
a desirable effect upon the therapeutic and social atmosphere of
a treatment program. It is unfortunately often the case that in
drug abuse clinics the nature of the relationship between patients
and the clinic can be a rather coercive and aversive one. Clinics
often establish rules regarding standards of behavior and thera-
peutic progress which are difficult for patients to satisfy, and
a pattern can develop in which some patients become characterized
as chronic “failures” who are repeatedly berated, threatened with
treatment discharge, and perhaps ultimately ejected from treatment
for noncooperation or obstreperousness. On the other hand, the
clinic (especially, for example, a methadone clinic) controls and
dispenses a commodity (i.e. , methadone) which is of considerable
importance and desirability to patients; consequently, a pattern
can develop in which some patients engage in various forms of
manipulativeness and deception in order to alter their methadone
dose or schedule or to preserve their treatment program enrollment.
The use of positive reinforcement techniques can reduce the
threats and manipulativeness which can occur between staff and
patients, and can provide a context within which patients can
succeed in achieving goals and be positively reinforced for that
achievement rather than facing threats and punishments for failure
to make the desired therapeutic progress. Explicit description
of the behavioral contingencies can be a positive contribution to
clinic operation; it can serve to reduce much of the manipulative-
ness , emotionality, and apparent arbitrariness which are so often
involved in clinic management. At the same time that staff are
freed from these distracting concerns, the contingency management
procedure itself can be exerting a direct therapeutic effect in
promoting the desired behavioral changes.
One important practical element involved in the design of con-
tingency management procedures utilizing positive reinforcement
procedures is the task of identifying and gaining control over
appropriate positive reinforcers. An ideal procedure is one in
which the therapist is able to gain control over some effective
reinforcer which already exists within the patient’s lifestyle
and to arrange for that existing reinforcer to be made available
on a contingent basis. In essence, this procedure of taking ad-
vantage of preexisting (i.e., so-called “natural”) reinforcers
allows one to implement positive reinforcement procedures without
the costly requirement of having to produce additional resources
to support the reinforcement procedure. Much of the discussion
which follows will involve application of this cost-effective
positive reinforcement procedure.
INTERVENTION SETTINGS
In this section we will discuss two drug abuse treatment inter-
vention settings which we feel are especially appropriate for im-
plementation of behavioral contingency management procedures.
These are: (1) residential treatment facilities, and (2) metha-
done treatment programs. In both cases we feel that these are
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appropriate for contingency management applications because they
represent settings in which significant positive reinforcers are
routinely dispensed to patients. Thus, they provide a convenient
opportunity to interpose a contingent relationship to insure that
these resources are dispensed in a way which promotes thera-
peutically desirable behavior.
Residential Facilities
In residential treatment facilities the treatment program can ex-
ert control over a very substantial proportion of the reinforcers
available to individuals within that environment. In such set-’
tings patients are dependent upon the treatment program for much
of their personal support. Such potential reinforcers as social
access, recreational access, quality of the living environment,
dietary quality, extra program activities, therapeutic activities,
personal autonomy, etc., are potentially available for incorpora-
tion in therapeutic contingent reinforcement arrangements. Such
settings should provide a fertile ground for the development and
implementation of positively reinforcing contingency management
procedures for promotion of therapeutic improvements.
However, this potential has yet to be realized. Elsewhere we
have recently reviewed the limited work which has been reported
concerning contingency management procedures within residential
treatment facilities (Stitzer et al. 1983). In general, reports
to date have utilized contingency management procedures only to
encourage the simplest forms of program rule compliance and per-
sonal hygiene activity among patients. It appears that, from a
behavioral management point of view, the therapeutic possibilities
of residential contexts have been dramatically underutilized.
Ideally, one would like to see designed into such facilities a
graded progression of contingent access to an increasingly large
array of reinforcers consequent upon desired therapeutic progress.
While this apparently has not yet been done by behaviorally
oriented therapists, it should be noted that on a descriptive
level one can suggest that similar procedures are being used in
therapeutic commmities of the Synanon type. Apparently in these
programs patients enter the facility at the lowest functional
‘status, with the lowest level of privileges, and then are per-
mitted progressively to rise in the hierarchy of the program and
in their level of privileges contingent upon their progressive
development of improved social skills and verbal behavior relative
to drug use and their development of occupational skills and per-
formances . From such a behavior analysis perspective it can
appear that such therapeutic communities are designed according
to sound behavioral principles. However, until behavioral
principles are utilized prospectively in the design of a thera-
peutic residential facility, our belief in the value of these
reinforcement procedures in such settings must remain speculative.
Methadone Treatment Programs
Methadone maintenance treatment programs represent a context in
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which the utility of behavioral contingency management procedures
has been clearly demonstrated. In fact, methadone treatment pro-
grams would appear to be an ideal context within which to conduct
therapeutic contingency management interventions. The clinic
provides a population of volunteer outpatient chronic drug abusers
who, upon enrolling at the treatment clinic, have agreed to report
to the clinic daily to receive under nursing observation a potent
pharmacological reinforcer. This arrangement provides a structured
basis for routine, frequent, convenient contact with drug abusers
who are freely residing in the community (presumably continuing
to be exposed to the high-risk situations of illicit drug avail-
ability), and it provides a basis for establishing behavioral
contingencies so as to promote therapeutically desirable behavior
change as a precondition for continued dispensing of reinforcers.
We would argue that treatment programs should take greater thera-
peutic advantage of the positive reinforcing characteristics of
methadone treatment so as to encourage desirable behavior change
among patients. In the present section we will describe pro-
cedural development studies illustrating how this can be done.
Methadone treatment is a reinforcing (-i.e., desirable) treatment
modality. This is documented by the patient acceptability or
popularity of this modality; it is one of the few substance abuse
treatment approaches for which it is possible to maintain a wait-
ing list for patient admission. But there are reinforcers in-
volved other than simple treatment admission. Inherent in the
operation of a methadone clinic there are a variety of reinforcers
available which could be used in therapeutic contingency manage-
ment interventions. Some of the parameters which might be con-
tingently manipulated so as to vary the reinforcing value of
methadone treatment are listed in table 1.
TABLE 1: Variations in Methadone Treatment
Procedures with Potential for Use
in Contingency Management Treatment
Procedures
Methadone take-home privileges
Daily clinic attendance frequency
Time of day of authorized clinic attendance
Clinic-controlled dose changes
Patient dose self-control
Extent of counseling or other adjunct services
Adjunct prescription medication
Clinic fee requirements
Lottery tickets
Vacation arrangements
The items listed in the table are derived from a casual “armchair”
analysis of the functioning of methadone treatment clinics. Two
studies have conducted questionnaire surveys of methadone patients
in an effort to identify factors which might serve as reinforcers
in contingency management procedures (Yen 1974; Stitzer and
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FIGURE 1. Methadone maintenance patients (N=53) ranked the de-
sirability of various potential reinforcers (1 = most desirable).
For each item the average rank is shown, as well as the percent
of patients ranking it among the three most desirable alterna-
tives. Reprinted from Stitzer and Bigelow (19781, p. 471, by
courtesy of Marcel Dekker, Inc. © 1978, Marcel Dekker, Inc.
Bigelow 1978); both have indicated that the methadone take-home
privilege is among the most effective of incentives available
within the methadone treatment clinic. Results of the Stitzer and
Bigelow (1978) survey study are presented in figure 1.
The initial experimental demonstration of the actual behavioral
efficacy of methadone take-home privileges to serve as reinforcers
to produce desirable therapeutic changes in the behavior of drug
abuse patients was provided by Stitzer et al. (1977). In that
study attention was focused upon a subgroup of methadone patients
who were chronically failing to attend their weekly counseling
sessions for the scheduled duration. Using a within-subject re-
versal experimental design the study evaluated the efficacy of
using methadone take-home privileges to reinforce counseling
session attendance. During two contingent reinforcement phases,
each of 2-month duration, a weekend medication take-home privilege
was available contingent upon attending a counseling session of
at least 45-minute duration that week. Results are shown in
figure 2. During the baseline and noncontingent phases the
average counseling duration per patient-week was approximately
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FIGURE 2. The functional efficacy of methadone take-home
privileges as reinforcers for improving counseling session
attendance was tested in a within-subject reversal design.
During the contingency phases a weekend take-home privilege
was provided contingent upon at least 45 minutes of counsel-
ing attendance. The average minutes of counseling attendance
per patient is graphed over successive weeks. Reprinted, with
permission, from Stitzer et al. Addictive Behaviors, Vol. 2(1),
p.11, © 1977, Pergamon Press, Ltd.
in the 15-30 minute range; during the contingent reinforcement
phases the average duration was approximately 40-60 minutes.
Thus, contingent reinforcement with methadone take-home privileges
effectively produced an approximate doubling in the desired target
behavior.
In a subsequent clinical study the applicability of contingency
management procedures within a methadone maintenance program was
extended to include the use of methadone dosage self-control as
the contingent reinforcer and the modification of supplemental
drug use as the target behavior (Stitzer et al. 1979). Partici-
pants were methadone patients who had shown consistent urinalysis
evidence of illicit supplemental use of benzodiazepine minor tran-
quilizers and who, as part of an effort to supplant some of their
illicit drug supplementation, had received a clinic prescription
making available to them up to two 10-mg diazepam tablets at each
daily methadone clinic visit. The contingency management inter-
vention trial focused upon self-administration of this prescribed
supplemental diazepam as the target behavior and compared the
efficacy of methadone take-hone privileges and methadone dosage
self-control as contingent reinforcers. A within-subject reversal
experimental design was used, and the order of exposure to the two
46
contingency conditions was counterbalanced across subjects. Dur-
ing the contingent phases subjects could, by refusing the avail-
able diazepam for 3-4 consecutive days, gain the privilege of
either a one-day methadone take-home privilege or a one-day op-
portunity to alter the methadone dose by as much as 20 mg above
or below the maintenance dose. Results are shown in figure 3.
During’ baseline conditions (i.e., with no contingency) 95.6% of
available diazepam doses were self-administered. When diazepam
refusal was contingently reinforced, this fell to 11.2% when the
reinforcer was a take-home privilege, and to 69.7% when the re-
inforcer was methadone dose self-control. Thus, both consequences
functioned to reduce supplemental diazepam use, but the methadone
take-home privilege was far more efficacious than was the dose
self-control option.
The studies described here are intended to be illustrative and to
demonstrate the scientific background for devising and implement-
ing contingency management interventions in methadone treatment
clinics. The studies are admittedly experimental demonstrations
rather than therapeutic trials. Our laboratory has, however,
continued this line of investigation in the direction of true
therapeutic trials. Some of those more recent procedures and
data are discussed by Stitzer et al. elsewhere in this volume.
The major point to be made here is that solid data now exist
documenting the feasibility and effectiveness of implementing
behavioral contingency management procedures within methadone
maintenance clinics to promote therapeutic behavior change.
PRACTICAL PROBLEMS
The above discussion has reviewed both the theoretical/conceptual
basis for contingency management approaches to drug abuse and the
practical empirical demonstration of the applicability and utility
of these approaches. We feel that these discussions clearly
document the appropriateness and effectiveness of this behavioral
approach to treatment of the variety of problems associated with
drug abuse. However, it is appropriate to note here that a
variety of practical problems remain which may limit application
of contingency management treatments in drug abuse clinics
(Bigelow et al. 1981).
Patient Diversity
Drug abuse patients are not a homogenous population, and they do
not present for treatment with a homogenous array of treatment
needs. This diversity is illustrated in figure 4 with data show-
ing the treatment-entry characteristics of methadone maintenance
patients enrolling in a behavioral treatment research project re-
ported by Bigelow et al. (1980). Although this was a “narcotics
addiction treatment” program, the intake data indicated that
only 40% of patients could measurably improve on the available
assessment index of narcotics use; This patient diversity argues
for the necessity of individualization of treatment regimens for
different patients. From a behavior management efficiency point
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SUCCESSIVE WEEKS
FIGURE 3. Contingent methadone take-home privileges and con-
tingent methadone dose self-control opportunities were compared
as potential reinforcers for reducing supplemental drug use. Sub-
Jects had available at the clinic two 10-mg diazepam (Valium(R))
tablets daily. During the contingent periods one of the alterna-
tive reinforcers was available contingent upon refusal of the
available diazepam. Reprinted, with permission, from Stitzer
et al. Addictive Behaviors,
Pergamon Press, Ltd.
Vol. 4(3), p.249. © 1979,
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FIGURE 4. Drug abuse patients are a diverse population, who
present for treatment displaying widely varying performance
levels and therapeutic needs. Shown here is the distribution
of clients across levels of illicit drug use (measured- as per-
cent of urine samples positive for various drug classes),
legal employment (categorized as none, part-, or full-time),
and treatment compliance (measured as percent of counseling
sessions attended) at the time of their enrollment in a metha-
done maintenance treatment program. Numbers at the right
indicate the percent of patients whose initial level was such
that they could possibly improve or worsen on that measure.
Reprinted from Bigelow et al. (1980), p. 434, by courtesy of
Marcel Dekker, Inc. © 1990, Marcel Dekker, Inc.
of view it would be attractive if “packaged” contingency manage-
ment programs could be developed and implemented on a program-wide
scale within treatment clinics. However, the data on patient di-
versity argue against the feasibility or desirability of such an
approach. It may, however, prove possible to devise such pro-
grammatic approaches for more homogenous subgroups of patients
who share similar needs.
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Access to Reinforcers
In the present paper we have discussed two primary settings in
which it was felt contingency management approaches might be es-
pecially applicable -- residential facilities and methadone
treatment programs. These were felt to be promising settings
specifically because they would appear to permit the behavior
therapist an especially easy opportunity to gain access to and
control over reinforcers which might then be utilized in contin-
gency management procedures. In other settings it may be much
more difficult to gain control over any relevant reinforcers, and
consequently the applicability of these procedures may be limited
in such settings.
Acceptability
At times contingency management approaches can encounter problems
of acceptability in the community. In our applications of posi-
tive reinforcement procedures we have encountered no problems with
patient acceptability; however, this could certainly happen if
contingent reinforcement procedures were implemented as a substi-
tute for a preexisting noncontingent free access arrangement.
At the societal level it is sometimes felt that it is inappropriate
to provide reinforcers to problem patients consequent upon im-
provements if those same reinforcers are not also provided to
patients who never displayed the problem in the first place. A
possible consequence of this view is that it may be suggested by
some that contingency arrangements take the form of aversive or
punishing contingencies for those patients who continue to display
problems; certainly difficulties with patient acceptability would
arise in such an eventuality. We feel it is essential that con-
tingency management applications emphasize positive reinforcement
procedures and that the ability to individualize reinforcer
availability be retained. It would certainly be regrettable if
the opportunity to promote therapeutic behavior change through
positive reinforcement were to be sacrificed to an administrative
requirement that reinforcers be dispensed noncontingently.
Measurement of Drug Abuse
Application of contingency management procedures to the target
behavior of drug-taking itself is made difficult by the practical
difficulties of detecting and measuring the occurrence of drug
use. Clinics must rely upon urinalysis testing as the best
available objective index of drug use. In many clinics this
testing procedure involves the. lapse of a week or more from the
time a sample is collected until the analysis results return from
an outside laboratory. This long delay may seriously impair the
efficacy of contingency procedures which are targeted upon drug
use behavior. In our clinic we utilize an on-site urinalysis
testing procedure to minimize delays and to maximize the immedi-
acy of contingencies. We would recommend this to other clinics
whenever it is possible.
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Reversibility/Relapse
Contingency management procedures are sometimes perceived as
having only short-term efficacy and of being uniquely susceptible
to the problem of reversibility or relapse. Certainly it is the
case that the data from many contingency management studies
illustrate this problem -- including the data presented in this
paper; when the contingency procedure is discontinued behavior
tends to return to its prior level. We would suggest that this
reversibility is not a problem unique to contingency management
approaches; this is basically the relapse phenomenon, and this is
an endemic problem for all varieties of substance abuse treatment.
It is probably unrealistic to expect brief, short-term treatment
interventions to display long-term behavioral efficacy. It is
possible also that the appearance of uniquely rapid reversibility
with contingency management procedures is an artifact of their
efficacy; procedures which are not efficacious are incapable of
appearing reversible. Further research on the relative reversi-
bility or durability of various treatment interventions is clearly
required. Until there exist clear data to the contrary, the con-
cern about rapid reversibility of contingency procedures will
probably continue to limit their application.
CONCLUSIONS AND FUTURE DIRECTIONS
Drug abuse can be productively viewed as an example of operant
behavior, with drug self-administration being reinforced by the
pharmacological effects of the drug. The operant behavior con-
ceptual framework provides a useful basis for understanding and
therapeutically influencing not only the drug self-administration
aspect of the drug abuse problem, but also many of the collateral
behavioral problems which are commonly observed in drug abuse
patients. The efficacy of contingency management approaches to
problems of drug abuse has been clearly documented in clinical
research, and several drug abuse treatment contexts would appear
to be especially suitable for contingency management interventions
because of the ease with which contingent access to preexisting
reinforcers can be arranged. Despite this promise, considerable
additional work is required to establish the extent to which these
procedures will have widespread application and acceptability.
We would suggest several directions as being desirable for future
work. First would be the task of continuing to improve the
efficacy of the procedures -- and of pursuing the task of estab-
lishing long-ten treatment efficacy. Second would be the use of
contingency management procedures as aids for assessing the value
of other treatments; a valuable treatment evaluation technique
might be to assess the extent to which other treatments enhance
patients ability to respond successfully to contingency pro-
cedures. A third valuable direction would be the use of con-
tingency management procedures to study the techniques used by
patients to accomplish changes in their drug use behavior -- that
is, to study what other aspects of the drug abuser’s behavioral
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repertoire change when drug use is discontinued (e.g., Burling
et al. 1982). Fourth, and finally, contingency management pro-
cedures would appear to offer strong opportunities for the study
of the relapse process.
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Behavioral Treatment of Drug
Dependence
Roy W. Pickens, Ph.D., and Travis Thompson, Ph.D.
There are many different Interpretations of the problem of drug
dependence. Sane believe it is a medical disease, while others
believe it is a behavioral problem. Some consider It to have gene-
tic origins; others consider It to be primarily environmentally
determined. Some examine it within a cultural context, others con-
sider it to be an individual adjustment reaction. Same view it as
a personality disorder, while others view It as a psychosocial
problem. It is probably true that there iS no single correct inter-
pretation of drug dependence. To scine extent all are correct, for,
like the blind men examining the elephant, each reflects how repu-
table individuals working in various disciplines view different
aspects of the same basic problem.
This is not to say that the interpretation given to the nature of
drug dependence is unimportant. While the treatment of drug
dependence may be unrelated to its causes, a clinician's view of
the problem will affect his or her approach to treating it. The
clinician who views drug dependence as primarily a personality
disorder will probably take a different approach to treatment than
will a clinician who views It as primarily a medical problem. The
validity of an interpretation of drug dependence is also in part
reflected by the effectiveness of treatment approaches suggested by
that interpretation.
The present paper examines treatment of drug dependence from a
behavioral perspective. Behavioral phatmacologists view drug de-
pendence as learned behavior (Thompson and Pickens 1969; Pickens et
al. 1978). According to this interpretation, repetitive and per-
sistent drug-taking behavior is established and maintained by the
consequences of that behavior. The consequences would include the
drug effect on the individual as well as any change the drug pro-
duces in the individual’s interaction with the environment. Within
this context, drugs (and events surrounding drug use) are viewed as
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reinforcers, that is, events that follow behavior and as conse-
quences make the behavior more likely to recur. Behavioral theo-
rists and practitioners typically make no attempt to explain reduc-
tionistically why drugs and related events function as reinforcers,
only that they do. Thus, the behavioral approach attempts to
relate drug self-administration to observable events rather than to
hypothetical constructs or other unobservable events (Thompson
1981).
Viewing drugs as reinforcers and drug dependence as a form of
learned behavior has been very useful. It has allowed factors con-
trolling drug use to be studied experimentally In both humans and
animals, and has also led to development of new techniques for
screening new drugs for dependence potential prior to their market-
ing (cf. Thompson and Unna 1977). Equally Importantly, however,
the approach has sugested new methods for treating drug dependence
(Thompson et al. 1973). The methods are based on behavioral prln-
ciples and are directed towards reducing drug-taking and increasing
alternative behavior. Clinically they are applied as behavior
therapy or behavior modification treatment approaches.
There is an extensive literature describing behavior therapy tech-
nlques to treat individuals with drug dependency problems. These
reports describe highly specific reinforcement and punishment pro-
cedures to modify the behavior of Individual clients. Relatively
few treatment programs have been based entirely on behavioral
treatment approaches. For the past several years we have operated
such a program for the treatment of drug dependence on a psychiatry
ward in the University of Minnesota Hospital. The program was
developed in part to support research activities In the area of
human studies of drug dependence (Pickens et al. 1977; Healey and
Pickens 1983).
It is the purpose of this paper to describe the ward's behavior
therapy program in detail and to explain how behavioral principles
are applied In the treatment of drug dependence. The reader is
cautioned that no comparative experimental test of the effectlve-
ness of the program has been made. Except in certain cases, lim-
ited resources have prevented followup of the patients treated on
the ward. Thus, the procedures described here should be viewed as
having possible clinical effectiveness, until their actual worth
has been determined by controlled experimental testing.
GENERAL WARD PROGRAM
Our program is patterned after that originally described by Ayllon
and Azrin (1965) for use in treating chronically hospitalized psy-
chiatric patients, but modified by us to treat acute psychiatric
patients (Pickens et al. 1979) and later to treat drug-dependent
patients (Pickens 1979). The program has two parts. One part uti-
lizes a ward-wide point-economy system to encourage desired behav-
ior and to discourage maladaptive behavior, while the second part
is an individualized treatment plan designed to meet the specific
treatment problem of each individual client.
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In the ward-wide program, points are used as the medium for behav-
ioraI change. Throughout the 24-hr day, points are given to pa-
tients contingent on desired behavior and taken away contingent on
maladaptive behavior. Point transactions are administered by all
staff who normaIly work cm the ward, including psychiatric nurses,
occupational therapists, alcoholism and drug abuse counselors, and
psychologists. All point transactions are recorded in a small
booklet that each patient is Issued dally.
Points are given to patients contingent on three classes of desired
behavior : participating in activities considered to be therapeuti-
cally helpful to patients, participating In social activities, and
grooming and personal care. Participating in therapeutic activi-
ties includes attending various classes that are offered on the
ward several times each week. The classes are designed to help the
patients in rational thinking about themselves, assertiveness, and
problem solving, and to improve interpersonal skills and communica-
tion. Not only are points earned for attending such activities,
but extra points may be earned for being on time and for the qual-
ity of participation in the activity. The points are given to
patients individually at the end of each activity. At this time a
staff person marks the points earned in the patients’ point booklet
and briefly describes how the quality of participation earned them
extra points, or how they might improve their participation In the
class to earn extra points in the future.
Other therapeutic activities that may earn points an the ward
Include work on the patient’s individualized treatment plan. This
plan Is devised during the patient’s first week of hospitalization.
It includes a detailed description of problem behaviors to be
changed, the desired behavior, the approach to be taken in changing
the behavior, and how the behavioral change is to be “consequated,”
that is, what the prescribed consequences of the behavior will be.
The plan is developed with the patient’s cooperation, and is signed
by both the patient and the primary staff person. It is considered
a document of agreement between the patient and the staff, indi-
cating goals and methods for behavioral. change during the patient’s
stay on the ward.
Points are also given to patients for attendance and for degree of
participation in other ward activities, such as planned  outings to
shopping centers, movies, or parks, as well as various work chores
that must be performed on the ward (e.g., watering plants, prepar-
ing meals). Personal care activities that earn points include
cleaning room, washing clothes, appropriate dress, and regular
showers.
The availability of activities for earning points and the number of
points to be earned by each activity are clearly defined in the
patient’s point booklet. However, points can also be given spon-
taneously by staff to a patient contingent on especially important
therapeutic behavior, such as acting responsibly or being particu-
larly helpful. On such occasions, the staff approaches the patient,
tells the patient what they observed and liked about his or her
behavior, and awards the special points.
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As points are given to patients for healthy behavior, points are
also taken away from patients for maladaptive behavior. Maladap-
tive behavior is defined as any behavior that is not in the patient’s
long-term best interest, regardless of whether it relates directly
to drug use or not. Examples of maladaptive behavior would include
verbal abuse, assault, theft, or not working on treatment plan. If
a particular behavior has been a major problem for the patient in
the past, that behavior is typically included in the patient’s
treatment plan. Otherwise, It is consequated as it occurs on the
ward. The same procedure s used in point loss as in point gain.
The staff person approaches the patient, tells the patient what was
observed and what was inappropriate about the behavior, and then
removes points for the behavior In the patient’s point booklet.
Points earned by patients are exchangeable on the ward for a vari-
ety of goods and services. Points earned during a day are exchange-
able for snack food and soft drinks, supplies, cigarettes, or per-
sonal care articles. Points not spent on a given day are placed in
a savings account, from which the patient may purchase access to
visitors, overnight passes, or weekend passes. The major use of
points, however, goes towards put-chase of the patient’s daily pri-
vilege or responsibility level on the ward. With a low level of
net point earnings, a patient’ may be able to purchase only the
lowest privilege level on the ward-confined to ward. However,
with higher levels of net point earnings, the patient may be able
to purchase higher and higher privilege levels. At the highest
privilege level, patients are able to purchase unlimited and unes-
corted privileges on the ward. The maximum privilege level obtain-
able by a patient is set by the staff and typically increases as a
patient progresses through treatment.
Thus, the ward’s point-economy program can be viewed primarily as a
means for getting patients in contact with the therapeutic activi-
ties on the ward. Our patients typically attend most classes and
participate actively in other ward activities. Though many of our
patients are Initially very disturbed, there is a low level of IT&-
adaptive behavior. While we tend to stress behavioral and cogni-
tive-behavioral approaches In the therapeutic activities available
to patients on the unit, the ward program could equally well be
used with other treatment approaches.
The program appears to be well liked by both staff and patients.
In a study of nursing staff attitudes toward behavior therapy,
after working on the ward for one year, the nursing staff said that
the behavior therapy approach was less superficial and less mechan-
istic than did nursing staff working on a more conventional psychi-
atry unit which emphasized Interpretative Individual and group
psychotherapy (‘Ihompson et al. 1980). While some patients may com-
plain initially about the “mickey mouse" nature of the point pro-
gram, most eventually report liking the program, especially as it
provides immediate feedback of progress through treatment. The
program seemingly works well with all types of patients. While
many of our drug-dependent patients are alcoholics or polydrug abu-
sers from lower socioeconomic levels, patients have also Included
physicians, psychologists, engineers, and other professionals.
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Why points are effective as reinforcers in changing the behavior of
drug-dependent individuals is not clear. One reason is obviously
that points can be used on the ward to buy goods and services. How-
ever, there may be other factors operating in the system as well.
One factor may be that the awarding of points requires staff to
Interact with patients many times throughout the day. Not only
does this Increase patient-staff interaction, but it makes the
staff more effective as social reinforcers and improves their abi-
lity to serve as role models for the patients. Another factor may
be that points are just lnherently reinforcing for many adults.
After a long history of exposure to a wide range of generalized
conditioned reinforcers, giving almost anything to an adult consis-
tently after behavior may be reinforcing. The inherent reinforcing
property of points is suggested by the fact that most patients earn
considerably more points than they can ever spend on the ward, and
leave the program with a large point surplus.
As an example of the type. of treatment plan employed on the ward,
figure 1 shows a representative treatment plan for one patient who
was a chronic alcoholic. In addition to participating in chemical
dependency counseling and attending AA meetings, the patient was
required to spend increasingly longer Intervals of time off the
ward. Upon returning to the ward, however, the patient was given a
breathalyzer test to determine if recent drinking had occurred. If
drinking had not occurred, the patient’s privilege level was ex-
tended and the patient was given an even longer pass for the next
day. If drinking had occurred, the patient was to be Incarcerated,
as a condition of a court order. ‘Ihe purpose of this plan was to
give the necessary counseling for alcoholism on the ward and then
to require the patient to practice drug-free living outside the
ward.
A representative treatment plan for a middle-aged housewife with a
sedative abuse problem is presented In figure 2. Since the patient
lived in a small rural town, her drug abuse problem could be easily
controlled by the cooperation of her physician who agreed to no
longer Issue her prescriptions for sedative drugs. The treatment
plan consisted primarily of getting the patient more involved in
activities outside the home and in reducing her dependency upon her
spouse for mediating other reinforcers.
CONTINGENCY CONTRACTING
The contingency contract is a behavioral device used extensively on
the ward. The contract is a formalized agreement between a staff
person and the patient that specifies the manner In which learning
principles are to be applied to the modification of the patient’s
behavior. Usually the agreement is in the form of a written con-
tract that both parties sign. The contract details the specific
behaviors to be changed, how such behaviors are to be monitored,
and the contingencies to be placed on the behaviors. Contingencies
are arranged to reinforce behavior that is to be Increased, or to
punish or extinguish behavior that is to be eliminated. Details on
writing contingency contracts can be found In a number of sources,
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FIGURE 1. Example of a treatment plan used with a chronic alcoholic
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FIGURE 2. Example of a treatment plan used with a chronic sedative
drug abuser
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including DeRisi and Butz (1975), Homme et al. (1966), Williams and
Anandam (1973), and Dardig and Heward (1976).
Contingency contracts have had wide application in psychology, edu-
cation, and the corrections area. One of the first applications of
contingency contracts in the treatment of drug dependence was by
Boudin (1972). He employed a contingency contract outside of a
residential setting in the treatment of a female amphetamine abuser.
The contract required the client to deposit $500 in the form of ten
signed $50 checks in a joint bank account with a therapist. The
contract specified that upon each occurrence of amphetamine abuse
by the client, the therapist would endorse one of the checks and
send it as a contribution to a political organization especially
disliked by the client. At the end of the contract period, the
money remaining In the bank account was to be returned to the
client. After only one application of the contingency, the proce-
dure was effective in eliminating drug use, which did not recur in
the 2-year followup period.
Bigelow et al. (1976) also used a contingency contract to maintain
disulfiram (Antabuse) ingestion by alcoholics outside of a residen-
tial setting. Clients were asked to deposit money or a valued
object with the therapist. If the patient failed to return to the
clinic or to ingest disulfiram as scheduled, then a portion of the
deposit was sent to a charity. The remainder of the deposit was
returned to the client at the end of the contract period. During
the time of the contract, 80% of the clients reported longer periods
of alcohol abstinence than had occurred during the past 3 years,
and 70% of all clients renegotiated for a second contract.
Use of contingency contracts in the treatment of drug dependence
has also been reported by Miller (1972), Polakow and Doctor (1973),
and Hall et al. (1977). Similar contingency contract procedures
have been used in treating drug-dependent clients during the time
they are Inpatients in the residential ward program and also after
hospital discharge when they return to their home environment. In
the residential ward setting, behaviors are easily monitored and
consequated by the staff. In the home environment, however, behav-
ior is more difficult to monitor, and individuals other than the
staff must participate In consequating the patient’s behavior.
In the ward program, the patients’ individualized treatment plans
are actually contingency contracts, as they Identify problem behav-
iors, specify desired behaviors, establish the approach to be used
in the behavioral change, state the contingencies to be employed,
and are agreed to and signed by both the patient and staff. Treat-
ment plans may be changed repeatedly while a patient is on the
ward, with new problem behaviors being added when found and old
problem behaviors eliminated when they no longer occur. Point loss
or gain offers a relatively easy way for the staff to consequate a
patient’s behavior. A patient who said she required drugs to get
to sleep at night lost points for being In bed at any time during
the day, but gained points for exercise during the day and taking a
warm bath and listening to relaxation tapes before going to bed in
the evening.
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In using contingency contracts on the ward, events other than point
loss and gain may also be used to consequate patient behavior. A
female patient who was unassertive in relationships with her hus-
band was provided with extra pass time during the coming week con-
tingent on each assertive statement by the patient in family dis-
cussions.
An “activity deck” can also be used to consequate behavior on a
contingency contract. The activity deck is a deck of 20-30 cards,
each describing a different activity the patient is expected to
carry out, which is shuffled dally and placed face down on a table
near the central nursing desk. The deck Is typically used with
nonpsychotic patients who occasionally report having disturbing
Ideas. In such cases a contingency contract is developed in which
the patient is Instructed to draw a card from the activity deck
upon each occurrence of the disturbing Idea and to carry out the
activity described. While it would appear that the purpose of the
activity deck is merely to distract the patient from continuing
with the disturbing thought, the activity deck actually serves two
other purposes as well. The procedure teaches patients how to deal
with such ideas in the future. Moreover, since each activity in
the deck is a moderately onerous task, carrying out the activity is
mildly punishing, so a sound behavioral principle is being used to
reduce the frequency of the disturbing; Ideas.
Point loss or point gain can be equally powerful as contingencies
In behavioral contracts, however. Points have been used as a means
for obtaining self-detoxification from sedative drugs in drug-depen-
dent patients. Self-detoxification is markedly different from the
detoxification procedure employed in most drug treatment programs,
where the physician controls all drug administration and determines
not only the starting dally drug dosage but the rate at which the
patient is withdrawn. Patients were initially allowed to self-
administer pentobarbltal until dally Intake stabilized and then
were allowed to contract (see figure 3) to take one less drug cap-
sule each day until detoxification was completed. Points were
earned by patients for reducing drug intake by one capsule per day
and lost if they remained at the same dosage level for more than 2
days or took more capsules than on the previous day or detoxified
at a rate greater than one capsule per day.
Figure 4 shows the effects of contingency contracting on the drug
Intake of all six subjects employed in one study. All were women
with confirmed histories of sedative abuse. The mean level of pen-
tobarbital intake during the self -administration part of the study
is shown along the left side of the graph. The subjects self-admi-
nistered form 400-1000 mg of pentobarbital per day, which is typi-
cally associated with physiological dependence. Abrupt cessation
of drug use at these dally doses is usually associated with moder-
ate to severe withdrawal symptoms. The variability in drug intake
from day to day for each subject was relatively small.
At the start of the detoxification phase, phenobarbital was substi-
tuted, and the subjects were allowed to contract for the number of
61
SELF-DETOXIFICATION CONTRACT
I understand the purpose of this procedure Is to allow me control
over my own rate of drug detoxification from my original addicted
state. I have received a schedule to guide me in undergoing detoxifi-
cation safely and gradually. I will assume all responsibility for
regulating my drug intake, and the credit will be all mine for the
accomplishments I make. Today I agree to take capsules of
medication; The number of capsules I took yesterday was . I
understand that If the number of capsules taken today is one less than
the number taken yesterday, I will receive points at midnight
tonight. If the number of capsules taken today is the same as the
number of capsules taken yesterday, I will receive no points. In no
case, however, can I remain at the same drug level for more than two
successive days without losing points. If I take more drug today than
I did yesterday, or if I take less drug today than is recommended on
the guide sheet, or if I remain at the same drug level for more than
two successive days, I will be required to pay points for each
capsule over or under the recommended number at midnight tonight. In
following the guide sheet, I am also entitled to any bonuses that I
have earned.
Date Patient’s Signature
Staff’s Signature
FIGURE 3. Example of a self-detoxification contingency contract
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FIGURE 4. Pentobarbital self-detoxification following pentobarbi-
tal self-administration
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capsules of drug to be taken each day. All subjects showed a reduc-
tion In the number of capsules taken each day. Five subjects
showed a systematic decrease in capsule intake, eventually reaching
and maintaining at least 5 days of abstinence. The sixth subject
initially showed a decrease in drug intake but was successful In
reducing her intake only to about 40% of self -administration level.
Withdrawal of this subject was then completed under medical. direc-
tion. Followup at 6 weeks after hospital discharge showed no drug
use by the patients able to undergo self-detoxification, while drug
use was evident In the patient who was unsuccessful at self-detoxi-
fication.
When patients self–detoxify with phenobarbital, two distinct pat-
terns of behavior emerge. The patient may show a gradual decrease
over time in the number of drug capsules taken throughout the day.
The other pattern Involves initial decrease in drug capsules taken
In the morning, with the capsules taken in the evening remaining
relatively unchanged until the final phases of the detoxification
process. Data are currently being examined to determine if these
two patterns of drug withdrawal reflect the presence or absence of
another clinical state, such as depression.
Contingency contracts are also used with patients during the first
several weeks after discharge, when they return to their home envi-
ronment following their hospital stay. The contracts are designed
to allow for the implementation of behavioral contingencies In the
patient’s home environment to reduce the likelihood of a return to
drug use. The contracts also make possible a gradual transition
between the highly controlled environment of the hospital ward and
the less controlled environment of the outside world.
The outpatient contract is similar to the inpatient contract,
except that events other than point loss and point gain are used in
the contingency. In the case of one patient who was a sedative
drug abuser from a small community, a contingency contract was
devised before she was discharged from the hospital program to aid
her in becoming more Involved in community affairs once she had
returned home. Working with a counselor In the community’s mental
health clinic, the patient was to plan at least one activity out-
side the home each day at the beginning of each week and to mail
the schedule of weekly activities to a staff person In the ward
program. On the schedule the patient was to include the date and
time of each activity, and a telephone number at the site of each
activity where she could be contacted. The staff person would ran-
domly call the telephone number listed and verify that the patient
was at the activity listed. If the patient attended at least five
of seven scheduled activities for the week, she was mailed a check
for $10. If she attended fewer than five activities, she received
no money. The patient did not fall to receive a check during the 6
weeks of the contract period, and she became regularly active In a
number of community programs as natural reinforcers replaced the
monetary rewards involved in the contract.
Other types of contracts have also been used to Insure that a pa-
tient will remain drug free after treatment. A middle-aged married
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woman with sedative dependence required involvement by her husband
in managing the contingency. This was done to prevent the husband
from sabotaging the patient’s efforts to remain drug-free, as he
had done on other occasions. Each week for 6 weeks the patient
was to return to the ward for have a blood sample analyzed for drug
content. If no drug was found, both the patient and her husband
benefited by the terms of the contract. The patient was allowed to
exercise a personal agreement negotiated with the husband before
her hospital discharge, and the husband was given back a portion of
a monetary deposit left with the staff ‘at the time of the patient’s
discharge. If drug was found in the patient’s blood sample, how-
ever, both the patient and her husband lost reinforcers under the
terms of the contract. The patient was not allowed to exercise the
personal agreement, and the husband had that portion of the money
he would have received sent as a contribution to a disliked organi-
zation.
While contingency contracts are widely used by the staff in the
ward treatment program and by others in other treatment settings,
most reports of the clinical effectiveness of contingency contracts’
have been in the form of case studies rather than controlled exper-
imental reports. Nevertheless, a small number of scientifically
valid studies have been conducted demonstrating the effectiveness
of contingency contracts in clinical settings (Stuart and Lott
1972; Winett 1973; Eyberg and Johnson 1974). It is clear that more
experimental research should be conducted on the effectiveness of
contingency contracts, particularly on the variables in contingency
contracting that enhance the effectiveness of this potentially use-
ful procedure in the treatment of drug dependence.
Of the drug-dependent patients treated on our unit at the Univer-
sity of Minnesota Hospitals, all typically have employed contin-
gency contracts as an integral component of inpatient treatment.
How the course of their inpatient stay would have progressed had
another form of treatment been used is not known, and in most
instances, only limited follow-up data are available on durability
of the treatment gains. We have learned that approaching treatment
design from a broad behavior analytic framework t-as led to emer-
gence of a viable strategy for treating patients who are psycho-
logically and physiologically dependent on alcohol, sedative hypno-
tics, and other drugs. Viewing the self -administered drug as the
nexus of interlocking learned and biological variables has been
useful in developing a technology for understanding and arresting
the drug dependence process.
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Contingency Contracting Treat-
ment of Drug-Abusing Physi-
cians, Nurses, and Dentists
Thomas J. Crowley, M.D.
Substance abuse often is characterized by remissions and
relapses (Armor et al. 1976; Nurco et al. 1978). Relapse
hazards are especially problematic among certain highly
responsible professionals, such as physicians, dentists, and
nurses. Thus, loss of professional privilege or licensure is a
common consequence of drug abuse in these professions.
On the other hand, these drug-abusing professionals know that
they have ingested drugs hundreds or thousands of times before
without loss of license and that they probably could "get away
with just one more" ingestion. Thus, their fear of future
loss of licensure may not very effectively induce abstinence
today. But if the loss of license could be "rescheduled" to
occur with certainty at the very next use of the drug, that
predictable, clear punishment might suppress the drug use
and permit the initiation of other outpatient treatments while
the m-abstinent professional person works and lives at home.
Moreover, since the only choices would be "abstain and work, or
do not abstain and do not work," the patients of that
professional person would be protected, in turn, from the
ministrations of an intoxicated doctor or nurse. This is a
report of an effort to "reschedule" therapeutically the
threatened loss of professional privileges or licensure with a
contingency-contracting procedure among 17 drug-abusing
physician, nurse, and dentist patients treated in our Halsted
Clinic. William Stewart Halsted (1852-1922) was the famous
American "Father of Modern Surgery." The Halsted Clinic
commemorates his ability to make brilliant contributions
despite a severe cocaine dependence (Heuer 1952); the clinic
offers outpatient treatment with contingency contracting for
drug-dependent health-care professionals.
PATIENTS AND PROCEDURES
Seventeen consecutive patients were referred for treatment from
employers, coworkers, or hospital staff committees (6); from
state licensing boards (5); by a friend, family member,or self
(4); or by private psychiatrists (2). Hospital boards or
licensing authorities had restricted or suspended the profes-
sional privileges or licenses of 12 of these 17 patients before
their admission to the Halsted Clinic, while three more had
been told that such actions would be forthcoming unless they
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immediately found effective treatment: for two others licensure
was a serious concern but had not yet been threatened directly.
This all-white group of 13 physicians, 3 nurses, and 1 den-
tist had a mean age of 39 (range 25-65) years, and included
3 women. The primary drug of abuse at admission was cocaine (5
patients), meperidine (Demerol; 4 patients), other opioids (5),
mixed and multiple drugs (2), and alcohol (1). The route of
administration was intravenous or intramuscular for 9 patients,
intranasal cocaine insufflation for 2, cocaine "free-base"
smoking for 2, and oral for 4. The mean interval from first
clear drug abuse to admission was almost 8 years (95 months;
range 5-300). The current episode of abuse had persisted for a
mean of 15 months (range 0-95: the zero results from 2 patients
who claimed abstinence for several months before admission,
saying they were entering treatment only to forestall relapse
and to reestablish their professional credibility). Prior to
signing contracts, 13 patients reported daily drug use; 2
reported using drugs several times per week, and 2 claimed no
use for several months. Five patients obtained their drugs
from friends or street sources; self-prescription or diversion
of drugs from legal sources supplied 11 patients, and one
alcoholic patient obtained his drug in bars and liquor stores.
Treatment Procedures
Treatment procedures are specified in the sample treatment
contract and also are exemplified in the case history which
follows. To protect identities, ages are rounded to nearest
decade (e.g., 35-44 is given as 40).
Sample Case History
Case 2  (figure 1). A 30-year-old single professional
woman had snorted 0.5-3, gm of cocaine almost daily for
3 months, while also using flurazepam, alcohol, and a
variety of other drugs. After a car wreck, she began
to abstain. Eight days later, fearing the great
attractiveness of cocaine, she entered treatment to
help assure continued abstinence.
Despite her professional work, her friends were
underworld figures. She obtained her cocaine from
them, supporting her habit from savings and by dealing
in drugs. To help reorganize her chaotic social
situation, she requested brief psychiatric hospital-
ization, but she went to work on pass from the
hospital after the first few days. The patient saw
loss of her professional license and her job as the
probable Outcomes of continued use.
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Her therapist remended a contingency contract to
use that fear of license loss as a motivator toward
abstinence. She wrote a letter to her State
licensing board confessing her drug abuse and
surrendering her license: the letter was deposited
with her therapist. In a written contract she
directed the therapist to obtain urine samples and to
mail the letter if any sample contained drugs or if
she failed to provide a scheduled sample. This made
the somewhat remote (albeit eventually probable)
consequence of license loss much more immediate and
certain, and the patient signed the contract, aiming
to force herself to remain abstinent until she could
develop a drug-free pattern of life. With the con-
tract as a powerful motivator toward abstinence, the
patient then used therapy sessions to dispose of her
extensive drug paraphernalia, to list her drug-using
contacts and make plans to end those relationships,
to list her non-using friends and make plans to renew
those contacts, to improve her work performance, and
to develop new strategies for problematic relation-
ships with men and with her parents. She remained
free of cocaine and other drugs of abuse (except
for alcohol and marijuana), repeatedly renewing
the initial 3-month contract for a total of 12
months. By that time she felt that the inherent
rewards of her drug-free life outweighed the combined
benefits and costs of resuming drug use; while she
still thought of cocaine, she said, "it just doesn't
seem worth the hassle." She has continued in
psychotherapy for 19 more months without urinalyses.
She has taken no more cocaine, has completed a course
of postgraduate training, and no longer associates
with underworld figures.
Patients often use these contracts to regain professional
privileges from their hospitals or licensing authorities. For
that reason, as well as to sustain their own motivation to
remain abstinent, patients readily see the need for a nearly
fool-proof drug-detection system. Conversely, the oontract
protects patients against mailing of the surrender letter as a
result of laboratory error by requiring duplicate analyses of
urine samples reported to contain drugs.
Physician's Sample Treatment Contract
This is an agreement between (the
patient) and Dr. Thomas crowley the patient
maintain a resolve to remain free of drugs of abuse.
By this agreement the patient directs Dr. Crowley to
establish a schedule for collecting urine specimens
from the patient. The patient initially will provide
urine samples each Monday, Wednesday, and Friday for
one month. For the next one month Dr. Crowley will
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prepare a random schedule giving a 67% chance that
the patient will be directed to produce a urine
sample on any given Monday, Wednesday, or Friday:
after the beginning of the third month there will be
a 33% chance each Monday, Wednesday and Friday that
the patient will be directed to produce a urine
sample. The patient will call Dr. Crowley's office
or clinic each Monday, Wednesday, and Friday after
the first month to determine whether that is a day
for delivering a sample. Dr. Crowley or one of his
trained employees will observe the urination. Half
of each urine sample will be submitted for analysis
and half will be saved at Dr. Crowley's office.
Samples, identified only by a code number, will be
assayed for a variety of drugs of abuse,
specifically including . If
the first half of any sample is reported to contain
a drug, the second half of that sample will be
submitted for a separate analysis.
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The patient has supplied Dr. Crowley with a letter
to the State Board of Medical Examiners. This
letter notes that the patient had used drugs
previously, had entered the present rigorous program
of outpatient drug abuse treatment, but that the
patient nevertheless has resumed drug abuse: in the
letter the patient surrenders his medical license.
By this agreement the patient directs Dr. Crowley to
mail the letter at any time that both halves of a
urine sample are positive for drugs of abuse, or at
any time hat the patient fails to produce a
scheduled urine sample. Each separate analysis
requires 1.5 ounces of urine; if the first portion
of a sample is positive for drugs, and if the
patient has supplied a quantity of urine insuffi-
cient for a second analysis, Dr. Crowley is to mail
the letter as described above. If the quantity is
insufficient for even one analysis, that shall be
considered a failure of the patient to provide a
scheduled sample, and Dr. Crowley is hereby directed
to mail the letter, as described above.
If the patient travels out of town, he will inform
Dr. Crowley in advance of leaving, and the urine
collection program will be suspended temporarily
during that absence. Dr. Crowley is authorized to
verify such absences with . If the
patient is sick enough at some time to require
hospitalization, Dr. Crowley will arrange to collect
urine in the hospital: if the patient is sick and
does not require hospitalization, the patient will
arrange to produce scheduled urine specimens in the
usual place. On certain major holidays Dr.
Crowley's office and clinic are closed. Dr. Crowley
and the patient mutually will agree to altered urine
schedules on these occasions.
If the patient needs, for appropriate medical
reasons, one of the drugs which sometimes are abused,
he will obtain that drug on a legal prescription from
another physician or dentist who knows of the
patient's drug problems. The patient will supply
Dr. Crowley with copies of that prescription, and
then the appearance of that drug in the urine will
not trigger the mailing of the letter. The patient
hereby directs Dr. Crowley to communicate by mail or
telephone with that prescribing physician or dentist
when Dr. Crowley deems that action to be appropriate.
This agreement shall remain in effect for
months from the date of signing. If for any reason
the patient moves away during the treatment period
agreed upon here, and if the patient does not arrange
for appropriate followup treatment, Dr. Crowley
hereby is directed at his discretion to inform the
State Board of Medical Examiners that the patient was
in treatment with Dr. Crowley for drug abuse but
that the patient prematurely withdrew from that
treatment: in this situation Dr. Crowley is not  to
mail the letter which surrenders the patient's
license. During the time of this contract the
patient and Dr. Crowley will meet for counseling
sessions at a frequency which they will determine.
The patient strongly is encouraged to review with
attorneys, family members, or other advisors, this
agreement, which may be modified before  it is
signed.
Followup Procedures
For all but one patient, more than 1 year elapsed from
initiation of contingency-contracting treatment to followup
(mean 20 months, range 10.5-38). Eight patients continued to
attend the Halsted Clinic at the end of the follow-up time: for
7 of these the followup data derive from regular clinical con-
tacts and frequent urinalyses: for the eighth (Case 2, figure
l), some data were derived during biweekly therapy sessions
without urinalyses. Of the 9 patients who no longer were in
treatment in the Halsted Clinic, the author, who treated all 17
patients, made followup contacts by telephone with the
patients and/or their spouses. Thus, followup data were
available for all patients. Obviously, there was more oppor-
tunity for underreporting of relapse with simple, post-
treatment phone contacts than there would have been during
periods of contingency contracting with frequent treatment
sessions and urinalyses.
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RESULTS
Reduction of Drug Use
During the contract periods, 1004 urine samples were collected
from these patients: 8 samples (obtained from 5 patients) were
drug positive. Most of these patients had been daily or nearly
daily users, and the record of only 0.8 percent positive urines
indicates a profound reduction of drug use while contracts were
in effect.
Figure 1 shows a time-line for patient outcomes during
treatment and followup, while table 1 summarizes outcome
categories. As shown in figure 1, 53 percent of patients
(Cases 2, 3, 4, 6, 8, 11, 14, 15, 17) remained drug free during
the first 12 months after signing a contract, and 7 of these
patients (Cases 2, 4, 8, 11, 14, 15, 17) sustained abstinence
throqhout the followup period.
FIGURE 1
FOLLOW-UP SUMMARY:
17 DRUG-ABUSING M.D., D.D.S., R.N. PATIENTS
Followup summary of 17 drug-abusing physicians, dentists,
and nurses. ARTS is the Halsted Clinic of the Addiction
Research and Treatment Service, University of Colorado
School of Medicine.
Of these seven, six were under a licensure-loss contract for
longer than 6 months while one (Case 4) was under a contract
for only about 3 months.
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Ten subjects used drugs at least once during the treatment or
followup periods. Five of these patients (Cases 3, 5, 7, 12,
13) used drugs after, and five (Cases 1, 6, 9, 10, 16) used
during, the contract period. In general, relapses appeared to
be briefer and outcomes better (figure 1) for those who used
drugs while under contract than for those who used after con-
tract termination, whether or not the license was surrendered.
Under the terms of their contracts, two of these patients,
Cases 9 and 10, lost their licenses because of drug-positive
urines. It can be seen in figure 1, however, that both of
these patients subsequently returned to treatment and signed
additional contracts. Loss of license need not produce
catastrophic consequences; in Case 9 a therapeutically positive
outcome ensued. This SO-year-old married male had been self-
administering up to 500 mg per day of meperidine intravenously
for about 6 months. His hospital had suspended him, and he
signed a contingency contract to regain those privileges. But
within two weeks his urine again contained meperidine. He
immediately entered a residential treatment program. Refrain-
ing from practice, he said, was within the spirit of the con-
tract, and he convinced his therapist not to send the license-
surrendering letter. The contract was renewed when he returned
two months later. But just before restarting his work, he
resumed meperidine use, avoiding detection for a few days with
a rubber bag-and-tube contraption which allowed him to deliver
a false sample even under observation. But then he wrecked his
car while intoxicated and pointedly did not produce a required
sample. The letter was mailed, and he ceased practicing.
With no contract he remained in outpatient treatment (and
Alcoholics Anonymous), apparently abstaining, for 13 months.
He then regained his license, renewed the contract, and has
resumed practice. The facts that the second relapse occurred
just before he resumed practice,
reapplication for his license,
and that he needlessly delayed
suggest that license loss may
not have been an aversive event for this patient.
Three patients (Cases 1, 6, 16) had drug-positive urines while
under contract, but their letters were not mailed because of
technicalities in their contracts. For example, after
producing drug-free urines for 12 months, one patient (Case 6)
gave two successive samples which contained drugs but which
were too small for double analysis. The contract in use then
required double analyses to mail the license-surrendering
letter. The patient then agreed to modify the contract to
close this loophole, and remained drug free for an additional
seven months. Patient 16 verbally reported two brief relapses;
one went undetected in the random urinalysis screens, and the
second relapse involved too-rapid self-dosing with a drug
obtained for legitimate medical reasons on prescription from
another physician. In general, the relapses seen in these
three patients while under contract were brief; they did not
precipitate sustained drug use or interfere with work per-
formance. Thus, although they did not completely remain
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TABLE 1
OUTCOMES FOR 17 PATIENTS DURING TREATMENT AND FOLLOWUP
Outcome
Totally Abstinent 12 Months
After Contract Signed
Totally Abstinent Throughout
Followup
Drugs Used During Contract
License lost Via Contract
License Retained Through
Contract Technicalities
Drugs Used After Contract
Termination
*Case numbers refer to figure 1.
Percent
53
41
Cases*
2, 3, 4, 6,
8, 11, 14,
15, 17
2, 4, 8,
11, 14, 15,
17
29
12 9, 10
18 1, 6, 16
29 3, 5, 7,
12, 13
abstinent, the five patients who relapsed while under contracts
may be considered relative treatment successes.
Followup showed that three patients had their licenses revoked
or suspended for reasons other than the contract. In me
instance (Case 3), this was due to drug use which occurred
after termination of the contract; in two other instances
(Cases 7 and ll), the revocation was unrelated to drug use.
Abstinence On-Contract vs. Off-Contract
Among these patients contract duration ranged from 1 to 38
months (figure 1). Figure 2 shows that about half of those who
signed remained in a contingency contract 12 months later.
Although the month-by-month decline in percentage of patients
remaining abstinent parallels the decline in those still on
contract (figure 2), it cannot be concluded that ending the
contract necessarily resulted in relapse. Although some
patients relapsed shortly after their contracts ended (e.g.,
Cases 5, 7, 12 in figure l), others reported no relapse after
the contract ended (Case 4, figure 1) and still others
continued with a contract despite a brief relapse (Cases 6, 16,
figure 1). Considering patients still on contract, together
with those now off amtracts, the fifth month after signing was
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the peak time (figure 2) for relapses to be occurring, but such
relapses actually had a fairly even distribution through the
first 12 months.
FIGURE 2
Abstinence for 17 patients in first year after signing of
contract.
Figure 1 suggests that these patients were more likely to
abstain when contracts were in effect than when they were not.
Patients abused drugs in 9 of the 187 patient-months when
contracts were in effect (4.8 percent), and in 18 of the 147
patient-months when contracts were not in effect (12.2
percent). Moreover, followup calls suggested that relapses
without contracts tended to be longer and more continuous than
those occurring during contract periods.
Figure 3 also may suggest more abstinence when patients were
on contracts. Month-by-month, an average of 96 percent of
patients still on contract appeared to abstain; whereas, of
those no longer on contract an average of 73 percent reported
abstaining each month. Stated differently, in an average month
of the year after contract-signing, abut 4 percent of those
with contracts still in effect used drugs, vs. abut 27 per-
cent of those with contracts no longer in effect. However,
these estimates may be biased in either direction, considering
such factors as a greater motivation to dissimulate during
contract periods, or greater ease of concealing relapses during
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FIGURE 3
Abstention on- and off-contract. In each panel the dashed
line shows the percent of the 17 patients who did, or did
not, have contracts in effect. The solid line shows the
percent of patients in each condition who abstained each
month.
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noncontract periods when urine is not examined, or a possible
tendency for more strongly motivated patients to bind
themselves to longer contracts. It might have been argued
further that those patients most prone to drug use quickly
would relapse, losing their licenses, terminating their
contracts, and loading the off-contract group with poor
prognosis patients; however, only two patients lost licenses
through the contract mechanism, and one of them (Case 9)
apparently remained abstinent thereafter.
DISCUSSION
Drug-abusing health care professionals require treatment, and
their patients must be protected from the consequences of the
drug use. Unfortunately, the availability of drugs to these
professionals, and their familiarity with drug administration,
may pose antecedents of high risk for drug abuse. To protect
patients, stern limits have been placed on the practice of
drug-abusing professionals; for example, Green et al. (1978)
advocate lifetime surrender of a physician's narcotics number,
immediate cessation of practice, and a very slow return of
responsibility after lengthy evaluation and therapy.
Such Draconian measures, whatever their merit, are not without
social cost. A medical or dental practice important to a
neighborhood or small community may close abruptly, perhaps
never to reopen. A hospital administrator, already critically
shortstaffed, may feel obligated to discharge a drug-using
nurse. Patients may be under-treated by a n-abstinent
physician or dentist who cannot prescribe controlled drugs.
And the rehabilitation of the drug-abusing professional may be
severely complicated by impaired self-esteem resulting from
unemployment or stringent limits on professional practice.
Indeed, among one reported group of 40 such probationers, 20
percent committed suicide in one recent year (Crenshaw et al.
1980); the therapist of the present 17 patients assessed a high
suicide risk at some point in the treatment of six of them, and
one patient did make a serious suicide attempt.
Drug-abusing professionals often are dispatched to remote
sanatoria for treatment. But if treatment could proceed with
the patients in their own homes, offices, and hospitals, they
and their families might better learn every-day decisions and
actions to promote continued abstinence. An anesthesiologist
who daily must handle fentanyl (Sublimaze), and who was
addicted to that drug, may need specific, repeated, on-the-job
practice in giving the drug to others and not to himself. And
while he does that, his family may need to practice with him
new behaviors to support his abstinence and to deal more effec-
tively with future relapses.
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Thus, there might be several advantages to treating such
drug-abusing professionals as they work in their own offices
and hospitals and live at home. But, for the protection of
their patients, these professionals must abstain as such
treatment proceeds. It is well established that drug-use
behavior does change when the reinforcing or punishing
contingencies of that behavior change (Cohen et al. 1971a, b;
Boudin 1972; Bigelow et al. 1972; Crowley 1972; Miller et al.
1974; Miller 1975; Hall et al. 1977; Stitzer et al. 1979;
Havassy et al. 1979).
This paper reports an effort to utilize contingency contracting
procedures to secure a period of abstinence among drug-abusing
physicians, dentists, and nurses so that they could participate
in other abstinence-promoting treatments as they lived and
worked at home. Hospital authorities or licensing boards had
restricted or suspended the professional privileges or licenses
of the majority of these patients before  their admission to the
Halsted Clinic, and licensure was serious concern to all of
the patients. With such a powerful contingency operating
naturally among drug-abusing professional patients, they would
seem to be excellent candidates for contingency-contracting
treatment, but this appears to be the first report of such
treatment in this group.
These patients knew, unfortunately, that they could continue’
using drugs for some time before final detection, proof, and
administrative action could occur. To encourage abstinence,
these contracts “rescheduled” the preexisting contingency of
license-loss, making it likely to occur very early in a
relapse.
Advantages and Disadvantages of the Treatment
An immediate effect of the contingency contracts was an abrupt
and dramatic reduction in drug use. Additionally, the patients
remained at home and at work. The written contract, with its
clearly stated contingency for drug use, apparently helped to
suppress relapses; drug-free behavior patterns resumed and
became prepotent over an extended time, even as the risk that
drug use would be detected gradually declined. As that risk
fell, the rewards of drug use gradually could be supplanted by
the rewards inherent in an abstinent life. Counseling during
the contract period aimed at assisting the patient to
reestablish behaviors which could regain those reinforcers
usually available to nonintoxicated professionals: the
contract, an abstinence-securing prerequisite to such
counseling, clearly was not by itself the whole treatment.
Spouses or other parties in important relationships with the
patients often were included in the counseling.
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Additional flexibility was gained by renegotiation of contracts
upon their termination. Several patients requested random
urine testing to support continued abstinence long after
termination of the original contract. With relapses appearing
to be uncommon after 6 months on a contract (figure 3), Halsted
Clinic patients now are encouraged initially to enter 12-month
agreements.
This technique offered practical and theoretical advantages, as
noted above, and produced results more favorable than those in
many recent reports (Johnson and Connally 1981; Dalton and
Duncan 1978; Talbott et al. 1977; Green et al. 1976;
Murray. 1976). But no reported treatment has eliminated
relapse totally. Even with this rigorous treatment a relapsing
patient could, prior to urinalysis detection, engage briefly in
professional practice while abusing drugs.
Privilege to Practice and License LOSS
on first review, these contracts seen only punitive: drug use
is punished by loss of license. But 70 percent of these
patients had lost their licenses or other privileges to
practice before they entered the Halsted Clinic., These
patients used the contracts to regain probationary privileges
which were unavailable to them immediately before they signed
the contract. Thus, for many patients there was an important
appetitive, or positively reinforced, aspect to the treatment.
Clearly, however, there also is a punitive, aversive element in
the threatened license loss. This raises a serious ethical
concern: is the risk of license loss for these patients
enhanced or reduced by signing a contract? Conceivably, the
risk might be greater because detection of relapses would be
more likely with the contract, or the risk might be reduced if
relapses were less common while the contracts were in effect.
This uncontrolled report cannot finally answer that question,
but our preliminary data appear favorable. Twelve patients had
lost hospital privileges, licenses, etc., before signing
contracts. Later, after all 17 were back at work with
contracts, two patients lost licenses through the contract
mechanism, and three others lost licenses for other reasons.
The contracts apparently resulted in a net gain in licensure
and privileges for our patients, while apparently reducing
relapses to drug use.
In an interesting contrast, inner-city heroin addicts with no
job or family encounter few immediate social rewards for
abstinence, and few immediate social punishments for drug use.
Most of the patients in the present report used drugs with
abandon until very powerful reinforcements or punishments were
rigidly scheduled as consequences of, respectively, abstinence
or drug use. Street heroin addicts, with very few immediate
social consequences differentially attached to abstinence or
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drug use, have a notoriously worse prognosis for abstinence
during treatment than did patients in the present report.
Limitations of this Report
Conclusions from this initial report must be limited due to
lack of a control group, some procedural variations among
patients' programs, and biases which may arise when the
therapist serves as the followup evaluator in a nonblind
study. Nevertheless, these preliminary data do suggest that
contingency contracting benefitted a number of patients.
SUMMARY
Seventeen drug-abusing physicians, dentists, and nurses entered
contingency-contracting treatment. They deposited with their
therapist letters to their respective licensing boards, con-
fessing renewed drug abuse and surrendering their licenses.
Each contract directed the therapist to collect frequent urine
samples and to mail the letter if a scheduled sample was not
provided, or contained drugs. The followup occurred a mean of
20 months after signing the contracts, which were of varied
duration. Drug use dramatically declined for most patients
after a contract was signed. Most patients' personal and Pro-
fessional lives also improved over the followup time. Twelve
patients had suspended licenses or professional privileges
before signing the contracts. All then worked; two subse-
quently lost their licenses through the contract mechanism, and
three lost their licenses for other reasons. About half of the
patients completed a full year with no apparent relapse.
Relapses were more common when contracts were not in effect.
than when they were.
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Contingency Management of
Supplemental Drug Use During
Methadone Maintenance
Treatment
Maxine L. Stitzer, Ph.D., George E. Bigelow, Ph.D.,
Ira A. Liebson, M.D., and Mary E. McCaul, Ph.D.
Methadone maintenance is a specific pharmacological treatment in
which a long-acting orally effective opiate provides a therapeutic
substitute for the shorter-acting illicit opiates upon which
patients have become dependent. The methadone maintenance regi-
men frees patients from the necessity of acquiring and using
illicit opiate drugs, as has been consistently confirmed by
treatment evaluation studies (Bale et al. 1980; Gearing 1974;
McGlothlin and Anglin 1981; Newman and Whitehill 1979; Simpson
et al. 1979). However,. it is also clear from these and other
treatment evaluation studies that some supplemental use of illi-
cit opiates continues during methadone maintenance treatment.
Furthermore, patients with preexisting histories of illicit use
of sedative and tranquilizer drugs as well as histories of ex-
cessive alcohol use may continue using these drugs during metha-
done maintenance treatment, since methadone produces no specific
pharmacological attenuation of these drugs’ effects. In short,
supplemental drug and alcohol use constitutes residual behavioral
problems which must be addressed during methadone treatment.
Clinic policies are often designed to influence the behavior of
uncooperative patients displaying evidence of continued supple-
mental drug use. Program privileges such as take-homes are
generally available to patients on methadone maintenance who ad-
here to clinic rules and guidelines, abstain from conspicuous
supplemental drug use, and are employed or otherwise socially
productive (Baldridge et al. 1974). On the other hand, clinic
policies generally impose an escalating sequence of program
sanctions, based on evidence of continuing drug use, which in-
cludes loss of take-home privileges, probationary status, and
ultimately termination from treatment. Such aversive control
methods generally have mixed results; some patients terminate
their supplemental drug use and others terminate their association
with the treatment clinic. Although clinics may differ widely in
their tolerance of supplemental drug use among their patients, it
.is one of the paradoxes of drug abuse treatment that patients are
routinely terminated from treatment for exhibiting the behavior
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which characterizes the disorder that initially brought them to
treatment.
The present paper describes an alternative treatment approach
based on contingency management principles of positive reinforce-
ment which has been evaluated for its ability to reduce drug and
alcohol use among methadone maintenance patients. The procedures
described differ from approaches ordinarily taken at treatment
clinics in that privileges and rewards, rather than being avail-
able only to patients who are functioning well, are offered to
poorly functioning patients contingent upon evidence of improve-
ment. In this way, aversive control methods are minimized as an
approach to elimination of behavioral problems.
There are ample precedents for the use of operant behavioral
approaches and contingent reinforcement procedures in particular
in the treatment of substance abuse disorders. Experimental
demonstrations of reinforcement of abstinence have been success-
ful in treatment of alcoholism (Bigelow et al. 1975; Griffiths
et al. 1978; Miller 1975; Miller et al. 1974), cigarette smoking
(Winett 1973), and drug abuse (Bigelow et al. 1976; Hall et al.
1977; Stitzer et al. 1979a). Furthermore, the outpatient metha-
done maintenance clinic has characteristics which make it uniquely
suitable for implementing behavioral intervention techniques since
it provides frequent patient contact, objective measures of recent
drug and alcohol use via breath and urinalysis screening, and
many potential reinforcers and punishers which can be utilized in
contingent arrangements to influence drug use.
The first half of this paper describes a series of studies which
focused upon reduction in use of three drugs widely used and
abused by methadone maintenance patients: opiates, benzodiaze-
pines, and alcohol. These studies have demonstrated the general-
ity across populations and drugs of the efficacy of behavioral
interventions based on positive reinforcement techniques. Con-
sideration will then be given in the second half of the paper to
advantages and difficulties associated with the clinical imple-
mentation of therapeutic procedures involving contingent reinforce-
ment of reduced supplemental drug use.
REDUCTION OF SUPPLEMENTAL OPIATE USE DURING METHADONE MAINTENANCE
AND METHADONE DETOXIFICATION
Chronic treatment with methadone provides cross tolerance which
functionally reduces the subjective and physiological effects of
supplementally ingested opiate drugs (Jones and Prada 1975;
McCaul et al. 1983). In spite of this partial pharmacological
blockade of the effects of opiate drugs, considerable supplemental
opiate use is detected among methadone maintenance patients during
routine urinalysis screening. Clinic-wide rates of opiate-posi-
tive urine reports during a single screening have ranged from
less than 10% (Harford and Kleber 1978; Siassi et al. 1977; Senay
et al. 1977) to rates as high as 38% of tests (Baldridge et al.
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1974; Goldstein et al. 1977; Havassy and Hargreaves 1981). In
analyses of the incidence of drug use, 20% to 40% of patients are
commonly reported as showing at least an occasional opiate-posi-
tive urine test over a period of several months (Goldstein et al.
1977; Bigelow et al. 1980; Newman and Whitehill 1979; Renault
1973; Stitzer et al. 1980), while incidences of 50% to 85% of
clients with at least occasional positive urines are also reported
(Goldstein et al. 1977; Ling et al. 1978; Siassi et al. 1977;
Woody et al. 1975). Persistent opiate drug use (e.g., more than
10% of urine tests positive over several months of urinalysis
screening) has been observed to occur in 20% (Bigelow et al.
1980), 33% (Ling et al. 1978), and 57% (Goldstein et al. 1977) of
clients in various reports where this statistic has been provided.
Although many factors may contribute to wide discrepancies in
estimates of opiate drug use prevalence, it is clear that use of
opiate drugs during methadone maintenance treatment occurs to a
significant extent.
A number of previous studies have utilized urinalysis results
both as an objective measure of use and as a target for contingent
reinforcement interventions. In these studies, drug abuse patients
have been reinforced for remaining abstinent from drugs and pro-
viding drug- free urinalysis samples. Use of an on-site urinalysis
testing apparatus allowed for frequent urine testing and immediate
feedback and delivery of contingent reinforcers. Several case
study reports (Bigelow et al. 1976; Hall et al. 1977; Stitzer
et al. 1979a) suggested that such contingent reinforcement pro-
cedures could be effective in reducing the rates of supplemental
opiate drug use by methadone maintenance patients. Some of these
case reports are of interest because they dealt with recalcitrant
chronic opiate abusers with whom previous efforts at contingency
management therapy had been unsuccessful. Abstinence from supple-
mental opiate use was eventually achieved by escalating the cost
of continued drug use (opiate-positive urines) and/or the payoff
for evidence of drug abstinence (opiate-free urines).
Stitzer, Bigelow, and Liebson (1980) conducted a controlled study
of the effects of contingent reinforcement for opiate-free urines.
Subjects were seven black methadone maintenance patients selected
for participation because of persistent positive urinalysis test
results. A within-subject reversal design was employed which in-
volved rapid alternation of experimental conditions. This design
was possible since opiate drugs such as heroin clear from the body
within days of use. Contingent reinforcement for opiate-free
urines was available during randomly selected weeks, while during
other weeks, no programmed consequences were associated with
urinalysis results. If the urine was opiate free during a con-
tingent reinforcement week, the patient could choose one item
from a reinforcer menu which included methadone take-home privi-
leges, cash payments, and methadone dosage self-regulation.
Contingent reinforcement and nonreinforcement weeks were presented
in random order for an extended period of time (3 to 36 weeks) and
were followed by a return to baseline condition.
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Substantial reductions in opiate-positive urine test results
during contingent reinforcement weeks were evident for five of
seven participants compared to their own prestudy baseline rates
of urine positives .(see fig. 1), while in two subjects the inter-
vention had no apparent effect on drug use. Four of the five for
whom reduced opiate use occurred during contingent reinforcement.
weeks also exhibited substantial reductions in opiate-positive
tests during the randomly occurring noncontingent study weeks
(fig. 2). This appeared to be a generalization of therapeutic
effects to weeks when contingent reinforcement was not available.
However, generalization was not evident after the contingency was
terminated, since drug use returned to baseline levels. Examin-
ation of urinalysis results for a variety of drug classes other
than opiates revealed no detectable increase in the use of these
other drugs during portions of the study when opiate use was re-
duced.
A logical extension of contingent reinforcement procedures for
reduction of opiate drug use would be application to patients en-
rolled in methadone withdrawal, since this period is one of par-
ticularly high risk for supplemental opiate use. Hall et al.
(1979) reported that contingent payment for opiate-free urines
reduced detected rates of opiate use among 41 narcotic addicts
undergoing 16-day outpatient methadone withdrawal. A similar
study was conducted by McCaul et al. (in press) which examined
the effects of contingent reinforcement for opiate-free urines
during a 90-day methadone withdrawal regimen. Twenty eligible
patients were randomly assigned to experimental or control con-
ditions which were in effect during weeks 4 through 13 of the
90-day detox program. Dose reduction from 30 mg to 0 mg/day
methadone occurred over a 6-week period (study weeks 4 through 9)
at a rate of 5 mg/week, and was identical for the experimental
and control conditions. Placebo methadone (cherry syrup vehicle)
‘was dispensed during the final study weeks. No experimental con-
sequences were attached to twice-weekly urinalysis test results
for control subjects. The consequences attached to urine test
results for the experimental group are listed below:
Consequences Attached to Twice-Weekly Urinalysis
Test Results for Experimental Subjects
Opiate-Negative Opiate-Positive
1) Receive $10 cash payment
2) Receive a single methadone
take-home dose
3) No extra data forms
4) No extra counseling
5) No extra urines
1) No cash payment
2) No take-home dose
3) Complete symptom check-
list daily
4) Participate in daily
directive counseling
5) Provide daily urine
samples
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FIGURE 1. Percent morphine-positive urine tests are shown for
pre- and post-intervention baseline periods (BL) and for study
weeks during which contingent reinforcement was available
(CONT RF) or was not available (NO RF) for providing opiate-free
urine specimens. Percent of positive tests for five individual
subjects was averaged to obtain the data shown. Data for two
additional subjects who failed to respond to the intervention
are not included. Error bars are ± 1 SEM.
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FIGURE 2. Percent opiate-free urine samples is shown during
successive weeks of a 90-day methadone detoxification program.
Subjects selected for this study had high rates of opiate-free
urine tests during the initial three weeks of treatment
enrollment, during which dosage was stabilized at 30 mg/day.
Methadone dosage reduction occurred during study weeks 4 - 9.
Placebo methadone was dispensed for the remainder of the treat-
men t program. Data are shown separately for 10 control subjects
(triangles) who received standard clinic treatment and for 10
experimental subjects (circles) who received privileges contin-
gent upon each urine sample which was opiate-free and penalties
contingent upon each sample which was opiate-positive. Missing
samples were treated as being opiate-positive.
McCaul et al., J Appl Behav Anal (in press). © Society for
Reprinted from
the Experimental Analysis of Behavior, Inc.
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Reinforcers scheduled for delivery as a ‘consequence of opiate-free
urines (1 and 2) were delivered immediately upon receipt of the
clean urine. Penalties scheduled contingent upon receipt of an
opiate-positive urine (3, 4, and 5) were in effect until an opiate-
free urine was obtained.
As shown in fig. 2, fewer opiate-positive urines were obtained
from experimental than from control subjects during the 6 weeks
of dose reduction. The between-group differences resulting from
the contingency were particularly apparent during the first 3
weeks of dose reduction (fig. 2), while during the final 3 study
weeks shown, when subjects were receiving 0 mg/day of methadone,
there was no longer any difference in rates of positive urines
between the experimental and control groups. Efficacy of the
contingent reinforcement intervention during the early portion of
the detoxification protocol was also evident in individual subject
data. Half of the experimental subjects remained opiate free
during the entire 6-week dose reduction period while none of the
control subjects did so.
The studies described above suggest that interventions which in-
clude contingent reinforcement for opiate-free urines are ef-
fective in reducing opiate drug use among methadone patients during
both maintenance and withdrawal treatment. An interaction between
methadone dose and positive reinforcement condition is suggested
in the opiate withdrawal study since incentive procedures were
efficacious while patients continued to receive active doses of
methadone and lost their efficacy when the methadone dose reached
0 mg/day.
REDUCTION OF SUPPLEMENTAL BENZODIAZEPINE USE DURING METHADONE
MAINTENANCE
Benzodiazepine tranquilizers also appear to be frequently used
and abused by methadone maintenance patients. Kleber and Gold
(1978) noted high rates of benzodiazepine use among their patients
while Woody et al. (1975) designated 40% of their methadone
maintenance patients as “diazepam users” on the basis of self-
reports of liking for the drug and/or recent use of street-pur-
chased drug. Similarly, Bigelow et al. (1980) noted high rates
of use based on persistent drug-positive urinalysis tests, and
Stitzer et al. (1981) found that 50% to 60% of methadone main-
tenance patients in two different clinics showed persistent (n-ore
than 50% of tests) benzodiazepine-positive urinalysis tests during
a single month of screening. Furthermore, self-report data indi-
cate that methadone maintenance patients generally use benzodiaze-
pine drugs such as diazepam in dosages and patterns which suggest
abuse rather than therapeutic self-medication (Stitzer et al.
1981). Specifically, patients generally reported ingesting a
single relatively large (median = 40 mg) daily dose of benzo-
diazepines close to the time of day that they ingested their
methadone.
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Stitzer et al. (1979b) evaluated the ability of contingent clinic
privileges to influence benzodiazepine self-administration by
methadone maintenance patients who exhibited persistent urinalysis
positives for benzodiazepines. Diazepam (20 mg/day) was pre-
scribed by the clinic in order to permit observation of supple-
mental drug use; patients could request or refuse diazepam daily
throughout the study. During contingent reinforcement portions
of the study, the patients could receive clinic privileges (either
a single methadone take-home dose or a single opportunity to regu-
late their own methadone dose by ± 20 mg) twice weekly by refusing
available diazepam on the preceding three or four consecutive
days. During baseline portions of the study, patients requested
99% of available diazepam doses. When take-home privileges could
be obtained by diazepam refusal, only 17.6% of available doses
were requested, while when the dosage self-regulation option
could be obtained, diazepam was requested on 77.4% of occasions.
The results indicate that drug self-administration at the clinic
was influenced by offering clinic privileges and that different
positive consequences differentially affected drug-taking behavior.
In a subsequent study, contingent reinforcement procedures were
applied to the reduction of benzodiazepine drug use in the natural
environment (Stitzer et al. 1982a, 1982b). Ten methadone main-
tenance patients were selected for participation on the basis of
persistent benzodiazepine-positive urinalysis results. These
subjects reported a typical daily diazepam dose of 72.5 mg diaze-
pam (interquartile range = 25 - 187.5 mg) and reported occasional
experience with much higher doses (median highest daily dose =
225 mg).
During the contingent reinforcement study, urine samples were de-
livered twice weekly (Monday and Friday) and tested for presence
of benzodiazepine drugs using an on-site EMIT urinalysis system
which provided the opportunity for immediate feedback and conse-
quences . After baseline evaluation, contingent reinforcement for
benzodiazepine-free urines was offered for 3 consecutive months.
During this period, a benzodiazepine-positive urine had no conse-
quence, while a benzodiazepine-free urine resulted in a choice
between methadone take-home privileges, cash payments, and metha-
done dosage self-regulation. The contingent reinforcement period
was followed by a return to baseline conditions. Composite re-
sults for the group of study participants are presented in
Figure 3. While few benzodiazepine-free urines were obtained
during pre- and post-intervention baseline periods, their occur-
rence increased dramatically during the contingent reinforcement
intervention. Five of the ten subjects became benzodiazepine free
and remained so, while three additional subjects were temporarily
benzodiazepine free but relapsed while the contingent reinforce-
ment intervention was still in effect. No consistent increases
in other drug use were noted during periods of time when benzo-
diazepine use was eliminated. This study demonstrates that pro-
cedures which include contingent reinforcement for clean urines
can effectively reduce or eliminate ongoing supplemental benzo-
diazepine use among methadone maintenance patients without pre-
cipitating substitute use of drugs from some other class.
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FIGURE 3. Percent benzodiazepine-positive urine tests is shown
for pre- and post-intervention baseline periods (filled bars)
and for study weeks during which contingent reinforcement was
available for providing bensodiazepine-free urine samples
(striped bars). Each study period was generally 12 weeks in
duration. Percent of positive tests for 10 individual subjects
was averaged to obtain the data shown. Error bars are ± 1 SEM.
Reprinted from Stitzer et al., NIDA Research Monograph 41, 1982.
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REDUCTION OF ALCOHOL ABUSE AMONG METHADONE MAINTENANCE PATIENTS
Prevalence estimates of excessive alcohol use among methadone
maintenance patients have varied from 10% to 40% of patients
(Bihar-i 1974; Maddux and Elliott 1975; Liebson . et al. 1973; Schut
et al. 1973) although as noted by Stimmel et al; (1978)) these
rates depend on the specific population screened, inquisitiveness
of the observer, and the definition of “excessive consumption”
employed. Some have suggested that methadone treatment may be a
causal factor in the development of alcoholism. Stimmel et al.
(1978) question this contention since epidemiological data indi-
cate similar prevalence of heavy drinking patterns among non-
drug-abusing populations and methadone maintenance populations
with similar socioeconomic profiles. Irrespective of the causality
issue, it seems clear that excessive alcohol use is commonly ob-
served in a substantial portion of methadone maintenance patients,
that this problem constitutes a barrier to successful rehabili-
tation and is thus a legitimate and important area for therapeutic
intervention.
The inappropriateness of both opiate detoxification and Alcoholics
Anonymous as effective treatment strategies for the methadone
patient with alcohol problems has been discussed (Stimmel et al.
1978). Methadone detoxification in particular appears to be
inappropriate since this treatment may itself be associated with
an increased incidence of alcohol abuse (Vaillant 1966; Schut et
al. 1973). Prescription of disulfiram can be an effective treat-
ment, but its success depends upon obtaining adequate patient
compliance. An elegant study by Liebson et al. (1973, 1978)
demonstrated that access to the daily dose of methadone can be
utilized as a reinforcer to obtain compliance with disulfiram
ingestion. The 25 methadone patient subjects who participated
had been or were about to be discharged from other treatment pro-
grams as a result of excessive drinking and associated disruptive
behavior. After initial alcohol detoxification and 15-day expo-
sure to disulfiram treatment, subjects were randomly assigned to
an experimental or control condition. Control subjects received
weekly supplies of disulfiram and were instructed to ingest a
daily morning dose, while the experimental subjects were required
to ingest a disulfiram dose daily which was mixed in with their
liquid methadone ‘medication. The study design allowed for trans-
fer of poorly performing control subjects into the experimental
treatment condition.
Better treatment retention was achieved during experimental than
during control conditions, as shown in figure 4. Eleven of 13
experimental subjects completed the full 6 months of treatment,
while this occurred for only one of 10 control subjects. Four
control subjects dropped out or were incarcerated, while five
were reassigned to the experimental condition following initia-
tion of a drinking episode. The experimental treatment also
resulted in less drinking. Subjects spent 21% of their total days
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FIGURE 4. Treatment duration and reasons for early dropout are
shown for two treatment conditions in which patients dually
addicted to opiates and alcohol participated. All patients
received methadone maintenance treatment. Patients assigned to
the prescription control condition (N=lO treatment episodes)
received supplies of disulfiram from the methadone clinic. For
patients assigned to the experimental treatment condition (N=13
treatment episodes), receipt of the daily methadone dose was
contingent upon observed disulfiram ingestion at the methadone
clinic. Subjects who drank excessively during their participation
in the control condition were reassigned to the experimental
treatment condition. Maximum treatment participation was 6 months
in both conditions.
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in the program drinking during the control condition as compared
with 2% of total days drinking during the experimental condition.
These figures actually understate the difference between the two
groups since they do not take into account the quantity of alco-
ho1 consumed. Prevention of alcohol use did not result in in-
creased use of illicit drugs. Illicit drug use was reported on
9% of days during the treatment intervention and 13% of days during
the control condition. Lack of “symptom substitution” is consis-
tent with findings from previous studies in which the use of a
specific class of drugs has been reduced by therapeutic inter-
ventions without an increase in other drug use.
The foregoing study illustrates that specific effective interven-
tion is available for the treatment of methadone maintenance
patients exhibiting chronic, severe problems with alcohol. The
efficacy of disulfiram treatment depends upon patient compliance
and the advantage of the program described by Liebson and coworkers,
is that it utilizes frequent contact and the inherent drug re-
inforcer available in methadone maintenance treatment to achieve
this end. The patient group selected for study was eminently
suitable due to manifest antisocial behavioral problems associated
with their alcoholic drinking. Interestingly, the treatment pro-
gram was well accepted by the patients studied, although they may
have viewed their options as limited since they had recently been
or were about to be discharged from other treatment programs for
drinking-related behavior problems. The utility of this program
for patients with less severe alcohol-related problems remains
to be evaluated.
CONTINGENCY MANAGEMENT OF SUPPLEMENTAL DRUG USE: ADVANTAGES AND
DIFFICULTIES OF CLINICAL APPLICATION
Therapeutic interventions have been described which arrange con-
tingent consequences for evidence of reduced drug and alcohol use
among drug-abusing patients. Reductions of supplemental drug use
were demonstrated in both methadone maintenance and methadone
detoxification patients whose habitual drugs of abuse were opiates
such as heroin and among maintenance patients who chronically
abused either benzodiazepine tranquilizers or alcohol. The inter-
ventions described were effective with a substantial portion of
patients exposed to the procedures. It must be remembered that
the patients selected for participation in all but the methadone
detoxification study showed chronic and persistent use of supple-
mental drugs during treatment. These were patients, therefore,
for whom a potent pharmacological treatment (methadone) combined
with standard clinical techniques of verbal persuasion and program
sanctions were ineffective in influencing supplemental drug use.
It would seem both appropriate and useful to develop effective
therapeutic interventions for these patients, and the data suggest
that contingency management procedures provide a reasonable
approach.
There are both advantages and difficulties associated with imple-
mentation of contingent reinforcement procedures designed to
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promote reduced supplemental drug and alcohol use in methadone
maintenance patients. The following discussion will first ex-
plore limitations imposed by the technology currently available
to measure drug ingestion as a target behavior. Secondly, the
discussion will point out limitations in the generality of thera-
peutic success which can be expected from this implementation.
Then advantages related to the use of contingency contracting
procedures in general and positive reinforcement techniques in
particular will be discussed, followed by consideration of the
therapeutic advantages of reducing supplemental drug and alcohol
use.
Since drug ingestion invariably takes place outside the treatment
clinic, technologies are needed which provide an accurate objec-
tive measure of recent drug and alcohol use. Breath tests are
readily available which meet this need by providing a convenient
measure of current blood alcohol levels. On-site urinalysis
testing systems (EMIT) are also available which detect the presence
of many major drugs of abuse. While convenient and reliable,
these urinalysis testing systems have several limitations. First,
they are expensive to purchase, which limits their availability
to treatment clinics. Secondly, they cannot test for all the
drugs that patients might be using. This limits the applicability
of contingent reinforcement procedures in treatment of multiple
drug abusing patients. However, the major supplemental drugs
abused by methadone maintenance patients (i.e., opiates and
benzodiazepines) can be verified with currently available on-site
urine testing equipment. Thirdly, urinalysis testing systems
provide basically a dichotomous measure of drug use versus no use.
For drugs metabolized within a few days of use (e.g., opiates),
therapeutic interventions can focus upon decreasing the frequency
of illicit use but cannot address the amount of drug used during
a given episode. In the case of drugs such as benzodiazepine
tranquilizers, whose metabolites may be detected for several
weeks after a single ingestion, even frequency of use is obscured
in urinalysis results, and reinforcement can be provided only for
prolonged abstinence. It would be desirable to obtain more
quantitative information from urinalysis testing as well as in-
formation about a broader range of drugs of abuse.
Studies discussed in this paper have demonstrated the efficacy of
contingent reinforcement procedures for controlling drug and
alcohol use among methadone maintenance and methadone withdrawal
patients. However, the successful application of contingent re-
inforcement procedures may not generalize to all patients with
whom they are tried or to all circumstances. Few current guide-
lines exist, for example, as to how these techniques might be
implemented with individual patients simultaneously abusing
multiple drugs and/or alcohol. If excessive alcohol use is in-
volved, it seems clear that this could be treated with the con-
tingent disulfiram procedure previously described, independently
of illicit drug use. As far as multiple drug use is concerned,
the beneficial effects of contingent reinforcement interventions
focused on a single target drug may generalize to other drugs
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being simultaneously abused by a given patient, but it is likely
that specific techniques will be needed for focusing on multiple
drugs either sequentially or simultaneously in order to achieve
control of multiple use. As previously noted, measurement prob-
lems currently hinder such therapeutic efforts.
Even in patients whose supplemental drug use is restricted to
compounds which can be readily detected with on-site equipment,
a favorable response would not be expected with all patients ex-
posed to a single contingency management intervention. A lack
of universal efficacy is perhaps not surprising in view of the
difficult patient population being treated and the relatively
weak reinforcers which can be offered at the treatment clinic as
alternatives to self-administration of potent drug reinforcers.
However, this limitation may be overcome by judicious selection
of reinforcers. Thus, it has been noted in case study reports
that, by escalating the magnitude of reinforcement for drug-free
urines and/or the penalties for drug-positive urines, conditions
could be found under which individual recalcitrant subjects
would respond to contingency management interventions (Bigelow
et al. 1976; Stitzer et al. 1979a).
From an experimental point of view, these individual differences
in response to a single treatment intervention are intriguing
and suggest that individual patient characteristics might be re-
lated to treatment response. These characteristics may exist
in recent as well as lifetime levels of drug use, history of
successful abstinence attempts, levels of sociopathic deviancy,
amount and type of social supports available to the individual,
and historical response to aversive versus positive reinforcement
contingencies. It is possible that patients who have a poor re-
sponse to positive reinforcement interventions might show a
favorable response to aversive control procedures. This notion
could be empirically tested and might provide a rationale for
more reliably matching patients with appropriate treatment inter-
ventions (McLellan et al. 1981).
The apparent impermanence of therapeutic effects following with-
drawal of interventions is perhaps the most troublesome limi-
tation of contingency management procedures which provide
tangible external reinforcers for behavior change. The observa-
tion of a return to drug use during treatment evaluation studies
does not necessarily limit clinical applicability, however. In
experimental demonstrations, interventions are withdrawn abruptly
at an arbitrary point in time and if relapse occurs, this pro-
vides strong evidence that the intervention modified behavior
while it was in effect. In clinical practice, on the other hand,
treatment procedures would not be withdrawn abruptly in the ab-
sence of other supports for continued drug abstinence. Additional
research is needed to explore possible long-term utility of con-
tingent reinforcement procedures which can be implemented at the
methadone maintenance treatment clinic and to delineate the con-
ditions under which these interventions may be withdrawn without
precipitating relapse to drug or alcohol use.
97
Several important advantages may be realized as a result of im-
plementing contingency management procedures with drug abusers.
Some of these advantages are characteristic of contingency
management procedures in general, which specify in objective
terms the behavioral goals of treatment as well as the conse-
quences of alternative behaviors. This provides the basis for
feedback to patients about their behavior and circumvents dis-
agreements and conflicts between patients and staff members
over therapeutic progress or its lack. Written contracts
further reduce sources of ambiguity about therapeutic goals,
progress, and consequences of behavior. The resultant clarity
and specificity may be especially important in treatment of
drug abuse patients who may attempt to manipulate the thera-
peutic situation in various ways in order to obscure behavioral
goals and avoid behavioral change.
Other advantages derive from the use of positive reinforcement
as opposed to aversive control to promote therapeutic change.
Implementation of these procedures can have few detrimental out-
comes for patients or staff members, since patients are essen-
tially presented with a choice between continued drug use and
other positive reinforcers. If the patient chooses to give up
drug use, the intervention has been effective; if he or she
chooses not to give up drug use, nothing has been lost. If the
intervention works, patients with a long history of therapeutic
failure will experience success and therapists can be supportive
for improvement and avoid punitive consequences for failure.
Finally, several advantages of contingent reinforcement pro-
cedures derive from the therapeutic outcome of suppressing drug
use in patients who are chronic drug abusers. In fact, the ad-
vantages of this outcome may be considerable. First, a decrease
in disruptive drug-related behaviors may be achieved along with
the decrease in drug ingestion. This outcome was particularly
notable, for example, in the alcoholic patients studied by
Liebson et al. (1978). Secondly, a diminution of drug-seeking
behavior may free patients to focus their attention and personal
resources on improving other areas of their lives such as em-
ployment and interpersonal relations. Any improvements in
economic or social stability which can be gained during a drug-
free episode would clearly improve long-term prognosis for the
patient. Thirdly, contingent reinforcement procedures which
suppress drug use can provide an opportunity to initiate ad-
ditional comprehensive therapies during a period when the
patient is exerting some degree of self-control over drug use.
Reduction or elimination of supplemental drug use would appear
to be an essential first step in the treatment of drug abuse.
Once drug use has been brought under control, two specific
approaches should be considered in developing additional therapy
interventions. First, in patients who have become abstinent or
who have substantially reduced their drug use, and agree that a
long-term abstinence goal is desirable, specific relapse pre-
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vention training may be useful. It has been reported, for ex-
ample, in cigarette smokers who had recently quit smoking, that
those who used either behavioral or cognitive coping techniques
were more successful at maintaining abstinence than were smokers
who did not use these techniques (Shiffman 1982).
A second approach which might be useful in the long-term treat-
ment of drug abusers is one which focuses upon developing al-
ternative sources of reinforcement and punishment in the natur-
al environment and then transferring control of drug use to
these new sources. Thus, for example, families, or non-drug-
using peers, might be utilized as sources of both behavior
monitoring and contingency management. Family therapy in par-
ticular has recently been shown to improve outcome in the drug
using clients (Stanton et al. 1982). Families have numerous
reinforcers and punishers available to them and could be taught
to influence drug use by more effectively applying contingencies
to the drug-related behaviors of the drug-dependent family member.
At the present time, contingent reinforcement interventions
warrant application in clinical settings as a means to promote
temporary control over drug and alcohol use in patients who
chronically abuse these substances. These techniques would ap-
pear to have significant advantages over usual clinical practices
which include disciplinary action for patients who exhibit the
behavior problem characterizing their drug abuse disorder. To
the extent that these techniques are successful in reducing
supplemental drug and alcohol use, they will free the patient
from continual drug-seeking activities and intoxication, allow
the patient to focus on other life problems, and facilitate
implementation of other more comprehensive therapies designed to
promote long-term rehabilitation of drug-dependent patients.
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A Contingency Analysis of
Family Treatment and Drug Abuse
Thomas C. Todd, Ph.D.
Historically, there has been relatively little interchange between
family therapists and behavior analysts or therapists, although
there are subareas with greater overlap, including teaching parents
to use operant approaches with their children (Patterson 1971;
Patterson et al. 1973; Mash et al. 1976), and teaching couples
behavioral skills and communication and problem-solving (Jacobson
and Martin 1976; Stuart 1969, 1980; Margolin and Christensen
1981). The aim of this chapter is to demonstrate that there is a
family treatment approach to drug abuse (Stanton and Todd 1979;
Stanton et al. 1982) that is based on sound behavioral principles
and to articulate these principles so that they can be applied to
any treatment program wishing to increase family involvement.
The chapter will deal with three major topics: (1) evidence of the
power. of the family to influence treatment outcome; (2) engagement
of the family in treatment; (3) development of a treatment plan
which includes the family.
Much of the material presented relates to the process of initial
engagement of the family in treatment and the broad contingencies
affecting the degree of family participation. Specific principles
will be presented which can dramatically increase the degree of
family participation in treatment. Less emphasis is placed upon
specific family therapy techniques which have been discussed in
detail by Stanton et al. (1982). This differential emphasis is
based on the rationale that a finegrained analysis of specific
therapeutic techniques is premature until a program develops
effective methods of involving the family in the program initially
and maintaining family involvement.
THE FAMILY AS A DETERMINANT OF CURRENT BEHAVIOR
Even when the drug user is a young adult, it is highly probable
that the family of origin continues to be a powerful determinant of
his current behavior.
imniediately obvious,
The validity of this statement may not be
since many drug clients are in their 3Os, and
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are often married and have children. Even with married clients,
however, the family of origin rather than the family of procreation
tends to have primary importance. There is an increasing body of
evidence documenting high rates of contact between patients and
their families. Vaillant (1966) found that 90% of patients
surveyed lived with their parents at age 22 and that this
percentage was still 59% at age 30. Similarly, Stanton et al.
(1978) found that 82% of young adult male patients in a Veterans
Administration program had at least weekly contact with their
mothers. Overall, it is clear that efforts to stabilize the
patient's marriage without first involving his parents are likely
to fail (Stanton et al. 1982, p. 121).
Potential Detrimental Effects of the Family on Treatment Outcome
Unless it is influenced by the treatment system, the family is
likely inadvertently to reinforce drug taking and undermine any
treatment program. Virtually any treatment program, regardless of
approach, has an extensive anecdotal "folklore" about ways in which
family members have subverted treatment. Family members often
behave in ways that overtly or covertly encourage drug taking (the
"enabling" role is similar to that described in the alcoholism
literature). Family members also will frequently undercut the
treatment program, especially at a stage when the client is
beginning to show progress (Haley 1980).
These observations are not surprising when one sees that substance
abuse can have powerful adaptive consequences in maintaining the
stability of the family system. The work of Steinglass and Davis
(Steinglass et al. 1977; Davis et al. 1974) has shown this
particularly clearly for alcohol. In their work, each family
member typically experiences a positive change in the pattern of
marital or family interaction at the moment alcohol is introduced
into the system. This may take a variety of forms, such as
decreased conflict and tension, increased intimacy or frequency of
interaction, or increased emotional expression.
For those unfamiliar with the family therapy literature, it is
important to point out that the reactions of family members may
often be viewed as maintaining drug-taking behavior whether or not
they served a predisposing causal role in the initiation of drug-
taking behavior. The family is seen as a relatively stable system
which tends to resist change, even those changes which might seem
desirable in the long run. Although some families exhibit this
"resistive" behavior more dramatically than others, some change-'
resistant behavior should be expected in any family in which the
drug abuse has occurred on a chronic basis for several years.
It is also suspected that family factors may play an important role
in the etiology of drug abuse, particularly in determining whether
a young person will move from drug experimentation to a pattern of
chronic abuse and dependence. In particular, the behavior of the
drug abuser may help the family to avoid difficulties in
negotiating transitions in the family life cycle, especially the
stage of "leaving home" (Stanton et al. 1982; Haley 1980).
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Potential Positive Effects of the Family on Treatment Outcome
Family members can also exert an important positive effect on
treatment outcome, even in the absence of specific efforts to
involve the family in treatment. Evidence for this conclusion
comes from several retrospective surveys. Eldred and Washington
(1976) interviewed 158 heroin clients and asked who had been most
helpful in their efforts to get off of drugs. The rank order of
responses was (1) family of origin, (2) opposite sex partner, (3)
Similarly, MACRO Systems researchers interviewed 462 clients and
found that the family was seen as second only to treatment (70.9%
vs. 79.6%) as an important influence in change (NIDA 1975). Levy
(1972), in a 5-year followup of 50 narcotic clients, found that
those whose treatment is successful typically have family support.
It is worth noting that similar conclusions have been drawn for
alcoholism, although with alcohol it is typically the spouse, not
the parents, who is most important. Regardless of the mode of
treatment used to deal with alcoholism (AA, inpatient treatment,
disulfiram, etc.), family and spouse involvement adds significantly
to the probability of success (Jacobson 1981).
ENGAGING THE FAMILY IN TREATMENT
Perhaps a more appropriate title for this section would be "active
recruiting" of families into treatment because, as will be noted,
considerable effort is required to succeed in involving families in
treatment. Family recruitment became one of the most important
aspects of our project, although we had initially underemphasized
its importance and difficulty. Space does not permit a full elabo-
ration of the principles and techniques of effective engagement;
the interested reader is referred to publications on this topic.
(Van Deusen et al. 1980; Stanton and Todd 1981; Stanton et al.
1982, pp. 39-106).
Use of Contingent Reinforcement to Engage Families in Treatment
Without specific attention to the contingencies affecting the
behavior of both the client and the family, it is extremely
unlikely that the client will give permission to contact family
members or that family members will agree to participate in
treatment. This results from a combination of factors, all of
which need to be specifically addressed.
First, the family therapist initially has few, if any, positive
reinforcers under his control. Certainly the "opportunity" to
participate in family therapy is not seen as a reward. This is
particularly important in the context of a methadone maintenance
program, where the most important reinforcers relate to medica-
tion. Several steps may be taken to offset this initial
difficulty. In the program described here, the family therapist
assumed the role of "drug counselor " to increase his salience and
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thereby become associated with methadone dispensation, which is-a
powerful positive reinforcer for opiate-dependent clients.
Next, efforts were made to increase the primacy of contact with the
family therapist, so that the client contacted the family therapist
early in the chain of treaters and overall treatment process.
Finally, we attempted to have the family therapist placed in charge
of the overall treatment, including all important treatment'
decisions. With respect to this final point, we learned that it
was important not to pretend to have control over contingencies
that would not actually be invoked, such as transferring the client
to another program.
A second major factor is the need for the client to receive
positive reinforcement from the family therapist before the
therapist broaches the subject of family involvement. This usually
means paying considerable attention initially to the client's
physical discomfort and to his requests for methadone or other
medications, since these issues are paramount from his viewpoint.
A third major factor is that the therapist must act to decrease the
client's anticipation of possible negative outcomes of family
involvement. The therapist must convey an attitude about the
family that indicates that no one will be blamed. It is crucial to
resist the temptation to create an alliance with the patient by
implying that his problems may be the fault of the parents. It is
also useful for the therapist to agree to "take the rap" for
involvement of the family and its outcome. Concretely, this means
asking the client for permission to contact the family directly,
removing the addict from the awkward position of having to persuade
the family that their participation in treatment would be helpful.
Neutralizing the Negative Connotation of Treatment
Initial contact with the family must be conducted with the
knowledge that the idea of becoming involved in treatment is likely
to have strong negative connotations. Such an attitude on the part
of family members is not surprising. It is likely that they have
been repeatedly disappointed through a long history of having hopes
aroused only to be shattered. Thus, they have ample justification
for the assumption that they may be blamed. Particular effort must
be made to decrease the atmosphere of blame and to emphasize the
potential helpfulness of the parents and other family members.
(See Stanton et al. 1982, pp. 124-127, on "Noble Ascriptions" and
avoiding blame.) It is also helpful for the therapist to elicit
the goals of the parents in some detail and then to propose a
treatment plan that will address these goals. For example, some
parents will emphasize employment, while others may emphasize
breaking away from undesirable friends and associations. AS in all
behavioral intervention approaches, effective family therapy using
these techniques benefits from individualized determination of
steps, goals, and reinforcers in treatment.
In general it is clear that conducting recruitment efforts
according to these principles can be quite effective. In a sample
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of 95 adult male heroin clients, 71% of all eligible families were
successfully engaged in treatment. The most frequent barrier was
the client's refusal to allow contact with the family. Of the
families for whom permission was obtained, 88% were successfully
recruited.
EFFICACY OF CONTINGENT PAYMENT FOR ATTENDANCE
A recent study (Stanton et al. 1982) has demonstrated that payment
for attendance improves treatment retention and the attendence of
family members at sessions. The subject families were lower income
and working class families who had a son, the index patient (or
"IP"), enrolled in a VA methadone program. The IP had to be opiate
dependent for at least 2 years and in regular contact with parents
or parent surrogates. The mean age of the IP's was 25.3 and 25%
were married. Each family was randomly assigned to one of three
treatment conditions which were adjuncts to the methadone program.
These included Paid Family Therapy, Paid Family Movies, and Unpaid
Family Therapy. (The family movie group served as a control for
the effects of payment and of family involvement.) Ten sessions
were scheduled, and in the paid groups every family member age 12
or over received $5 at each session attended. In addition, there
were other contingencies, discussed below.
Once families were engaged in treatment, remarkably high rates of
treatment compliance were achieved. In the paid family therapy
group, all families attended a minimum of four sessions. Equally
striking was the finding that 81% attended ten or more sessions as
specified by the initial treatment contract.
Comparable figures for unpaid family therapy showed a clear payment
effect, although attendance was still much better than might have
been expected for such a difficult population. Eight per cent
dropped out before treatment began, and 40% attended only one to
three sessions. Fifty-two per cent completed at least four
sessions, and 40% completed ten or more.
Although payment did influence attendance, it did not significantly
influence treatment outcome, above the contribution of attendance
alone. (See Stanton et al. 1979 for statistical analysis of the
comparative contributions of payment and family therapy.)
Interestingly, many family members went to considerable lengths to
emphasize that the money was not important. These statements do
not necessarily imply that payment did not influence their
behavior. It does appear likely that considerable cognitive
dissonance was created by the possibility that their behavior was
motivated by money, especially since life-and-death issues were
often at stake. Even if payment is not a realistic possibility,
either legal or program pressure may be brought to bear to increase
family involvement, as long as effective treatment can be conducted
when the family does attend. Clearly, whenever possible, an effort
should be made to establish contingencies which rely on positive
reinforcement and minimize the aversiveness of the treatment
setting for the client and family.
1O8
DEVELOPING A COMPREHENSIVE TREATMENT PLAN WHICH INCLUDES THE FAMILY
The focus of the treatment efforts described is, of course, the
interaction between the client and his family. While this would
typically be labelled "family therapy," the designation of "family
therapy" often creates unnecessary resistance, since it implies
that the family has the problem, not the addict. For this reason,
we emphasize the helping role of the family and avoid labelling
this as family therapy.
Whether or not formal family treatment is involved, and regardless
of the other components in the treatment plan, the family can
almost always play a positive role. For example, the family can
help to increase compliance with treatment involving a narcotic
antagonist or can help to insure attendance and treatment compli-
ance in an outpatient methadone program. Conversely, it is almost
invariably a mistake to keep family members in the dark about
treatment or to set up covert competition about who can be most
helpful to the client. Again it should be noted that general
procedural rules are helpful but it is always necessary to
individualize the approach and maximize positive reinforcement.
The beginning stages of treatment should be designed to create an
initial experience of success. In this regard there are many
specific things that the therapist should do. The therapist should
'create an overall favorable climate and maximize the opportunities
for positive reinforcement. The treatment should be time-limited
and goal-directed, especially directed toward goals identified by
the family. In the present program, an attempt was made to develop
explicit goals in three areas, including: drug abuse itself,
employment and other productive use of time, and living/social
situation. Tasks addressing and directed towards achieving these
goals were delineated in small steps, with success a high
probability.
There are also issues and problems that the therapist should
definitely avoid. These include. leaving treatment open-ended and
vague, with only marginal relevance to the drug problem. It is
particularly important to avoid conflict between the parents, and
it is equally important to discourage a "catharsis" of negative
emotions. While many drug-dependent clients have come to expect
unpleasant encounters as part of treatment, such an emphasis makes
therapy extremely aversive for one or more family members, and the
treatment will almost certainly fail.
The parents (often, in these families, the father) should be given
a major advisory and decisionmaking role in all important aspects
of the treatment program. In the family treatment program
described herein, parents have been encouraged to become involved
intimately in the overall treatment program. Naturally, in order
to do this effectively, the parents need education, support, and
guidance from the therapist. Typical areas in which parents are
asked to become involved in discussion and decisionmaking include
take-home privileges, decisions about hospitalization, readiness to
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decrease dosage or terminate methadone, and the credibility of
urine reports intended to screen for drug use.
There are several important reasons for involving the parents in
spite of the complexities involved. First, explicit involvement of
the parents minimizes the client's opportunities to play the
therapist and parents, or parents themselves, against each other.
For example, without family involvement, the client is likely to
complain to the parents about aspects of the treatment and enlist
their support, while concurrently complaining to the therapist
about the parents. Second, the participation of the parents in
treatment decisions enhances the power of the parents, which
enables them to be more helpful. Finally, such participation has a
major effect on the degree of committment and investment that the.
parents have in the long-range success of the treatment, which
helps to ensure that gains made during the program are maintained
afterwards.
It has been particularly evident that a behaviorally oriented
treatment approach can be useful in keeping treatment focused.
Although the treatment program described here is not primarily
behavioral in orientation, it successfully incorporates several
behavioral elements.
First, in all of the family treatment cases, the therapist provides
systematic feedback about current drug use to the parents, based on
the result of the latest urine tests. This feedback is very
important because it maintains the focus of the treatment on hard
data. It is also extremely important that the therapist be present
to guide the family in evaluating the feedback in the light of the
patient's overall pattern of success and failure and to help shape
the family's response to this feedback. These data permit the
therapist to keep the family focused on what they will actually do,
rather than remaining at the level of vaque generalities. The
therapist may allow the family to accept-the-client's initial
excuses but at the same time point out problems which may arise in
the future concerning falsification of urine test reporting and the
like.
In the research project, the effects of contingent payment for
clean urines in combination with program attendance have been
examined. Using this procedure, both the client and the other
family members have a financial stake in having everyone attend and
having the client maintain abstinence, as reflected by uncontami-
nated urine samples. (For details of the complex contingencies
involved, see Stanton et al. 1979, pp. 14-15.) As mentioned
earlier, contingent payment has a clear effect on attendance and
encourages the family to be present so that treatment can work.
There is modest evidence that offering contingent payments to the
family as a whole for the success of the client at providing clean
urine samples and hence being "drug free" has a positive effect on
treatment outcome, although payment alone is consistently less
powerful than family therapy.
110
A promising new approach for changing the consequences to the
family of the client's relapse to drug taking has been the
development of a "home detoxification" procedure. The idea of
having the addict detoxify at home grew naturally out of work with
the clients and their families and was also heavily influenced by
Haley (1980). It is clear that admission of an addicted family
member to the hospital for withdrawal is generally a "nonevent" for
most families and produces little emotional involvement in its
success or failure. In fact, for many families, hospitalization is
positively reinforcing, since it relieves stress and reduces
anxiety and guilt. It is a socially acceptable means of demon-
strating that the problem is being addressed and that it is out of
the family's hands. Given these contingencies, it is not sur-
prising that the typical result is a cycle of repeated hospitali-
zations and unsuccessful attempts to terminate administration of
methadone or other opiates.
Home drug withdrawal attempts to keep the family focused on the
therapeutic realities and has aversive components that the family
is not eager to repeat. Several principles should be kept in mind
when implementing a home drug withdrawal effort: (1) The condi-
tions for the eventual home drug withdrawal must be carefully
worked out. (2) It is important to build on the strengths of the
family and upon success experiences earlier in therapy. (3) The
family must not be allowed to escape from the home detoxification
through initial failure. Instead, the possibility of failure must
be anticipated and a backup plan developed. (4) While the con-
ditions for success should be carefully managed, it is nevertheless
important that the home detoxification experience should require a
high level of family involvement. They will therefore experience
success as more meaningful and, as noted, will also not care to
repeat the experience (Stanton et al. 1982).
ENDING THERAPY
One of the major advantages of involving the family in treatment
comes at the end of treatment. If family treatment has been
successful, the formerly drug dependent client is left with an
important natural support system that will continue after treat-
ment is over. This is in marked contrast to other treatment
approaches. For example, a frequent problem with methadone
maintenance and therapeutic community programs is that successful
treatment leads to loss of the reinforcers in the therapeutic
support system. That is, success results in diminished contact
with all phases of treatment ranging from the conversations with
other clients, the dispensing pharmacist, and the drug counsellor
to contacts with various medical and mental health professionals.
Although the problem is diminished in family treatment, loss of
support or decreased availability of reinforcers may still be a
significant issue for the family when therapy ends, since the
family loses the therapist as an important source of support. The
therapist can utilize three techniques to minimize the disruption
of ending therapy. First, throughout therapy, it should be
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emphasized that credit for success belongs to the family and the
drug-dependent client, not the therapist. This will be most
meaningful if the therapist clearly identifies how the success was
achieved and how the family could handle similar issues in the
future. Second, the therapist should promote a model of episodic
involvement in treatment. That is, the family should not feel that
they have failed if they need to return for a "booster" of a few
additional sessions. Indeed, planned followup sessions are often
helpful. Third, it is especially important to avoid a dichotomous
success-failure perspective that is extremely likely to lead to
relapse. The therapist should assist the family in anticipating
potential problems and should discourage the notion that the future
will be problem free. It is often useful to rehearse strategies
for solving problems that may occur.
EVIDENCE OF EFFECTIVENESS
Despite reported widespread use of family therapy in drug abuse
treatment agencies (Coleman and Davis 1978), unfortunately there
are few controlled outcome studies. Recently evidence has been
obtained from a controlled treatment outcome study that a family
treatment therapy program can have a significant impact on heroin
abuse. In addition to the initial outcome data (Stanton et al.
1979, 1982), which were highly positive, there is accumulating
evidence that the results are well maintained in a 2- to 3-year
followup period. The home drug withdrawal approach is currently
being tested and appears to be relatively successful when it is
implemented, but it is not always readily initiated.
Results have been obtained for several outcome variables and will
only be briefly summarized here. For the best treatment condition
(paid family therapy), 67% of the cases showed a successful outcome
in abstinence from use of illegal opiates. Successful outcome was
defined as free from use of illegal opiates for at least 80% of one
time interval. This contrasts with 33% in the non-family treatment
condition and 39% in the control Condition. Results for legal
opiates (including detoxification from methadone) were similar:
paid family therapy, 62% success; non-family treatment, 27%
success; control, 28% success. The results for unpaid family
therapy were less dramatic, but the differences between paid and
unpaid family therapy were not statistically significant. Finally,
a dramatic finding was related to the difference in death rates
between clients in the family and non-family treatment groups. For
non-family treatment clients, there was a 10% death rate, compared
to 2% for clients whose families were involved in treatment. This
is not only highly significant statistically, but is also of
obvious social significance.
In conclusion, it should be evident that behaviorally based family
treatment requires both skill and effort in implementation. It
should be equally clear that there is no implication that similar
results can be obtained with "garden-variety" family therapy.
Treatment was highly structured and systematic, although it should
be reemphasized that these results were obtained with only 10
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sessions. There is little doubt that, given ample training and
administrative support, this approach can be implemented in other
settings with positive results.
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The Job Seekers’ Workshop: A
Skill Training Program for Drug
Treatment Clients
Sharon M. Hall, Ph.D., Peter C. Loeb, M.S.W.,
and Tim Allen
The Job Seekers’ Workshop is a behaviorally based skill train-
ing program designed to assist exheroin addicts to increase job
interviewing and job finding skills. It is one example of the
way in which behavioral skill training can be used in drug
treatment.
Some of the impetus for the workshop came from data gathered on
the need for specific ancillary services in methadone mainten-
ance, completed in San Francisco by another University of
California, San Francisco faculty member (Hargreaves 1980).
Three methadone programs in the San Francisco area were includ-
ed. The programs varied in size from 128 to 270 active clients
but were similar in that systematic ancillary services were not
well developed in any of them.
All clients in the three programs were asked to complete a brief
questionnaire. Approximately forty-one percent (269/661) comp-
leted a 19-item inventory of interests in ancillary services.
The 19 activities on the questionnaire are shown in rank order
of preference in table 1. Rank preference was computed from a
mean preference score where raw scores ranged from 1 for “Never
want to do that” to 4, “Want to do that very much.” In the
second column is the proportion of responders who indicated a
strong interest in that particular activity (a score of 4). Of
the ‘five top areas of interest, three have to do with
vocational activities, including either job help, educational
services, or job experience. Job experience, job help, legal
problems, and educational services form what Dr. Hargreaves
called an “adult role functioning” factor. The factor structure
of the questionnaire is shown in table 2. The services making
up this factor have not been addressed in the literature in
systematic studies to any great extent, except the supported
work studies of the last decade (Friedman 1978: Bass and
Woodward 1978; Dickenson and Maynard 1981). Despite their
high ranking, they are also services most clinics do not
provide (Hubbard and Harwood 1981).
115
TABLE 1
Expressed Interest in 19 Activities
by Methadone Maintenance Clients
(N=259 respondents out of 661 total clients)
PERCENT EXPRESSING
ACTIVITIES IN RANK ORDER STRONG INTEREST
LEGAL PROBLEMS 56
JOB HELP 54
EDUCATIONAL SERVICES 52
JOB EXPERIENCE 52
CLIENT COUNCIL 48
HOW MY BODY WORKS 41
RELAXATION TECHNIQUES 42
PEOPLE'S GUIDE TO THE CITY 37
INDIVIDUAL COUNSELING 38
"PSYCHOLOGY TODAY" 37
FUN AND GAMES 31
SPORTS PROGRAM 32
COUPLES COUNSELING 29
A LOOK AT THE "STRAIGHT LIFE" 23
GROUP THERAPY 24
PROBLEMS OF PARENTS 25
HOMEMAKING SKILLS 22
FAMILY COUNSELING 20
WEIGHT CONTROL 22
From, Hargreaves, W.A. Interest in ancillary services in
methadone maintenance. © J Psychedelic Drugs,  12:
47-52, 1980.
Reprinted with permission.
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TABLE 2
Rotated Factor Loadings for 19 Interest Items1
Activity Factor I Factor II Factor III
Job Experience 74 12 2
Job Help 68 10 9
Legal Problems 32 3 6
Educational Services 26 14 8
“Psychology Today” 8 79 7
How My Body Works 21 66 17
A Look at the “Straight Life” 7 33 27
Relaxation Techniques 7 29 17
Individual Counseling 6 17 71
Group Therapy 10 13 44
Family Counseling 7 3 27
Client Council 18 3 27
Couples Counseling
Homemaking Skills
Fun and Games
Weight Control
People’s Guide to the City
Problems of Parents
Sports Program
11
8
6
10
7
6
13
5 20
21 5
15 10
9 14
26 15
15 16
16 9
Mean Interest Rating (x 100)
Mean Percent Expressing
Strong Interest
Mean Estimated Percent
Total Interest
123 83
54 36
21 14
72
33
13
From, Hargreaves, W.A. Interest in ancillary services in
methadone maintenance. © J Psychedelic Drugs,  12:
47-52, 1980.
Reprinted with permission.
1. Factor I is focused on practical help with adult role
functioning; Factor II relates to psychological education;
Factor III relates to personal counseling and psychotherapy
approaches.
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Dr. Hargreaves' data, combined with our interest in behavioral
skill training techniques, resulted in a series of three
studies, all focused on evaluating the Job Seekers’ Workshop, an
intervention designed to provide drug treatment clients with
the skills necessary to find jobs in both the public and private
sector.
The activities included in the Workshop were based on our
observations of the problem behaviors drug treatment clients
showed in interview situations, as well as in their general job-
seeking strategies. These included 1) poor work histories,
especially few jobs or many short-lived jobs, long gaps in work
history, or repeated firings; 2) criminal records;  3) ignorance
of effective behaviors in an interview situation,  including
ineffective masochistic honesty or poorly formulated lies, use
of addict slang, distracting mannerisms, or inappropriate dress;
4) ignorance of informal job-seeking resources,  Such as tele-
phone books, Friends, and interviewers.
The initial project (Hall et al. 1977) had three specific aims:
1) to determine whether the experimental workshop would be
attractive to drug treatment clients; 2) to test the hypothesis
that experimental subjects would be superior to controls on
ratings of employability or training acceptability, and 3) to
test the hypothesis that experimental subjects would be more
likely than controls to find vocational placement.
The subjects were 49 methadone maintenance clients referred to
the project from four clinics. Only subjects who were psychotic,
illiterate, or who anticipated serving jail time within three
months were ruled out. We accepted subjects from two placement
categories. Fifteen subjects indicated their interest in a
competitive skill training program, and the remaining 34
subjects were seeking jobs. A competitive skill training pro-
gram was a publicly-supported work or training program that
demanded an application procedure and an admission interview
and only accepted a certain percentage of applicants. The
sample is described in table 3. Most of the subjects were
Caucasian, although almost half were black or of Latin
descent; 34 subjects were male, and 15 were female. The mean
number of months in treatment at the current treatment clinic
was slightly under 11.
Subjects were randomly assigned to experimental or minimal
contact control conditions. Five two-week workshops were held
over a six-month period. Each consisted of three to six in-
dividuals. During each week of the workshop subjects met on
two days for approximately five hours and one each for three
hours. Both experimental and control subjects attended an
initial meeting during which the director of Vocational
Rehabilitation services for the four clinics provided all sub-
jects with information about places and training programs and
resources open to them. The assessment interview was explained
to subjects and they were then told of their condition assign-
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TABLE 3
Composition of Control and Experimental Job-Seeking and Training-Seeking Groups by Age, Sex,
Level of Education and Job History Variables
MEAN AGE (Yr)
LEVEL OF EDUCATION:
CONTROL EXPERIMENTAL
J ob - Training- Job- Training-
Seeking Seeking Seeking Seeking Overall
(N=15) (N=8) (N=12) (N=7) (N=42)
31.50 30.62 29.17 31.14 30.48
High School Graduate
or GED 6 5 6 5 22
High School, GED
not completed
MEAN NUMBER OF JOBS
IN PAST 5 YEARS
MONTHS WORKED IN
PAST 5 YEARS
MEAN SES STATUS1
OF PAST JOBS
9 3 6 2 20
1.54 2.21 2.27 1.86 1.92
21.60 18.13 30.77 15.57 24.14
5.65 5.63 5.80 6.00 5.78
1The scale ranges from 1 to 7, with 1 indicating professional positions, and 7 indicating unskilled labor.
ment. Control subjects were dismissed at that point. They were
scheduled for an assessment interview at the same time as the
experimental subjects. Experimental subjects then reconvened
for an afternoon session where the format of the workshop was
outlined. At this point, the content of the workshop included
a discussion of vocational aspirations followed by a brief re-
laxation training session. Subjects used active coping relax-
ation to relax before the interview. Subjects then role-played
short segments of the initial interview and the final component
of the interview. At the end of the second day, difficulties
involving completing job application forms were discussed.
Subjects were given a form to complete before the next session.
They also formulated a “next step” in the placement process
which they were to have completed in the free day that followed.
Following the “free day,” subjects met for a half-day session.
They discussed the difficulties encountered and ways of handl-
ing these difficulties.
The remainder of the session was devoted to written application
forms. The rest of the workshop was concerned with the complete
interviews. Subjects had opportunities to role-play interviews
in progressively more difficult situations; that is, the inter-
viewer acted cold, hostile, or distracted. Subjects also took
the interviewer role with other subjects, and proved to be
difficult interviewers, indeed, usually by drawing from their
own experiences.
At the end of the workshop, all subjects participated in a
simulated interview. A single interviewer, blind to experi-
mental condition, rated subjects on a global scale tapping
employability/acceptability as a trainee. Three months after
the end of the assessment interview, subjects were contacted
and asked to indicate whether they had found a job, the date
of the placement, and the number of interviews attended since
the end of the workshop. The place of employment and date of
placement were verified by checking with the subjects’ counsel-
or.
The results from this initial study were promising. Only 17%, or
four of the experimental subjects, dropped out (three of the con-
trol subjects “dropped out” also; that is, they did not appear for .
this final interview). Participation in the experimental condi-
tion resulted in significant increases in vocational placement.
As figure 1 indicates, at follow-up, 50% of the experimental
subjects had been placed as compared with 14% of the controls.
Experimental subjects were rated also superior to controls on
both interview performance and written applications.
This study led to two companion studies. In both of these
studies, the effect of the Job Seekers’ Workshop on job finding
only was examined. We did not. accept potential subjects
attempting to find placement in a competitive training program
as we had in the original study, mostly because of design
considerations.
120
FIGURE 1
Percent of Subjects in Job Seekers’ Workshop and Control
Conditions Placed by Three-Month Follow-up
In the first of these, a revised version of the Job Seekers’
Workshop with exheroin addicts drawn from the criminal justice
system was evaluated (Hall et al. 198la). In the second, the
Workshop was cross validated in a methadone maintenance sample
(Hall et al. 1981b). The criminal justice sample provides an
interesting contrast with the methadone samples.
In the criminal justice study, subjects were 55 parolees or pro-
bationers who had documented histories of heroin abuse who were
referred to the project from either county probation officers
or State parole officers.
Agency personnel were blind to experimental conditions and
assignments. Again, we ruled out only subjects who were psy-
chotic, illiterate, or who anticipated serving jail time within
three months. The characteristics of the sample are shown in
table 4. The majority of the subjects were black. A sizeable
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TABLE 4
Characteristics of Criminal Justice Sample
AGE MEAN
NUMBER OF MEAN
JOBS, PAST
FIVE YEARS
MONTHS SINCE MEAN
LAST JOB
MONTHS WORKED MEAN
PAST FIVE
YEARS
Experimental Control
( N = 3 0 ) (N=25)
34.41 33.24
 1.28 1.67
Entire
Sample
(N=55)
33.87
1.46
27.44 30.22 28.65
12.21 15.58 13.74
SEX MALE
FEMALE
EDUCATIONAL
LEVEL; HIGH
SCHOOL
DIPLOMA/GED
YES
NO
24
6
18
12
23
2
10
15
47
8
28
27
CRIMINAL PAROLE 15 18 33
JUSTICE PROBATION 7 5 12
STATUS BOTH 4 5 9
minority were Caucasian. There was a greater proportion of male
subjects than in our previous study. The two samples did not
seem to differ markedly in educational level or job indicators.
However, the job data are not meaningful, since many subjects had
spent significant amounts of time within the last five years in
jail or the penitentiary.
A treatment/no-treatment design was used again. Treatment con-
tent was streamlined to three components: 1) job interview
training; 2) instruction in completion of application forms;
3) job search procedures. The components of each are shown
in tables 5. Emphasis placed on job interview training and on
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T A B L E  5
Three Components of the Job Seekers’ Workshop
1. JOB INTERVIEW TWINING
A. Video desensitization
B. Desirable entrance and exit behaviors
C. Eliminate distracting behaviors
D. Positive presentation of self
E. Video and verbal feedback
F. Gradually increasing “difficulty” of interview
2. COMPLETION OF APPLICATION FORMS
A. Know crucial personal information
B. Handling difficult items, especially drug histories
and arrests
C. Emphasizing positive aspects of job history
3. JOB SEARCH PROCEDURES
A. Sharing job leads
B. Using friends and relatives as resources
C. Unexpected resources--job interviewer, the telephone
and telephone books and the newspaper
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completion of application forms was increased. The job search
procedures were largely modeled after the work of Azrin and
his colleagues (Azrin et al. 1975’; Azrin and Philips 1979). They
included sharing of job leads and learning how to obtain them
from friends, relatives, job interviewers, newspapers, and
telephone books. Subjects also practiced making telephone calls
with coaching and suggestions by the leaders.
In this study, as in the subsequent one, the “free day” activity
and relaxation training were omitted. The “free day” activity
was omitted because subjects in the initial study failed to
follow through with these activities, viewing them as un-
important, ‘make work” tasks. Relaxation training was omitted
because anxiety wasn’t a problem for many subjects. Also,
for those for whom it was a problem, knowledge of interviewing
skills seemed to be more potent in reducing anxiety than re-
laxation training. A more sophisticated assessment device, a
factor-based instrument called the Interview Rating Survey
was used. It included two scales, the items of which are
shown in table 6. The first might best be characterized as a
general, primarily verbal, competency factor. The second con-
sists mostly of specific nonverbal behaviors.
At a mock assessment interview, subjects were rated on this
scale by two interviewers who were blind to treatment condi-
tions, and blind to the content of the experimental intervention.
Following treatment, subjects were contacted once a month for
three months and information about the day of their hiring
and the amount earned obtained. Again, we verified employ-
ment whenever possible. Results of this study are shown in
figure 2. These data represent a Life Table Analysis (Fleiss
et al. 1976; Cutler and Ederer 1958). At the end of three
months, this analysis indicates approximately 86% of the experi-
mental subjects had found employment as compared to 54% of the
controls . The differences, between the conditions were apparent
as early as one week posttreatment. The difference at this
point is significant, and remains so throughout the three-month
period.
Resides having higher placement rates, the experimental condi-
tion differed significantly from the control condition on the
second IRS scale--the one measuring specific, nonverbal
behaviors.
We were surprised at the high general rate of employment in
both experimental and control conditions in this study. We
had selected this population for replication because we thought
they would provide a more stringent test of the effectiveness
of the intervention since they had both recent prison histories
and a history of heroin abuse. There are several factors that
might explain the reason for the differences between this condi-
tion and the methadone sample,’ including prevailing employment
rates, differences in leaders, and differences in subjects’
abilities and degree of addiction. Our hypothesis was that
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1. Level of information provided about job skills
2. Level of information about past jobs
3. Responses to interviewer questions
4. Possesses relevant job skills
5. Absence of self-disparaging statements
6. Ability to explain problem areas
7. Positive presentation of self
8. Likelihood of hiring, if position available
TABLE 6
Interview Rating Scale
FACTOR 1 FACTOR 2
1. Posture
2. Tension level
3. Absence of distracting mannerisms
4. Appearance
5. Eye contact
6. Courtesy
7. Appropriate exit and entrance
8. Use of an assertive closing
9. Manner of speaking
FIGURE 2
these differences were the results of a potent contingency.
That is, many of these subjects faced a return to prison
if they did not find jobs.
In the final study we returned to methadone maintenance clinics.
Sixty job-seeking methadone maintenance clients were assigned
to either the Job Seekers’ Workshop or to the information-only
condition. The sample for this study is described in table 7.
In this study, the program was presented over four days with
the assessment interview on the final, fifth day. However, the
content was the same as that used with the criminal justice
sample. The outcome, which was again percentage of subjects
employed at each week, is shown ‘in figure 3, which is also based
on a Life Table analysis. A comparison for all experimental
subjects with controls indicated differences which narrowly
failed to reach conventional levels of statistical significance,
although they were in the expected direction. Of the experi-
mental subjects, 52% were employed, as compared with 30% of
the controls. Four experimental subjects left immediately
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TABLE 7
Characteristics of Second Methadone Maintenance Sample
AGE
NUMBER OF
JOBS, PAST
FIVE YEARS
MONTHS SINCE
LAST JOB
MONTHS WORKED
PAST FIVE
YEARS
MEAN
MEAN
MEAN
MEAN
MALE
FEMALE
Experimental  Control
(N=30) (N=30)
30.14 30.83
1.43 .96
Entire
Sample
(N=60)
30.52
1.37
33.12 49.76 36.94
10.71 8.00 9.25
SEX
EDUCATIONAL
LEVEL: HIGH
SCHOOL
DIPLOMA/GED
YES
NO
16 19 35
14 11 25
14 19 33
16 11 27
CRIMINAL PAROLE 5 3 8
JUSTICE PROBATION 9 8 17
STATUS NEITHER 16 19 35
following the information presentation and therefore never
received the experimental treatment. If they are excluded,
along with their matched controls, differences in employment
are significant. In interview behaviors, as rated by blind
interviewers, we found that participation in the workshop
increased scores on the general competency scale of the IRS
but not on the specific behavior scale.
These data indicate that the Job Seekers' Workshop is effective
in helping drug treatment clients find employment. However,
demonstrating effectiveness is one thing. Motivating programs
to implement treatment techniques of demonstrated effectiveness
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FIGURE 3
may be another. This is the dissemination problem: once an
approach has been shown to be of value, what methods effectively
motivate service providers to adopt it?
To answer this question, a study is currently being conducted
through the Human Interaction Research Institute (HIRI) in Los
Angeles in collaboration with our group. The participating
investigators are Drs. Edward Glaser (Principal Investigator)
and Paul Greenberg of HIRI, Dr. James Sorensen, and the authors
from University of California, San Francisco.
This project has two goals: 1) to disseminate the Job Seekers’
Workshop to drug treatment programs in the western United
States, and 2) to evaluate the effectiveness of three different
strategies for encouraging programs to adopt the approach.
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One hundred and ninety drug treatment programs will be recruited
over the next year. Participating programs are stratified by
modality (outpatient drug free, methadone maintenance, and
residential) and randomly assigned from within these blocks to
one of four conditions:
Printed Information Only.  These 65 programs receive a 20-page
booklet. The booklet describes the Workshop. summarizes the
research, and discusses issues of appropriate clients, staffing,
and equipment. They also receive a 52-page Leaders’ Manual,
which is a step-by-step “cookbook” for conducting the research.
The contents of the Manual include discussions of recruitment
and screening of clients, equipment and materials needed, and
detailed descriptions of Workshop activities, including suggest-
ed comments for the leader and anecdotal material about issues
that arise.
Site Visit. The 30 programs in this condition receive the
printed information plus a one-day site visit from a project
staff member. The site visit includes a one-hour videotape of
an actual workshop, brief training in role-play interviews
and videotape feedback, and development of specific plans to
implement a Job Seekers’ Workshop in the program. Programs are
called one week after the site visit to review implementation
plans, and to remind them that project staff are available for
telephone consultation. Programs can receive as much telephone
consultation as they wish.
Training Conference. These 30 programs receive the printed
material, and are invited to attend a two-day training confer-
ence in San Francisco. Approximately eight programs partici-
pate in any one conference, which includes intensive experience
in role-playing and videotape feedback, discussion of implement-
ation, and interaction with the entire project staff. Followup
consultation is available as in the site visit condition.
Control. The 65 programs in the, control condition receive
printed information after  the study period is completed.
All programs are followed at three and nine months after con-
dition assignment. They are assessed by mailed questionnaires and
telephone to determine adoption rates, and other ways in which
the intervention has influenced the provision of vocational
services by the program.
The first wave of recruitment is underway. Recruitment letters
have been sent to a total of 127 programs in two separate
mailings. About 50% of the eligible programs have agreed to
participate. Programs agreeing to participate have indicated
interest and enthusiasm and commented on the relevance of the
Job Seekers’ Workshop to their clients’ needs. Programs declin-
ing have most frequently given lack of sufficient staff as their
reason for declining. No additional data are available at this
time. The projected completion date for data collection is
May, 1984.
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Brokerage Model Rehabilitation
System for Opiate Dependence: A
Behavioral Analysis
Travis Thompson, Ph.D., Jon Koerner, and
John Grabowski, Ph.D.
INTRODUCTION
Clinicians and policy tacticians have attempted to determine
whether refinements in the existing methadone treatment system
might lead to improvements in treatment. Thus, for example,
specific aspects of methadone administration (e.g., dosage and
duration) have been reviewed (e.g., Cooper et al., 1983) and
overviews of the prevailing system have been provided (Dole and
Nyswander 1983). The suggested resolution to problems depends in
part on the theoretical perspective of the observer. Indeed, Dole
and Nyswander (1983) have observed that "priorities in treatment
have been complicated by ideological arguments, competition for
public funds and deeply felt issues of morality." In a similar
vein, Pickens and Thompson (this volume) have noted that differing
theoretical perspectives have resulted in different interpretations
and approaches to treating drug-dependent patients. Inroads have
been made in developing effective therapeutic strategies, but it is
clear that some of the problems in treatment will not be resolved
through further refinement of the current system. The time may be
appropriate to examine the systems within which drug dependence
treatment services are provided and, if necessary, to make
appropriate modifications. This may be particularly true with
respect to treatment services provided for heroin use.
Discussions of heroin dependence are usually based on two
assumptions: (1) The individuals have an underlying biological or
psychological abnormality, which, if rectified, will make them well
again, and (2) Specific treatments exist, or can be discovered,
which will eradicate the disorder suffered by the heroin user.
Based on these assumptions or variants of them, practitioners
attack the putative illness of the opiate-dependent person.
Treating activities are designed to eliminate, or at least
modulate, the underlying disorder, which it is believed is heroin
dependence. Treating, in this sense, becomes an activity equated
primarily with process rather than effect. Depending on the
practitioner's theoretical orientation, the focus of treatment
could be methadone maintenance, group therapy, individual
counseling, or biofeedback training. Aspects of the client's life
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not central to the primary "treating" activities of the
practitioner are typically viewed as adjunctive services to which
attention may or may not be directed in a systematic fashion.
Considerable variability exists from facility to facility in terms
of these services.
The line of reasoning on which much treatment is based is flawed in
several respects. The analysis of what it is to be a stereotypic
heroin-dependent individual is inaccurate. First, heroin
dependence is not an illness per se or a thing, akin to a diseased
appendix which can be extirpated to render a sick patient well.
Rather, heroin dependence is a behavioral state, defined by the
nexus of environmental and pharmacological factors which has
impinged on the individual, and interacts with the current
environmental conditions to engender the characteristic pattern of
deviant behavior. Second, although numerous individual procedures
exist which effectively alter one or another of the deviant
behaviors or deficiencies characterizing the lives of heroin users,
they are seldom applied in concert in an organized way.
Combinations of technologies, addressed to the array of variables
characterizing heroin dependence processes, are required for
meaningful rehabilitation. Moreover, no procedures can be
effective if they are irregularly or improperly administered, alone
or in combination. Overall it is apparent that no single treatment
or technology can be applied which will cure or ameliorate the
problems of the heroin-dependent individual. As should be evident
in succeeding pages, an alternative policy and associated
technology may prove more effective than the current dominant forms.
BASIC MECHANISMS INVOLVED IN HEROIN DEPENDENCE
The prevailing scientific opinion until the early 1960s was that
opiate use and dependence were synonymous with physical
dependence. In the early 1960s several studies were conducted with
rats and monkeys suggesting compulsive opiate self-administration
was a special case of operant behavior in which the
dependence-producing drug serves as a rewarding event (Deneau et
al. 1969; Schuster and Thompson 1962; Thompson and Schuster 1964;
Weeks 1962) maintaining drug-seeking behavior. While physical
dependence could serve an important role, as a setting condition
for further self-administration, it was not essential to the drug
dependence process. Growing out of this early work has been an
extensive literature with opiates, alcohol, and other drugs of
abuse corroborating the generality of this model (cf. Schuster and
Thompson 1969; Thompson and Pickens 1969; Meisch 1982; Griffiths et
al. 1980; Spealman and Goldberg 1978; Johanson and Schuster 1981;
Pickens et al. 1978; Thompson and Johanson 1981). This literature
has pointed to the importance of interactions between behavioral,
environmental, and pharmacological variables as determinants of
drug use. Conceptualizing drug dependence in this way has lea to
new treatment technologies which have successfully reduced the
control drugs exercise over the behavior of the user under specific
circumstances. Broader implications of a behavioral analysis of
drug dependence processes have been limited. Behavioral
practitioners attempting to treat heroin-dependent individuals in
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the natural environment have often believed that while they could
identify major variables requiring attention, they could not gain
the control over Family, vocational, educational, or drug resources
that iS necessary to engender enduring behavioral change. The
solution has typically been to Focus on one or two Factors which
have been accessible, and to deemphasize or ignore the remainder.
This is an understandable practical response to a Frustrating
problem, but, as with other approaches, has diminished the
effectiveness of otherwise very effective procedures. Thus
problems may reemerge to original proportions as treatment is
removed. It should be noted that one consequence of the behavioral
treatment perspective, i.e., its attention to data and
documentation, has resulted in acknowledgment of its Failures as
well as its successes. Nevertheless, an analysis of the behavioral
repertoire and environment of a typical urban heroin user reveals
that such modest efforts with primarily a single focus cannot be
expected to bring about more than modest results.
ANALYSIS OF HEROIN USERS' OPTIONS
Three groups of options may be identified as available to a
prototypic urban heroin user: (1) a licit life style; (2) a
treatment/rehabilitative life style; and (3) an illicit life
style. A method of analysis developed by Findley (1962, 1966) and
pursued by others is helpful in elucidating relevant variables and
understanding complex multioperant behavioral repertoires. Using
this analytic technique, major components of behavior are
identified and systematically examined. Findley proposed a useful
system for schematic presentation Of the elements of a behavioral
system and repertoire, and this has been used here to delineate
major components of the heroin user's behavioral choices, or
options.
As has been discussed in the context Of specific examples by other
authors in this volume, the options can be compared on numerous
dimensions, two of which are (1) positive reinforcement parameters
and (2) punishment parameters. Presented in Figure 1 is an
analysis of what might be termed the behavioral space of an urban
heroin user. While it is clear that the complete array of possible
detailed analyses For all categories of heroin users, or even urban
users, is not represented, one can obtain a sense of the necessary
Form Of analysis by the example presented. In this case the First
sequence of behaviors (or operant 1)1, illicit activity, would
typically involve theft or burglary, leading to selling the stolen
goods (operant 2). The heroin user would then buy drug, most
likely from a dealer (operant 3), which would be self-administered
(operant 4). The likelihood of a given act of theft or burglary
being detected by the police (operant 8) is extremely low; hence
the punishment branch of the multioperant schedule is rarely
experienced. Concurrently, the individual may apply for public
assistance and then wait for money (a generalized conditioned
reinforcer) (operants 12, 13) to be delivered without regard to
events in the other branch Of the schedule (operants 2-7). That
is, the several different layers of the system reinforce deviant
behaviors, and the contingencies of one are counterproductive For
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FIGURE 1
Overview diagram of options available to a stereotypic opiete using client.
The sequence starting with 1 has the most consistently reliable conse-
quence in the form of drug use with occasional interaction with police.
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The sequence beginning with 12 is fairly reliable, but benefits are remote
and can occur concurrently with drug use. The sequence beginning with
15 is the most difficult and has the greatest delay of reinforcement.
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the requirements of another. In this case providing assistance,
even though it is clearly needed, may undercut other aspects of
rehabilitation, not because it is provided but because of the
manner in which it is provided. The schedule of illicit behavior
itself is also under strong stimulus control, with several daily
intravenous heroin reinforcements sustaining the overall
repertoire.
Consider a rehabilitative alternative: a weaker delayed opiate
reinforcer is self-administered once daily (oral methadone) at a
clinic (operant 11). A relatively minor response requirement, that
of appearing at the clinic, is placed on the client. Successful
engagement in such other activities as academic or vocational
training (operants 15-17) is highly improbable. Typical adolescent
or young adult heroin users may have such deficient academic skills
that the reinforcers available in most educational settings have
little possibility of being effective (e.g., approval,
satisfaction, praise, high grades). Those reinforcers which are
available are infrequent, delayed, and not very powerful. However,
punishment for inappropriate academic behavior is immediate and
frequently provided by school personnel (e.g., verbal disapproval
or threats). The result is that most heroin users drop out of
educational programs. The situation for job training is virtually
identical. In both instances they are then further removed from
the licit system of reinforcers which would lead to a more adaptive
lifestyle.
A brief examination of the licit lifestyle reveals that this option
would probably be sustained by only a limited number of typical
young heroin users. Jobs are very difficult to obtain, and only 15
percent of potential employers say they would ever hire an "addict"
or "ex-addict,"  while only 33 percent of the individuals have ever
held a job (Gildenberg 1972). If they do obtain work, the rate of
pay is typically very low and the delay of reinforcement is long (a
minimum of 1 week and often 2 weeks). Since their experience with
obtaining monetary reinforcement, i.e., time to receiving a
paycheck, is in the main characterized by immediate payoff for
illicit activity, delay in obtaining money, a feature which
characterizes most jobs, is not acceptable. This is a skill which
must be acquired. In addition, these individuals are unlikely to
find social support initially from fellow workers and hence will be
exposed to very few conditioned reinforcers to sustain work-related
performance over the period between paychecks. Absenteeism,
tardiness, or poor work skills, all of which are likely in
unskilled, inexperienced workers, will be punished by supervisors,
thereby tending to weaken overall work-oriented behavior and will
lead to dismissal if repeated. Most of the other skills and
environmental supports for sustaining an abstinent and licit
lifestyle are typically lacking. A further impediment to success
under the normal licit contingencies for an individual with the
history described is that existing neighborhood social and leisure
time stimuli set the occasion for illicit behavior, including drug
taking. An appraisal of the behavioral options makes it clear why
most heroin users alternate between illicit and rehabilitative life
styles, rarely engaging in sustained licit performance. Overall,
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the prevailing contingencies in combination with the drug user's
experience are such that the reinforcers for maintaining an illicit
life Style are considerably more powerful than those which would be
necessary to produce change in the direction of maintenance of the
diverse behavioral repertoire of a licit lifestyle.
BEHAVIORAL TECHNOLOGICAL SOLUTIONS
The foregoing analysis suggests attention must be directed to a
number of critical loci in the lives of heroin-dependent
individuals if diverse forms of interaction are to be
rehabilitative. Table 1 presents seven loci of client behavior,
the site(s) in which these actions take place, and the objectives
of rehabilitation in each of these sites. An overall
rehabilitative program must attend to all of these variables if it
is to effectively develop and maintain-e necessary behaviors.
While many current treatment programs provide methadone in a
controlled clinical setting and/or group counseling at a clinic,
they have only limited resources or control to alter other
conditions and are often restricted to making referrals and
advising the patient to change his/her behavior.
Numerous agencies and sites must be involved in a heroin dependence
rehabilitation program. In many instances, technologies already
exist which can be applied in such settings (e.g., public schools,
job training, methadone clinics) and in other cases (e.g.,
residential, health care) technologies can be modified from those .
designed for other clinic populations (e.g., juvenile delinquent,
mentally ill, mentally retarded (cf. Phillips 1968; Thompson and
Carey 1980). Thus, it is not necessary to build new behavioral
intervention systems, but, rather, use can be made of extant
approaches. Perhaps the most important issue is that the problems
are not so much in designing individual rehabilitative programs
within a given site (e.g., a school), but rather in engendering
coordinated rehabilitative services and contingencies concurrently
across all sites. Coordination must emanate from overall public
policy and funding mechanisms. It is clear that coordination will
not arise spontaneously and that instead a systematic integrative
effort must be made to organize the various components of the
rehabilitative services. Current policy emphasizes treatment
delivered at specific sites (e.g., a clinic) and provides few
incentives for coordination across facilities. Indeed, funding
mechanisms may hinder cooperative effort. Thus, for example,
funding is generally contingent on the number of client slots
filled, i.e., the number of people being provided service rather
than number of cases treated successfully. This constitutes a
disincentive for graduating, or discharging, clients. It should be
apparent that no treatment group is attempting to preclude advances
by patients. Instead, the prevailing system of contingencies is
contrary to the goals that staff members are attempting to
achieve. It is not surprising that some clients remain in
treatment for years without appreciable change of status.
A superficial analysis might lead to the proposal that a
"fee-for-service" model would be a preferable alternative to the
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TABLE 1
LOCI OF DRUG ABUSE CLIENT BEHAVIORS AND SERVICES
LOCUS of Sites Therapeutic Objective
Residential Public housing Remove discriminative
and reinforcing
stimuli associated
with heroin
Educational Public schools
Vocational Vocational schools;
on-the-job
training
Opiate management Clinics
Health
Relational
Leisure time
Health providers;
HMOs; pharmacies
Individuals;
therapist;
support groups
Support groups;
service organiza-
tions; community
organizations
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Increase basic academic
skills; math and
writing related to job
Skills
Train job skills;
increase tolerance for
delays of reinforcement
Decrease reinforcing
properties of opiates;
reinforce clean urines,
punish dirty urines
Extinguish health
providers as discrimi-
native stimuli for
drug seeking
Increase responsible
social relationships
Increase leisure acti-
vities outside drug
culture
current system. Several problems suggest this is an unsuitable
alternative in and of itself. Without coordination,' service might
be duplicated or delivered unnecessarily and reimbursement of the
redundant providers would be required. Moreover, other critical
services might never be provided, since administratively these
activities are often funded under auspices of different public
agencies (e.g., vocational or educational versus medical).
Finally, since the current system reinforces "treating" activities
in the main independently of outcome, ineffective treatment will be
reimbursed at the same rate as effective treatment. This is
obviously disfunctional in two respects. It may deprive the client
of effective rehabilitation procedures, and more generally, may
perpetuate ineffective procedures.
The process of modifying the environment within which a service is
provided to shape organizational behavior to meet the needs of
clients is called formative management (Budde 1979). The notion
that management of human service systems should be based on
performance measures of system components is not new. However,
problems have typically arisen in that financial resource
allocations are often made with minimal regard to the degree to
which services meet client needs. This is especially troublesome
in the human service industry, where specification of goals and
success may be difficult. The questions are not whether regulation
of rehabilitative services to heroin-dependent clients is
necessary, but which data are necessary, to whom they should be
provided, and what consequences flow from such performance
evaluation.
Alternatives to extant service delivery and performance evaluation
systems have been employed in other areas of human service and
rehabilitation. An interesting and instructive example derives
from the efforts of a group of families of mentally retarded people
in Victoria, British Columbia, who were faced with the problem of
devising an adequate service-delivery system for their handicapped
family members. This need resulted from the closing of
institutions which had previously provided residential care, a
situation even more difficult than that provided by patients who
already have necessary skills for living in the community. They
formed a nonprofit organization (the Community Living Board) which
established a brokerage system for services to their family
members, ranging from where the people lived to who provided
medical, dental, and other health care services, and which
recreational services were purchased. The Province of British
Columbia provided a per diem for each client to the broker, and it
was the broker's responsibility to purchase the most appropriate
and effective services for each client (Rioux and Crawford 1982).
The brokerage model may have numerous advantages. The broker
selects providers, which in the case of treatment for heroin
dependence represent seven classes of services (see table 1).
Service selection must be based on client needs, cost, and data
concerning effectiveness of services previously provided by a given
vendor. The broker's fees, in turn, are based on objective
measures of client outcome. Centralization of services in
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specialized centers, as exemplified by "methadone clinics,"
unnecessarily segregates these patient/clients. These facilities
arose because of a need and serve a valuable function. But like
State hospitals serving mentally ill and mentally retarded people,
they are, in many respects, not an optimum service model. The
clinics do serve to monitor urines for illicit drugs and prescribe
and administer methadone. They also provide ongoing monitoring of
general health and referrals to appropriate medical services,
counseling, and referrals for other services. However, as noted in
other chapters in this volume, methadone clinics are likely to
experience problems with loitering, vandalism, muggings, and
related criminal activity in the vicinity. These are precisely the
behaviors one would expect at a site where a major reinforcer is
reliably administered every day to individuals whose repertoires
include these illicit or antisocial behaviors and for whom other
activities (e.g., work, educational opportunities) are not readily
available. Parallel behavior patterns can be demonstrated in
laboratory experiments, clinical settings, and the natural
environment. Notable recent social examples of difficulties which
arise in crowds around dispensers of reinforcers are the
disagreements in gas lines during shortages or similar "scuffles"
in groups waiting to obtain concert tickets or enter a variety of
large entertainment events. The added fact that in this case the
group encouraged to congregate has an extensive repertoire of
illicit or socially difficult behaviors increases the probability
that problems may emerge. The contingencies of the methadone
clinic encourage regular attendance, segregate drug users in one
area, assure daily interactions, and set the occasion and provide
reinforcers for drug-related deviant behavior. In brief, the
clinic inadvertently creates an "addictive institution" within the
community which assures that difficulties are most likely in the
vicinity. It is essential to note that it is not the dispensation
of methadone per se which establishes this "institution" but rather
the contingencies and conditions governing its dispensation and
provision of other services. Overall, it is remarkable that many
clinics have been as effective as they have at minimizing the
problems which emerge.
The need for central clinics has become less evident as a strong
human services system has evolved. In general, all of the services
provided by most specialized drug treatment clinics could be
provided by vendors integrated in the community. Private
physicians or public clinics could prescribe methadone and monitor
urines as well as monitor their patients' health. To the extent
that medical supervision and care were widely distributed among
doctors throughout a community, problems with loitering or other
related deviant behaviors would be minimized. Similarly, housing,
family counselors, and recreational services are available
throughout a community, not only in the poorest neighborhoods with
the highest crime rates. By dispersing these individuals widely
throughout a community, many of the problems with deviant behaviors
which exist in the current clinic system would be diminished.
A single broker would be unable to monitor all seven service
domains for each client (table 1) and maintain an adequate client
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load. A proposed administrative arrangement might involve a single
broker, 8 case managers, and 96 clients. Case managers would
collect data. and serve as liaison consultants to service
providers. While brokers would be technically knowledgeable, their
primary job would involve performance evaluation. Case managers
could be baccalaureate-level behavioral science technicians trained
to collect data and provide technical expertise to vendors. The
question which arises is what assures that each of the major
participants in this process will, contribute effectively to its
success. Table 2 shows the incentives for the client, the brokers,
and vendors for participating in the program and for performance
evaluation. Each participant has a good reason to cooperate with
program activities and work toward program goals.
Estimates of costs of drug abuse must be viewed with caution. They
may, however, give a general sense of the relative magnitude of the
problem. Such estimates for heroin use in New York City in 1978
provide an example. It was calculated that a heroin user in the
city, untreated, cost society about $25,000 a year in criminal
activity. Imprisonment, at the time, cost about $15,000 per year.
A methadone maintenance treatment slot was considered to cost
approximately $1,800 annually, while a drug treatment slot
including services in excess of methadone was estimated to cost
$2,700 per year. Of the approximately 290,000 narcotics abusers in
New York State, about 77 percent (or 223,000) lived in New York
City (U.S. Congress 1978). Given these figures for the city, if no
treatment services were available, the cost to society in criminal
activity would be $5.575 billion per year. Since some portion of
the individuals were in treatment (about 50,000). the figure might
be reduced to $4.325 billion per year. Exclusion of some portion
of the population of users because they pay for drugs through licit
income would still result in costs of substantial proportions. Any
treatment program that led to better client health and adjustment
and reduced costs would be considered successful. If it were only
'possible to reduce the number of individuals engaged in the illicit
life style by 10%, it would represent a large savings in New York
City alone, and monumental annual savings nationwide.
An obvious question is whether the cost of a brokerage program
would be less than or equivalent to costs for the extant system.
It is likely that the proposed approach, or a similar one, with
clear contingencies for client improvement, would cost no more, and
it is clear that the benefits of such a program would be
considerable.
The system would consist of a token economy, along the lines of
that described by Ayllon and Azrin (1968). A program would be
designed for each client in accord with his or her needs. A
bookkeeping system with specified monetary equivalents would be
maintained to provide a ledger of reinforcement for patient
successes. Acknowledgment of success would be tangible, immediate,
and consistent. Money earned would be credited to the patient and
would be in excess of the subsistence provided for food and
shelter. The token system would not only provide reinforcement for
remaining in treatment but would explicitly provide positive
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Locus of What's In It
Client Action For the Addict
Residential
Educational
Vocational
Opiate management
Health
Relational
Leisure time
TABLE 2
INCENTIVES FOR PARTICIPATING IN THE BROKERAGE REHABILITATION SYSTEM
Decent place to
live, free rent
for 6 months
Money
Money; prospect of
job
(1) No worry about
withdrawal
(2) Methadone
(3) Money
Free health care
(1) Improved family
relationships
(2) Money-
(1) More enjoyable
(2) Money
Why Provider Should
Cooperate
Rent for 6 months;
guaranteed clientele
Tuition paid to
school
Tuition to school;
free workers
Fee for service
(physician and
pharmacist)
Fee for service
(physician)
Fee for service
(therapist)
Voluntary
Voluntary
Broker's
Responsibility
Monitor living
environment
Provide money
administered by
school staff
Provide money
administered by
staff;
supervise point system
Provide money for
clean urines
Followup
Provide money for
responsible family
life
Provide money for
time in nondrug
culture activities
consequences for successful responses. Specific requirements would
be adjusted as needed for the duration of treatment with the tokens
exchangeable for money throughout. There would, of course, be
continuing examination and updating of goals based on progress. The
proportion of the total of tokens which could be earned each week
would vary across the seven doci of client activity over the period
of involvement with the rehabilitation program. The relative
availability of tokens for each activity would assure systematic
"economic pressures" to emphasize certain activities, and the
values would shift as a function of progress, thereby moving
behavior in the direction required.
The government would serve the important role of determining the
accuracy of brokers' reporting practices and providing financial
support for the system. The performance evaluation would be done
on a random sampling basis to verify brokers' evaluations of client
outcomes. Sampling similar to that done with income tax returns by
the Internal Revenue Service could be used to assess reliablility
of brokers' reports. The brokers themselves would require only
relatively small numbers of data points per client per week to
effectively monitor progress, and for any given broker the data
could be maintained on currently available small business
computers. Summary outcome data (e.g., quarterly change scores)
would be used to determine funding levels to vendors. By providing
vendors with timely information concerning client progress or its
absence it would be possible to assist service providers in making
appropriate changes in their programs. The contingencies for
broker and client alike would, within this system, be directed to
progress and change.
Inevitable questions arise concerning fee structure and client
characteristics. Similarity in fees for all clients would
encourage vendors to serve only those clients with the least
serious problems, as is inherent in the current system, but this
problem could be readily circumvented, since, again, equivalent
models exist for other services. At present, insurance companies
make decisions based on actuarial data concerning risk; for
example, clients with high health risk may pay more for health or
life insurance. Development of a parallel system of adjusted fees
permitting translation of client characteristics into differential
service-delivery costs based on our knowledge of treatment outcome
with similar clients would be an essential component of the
system. This would minimize the incentive for vendors to deal only
with the easiest cases. Numerous problems, some of which could not
be anticipated, would evolve and require resolution but should not
deter the formulation of a workable system.
The disincentives to change which may in some cases be produced by
public assistance must be considered. There are divided views on
the issue of whether any contingencies may ever be attached to
availability of public funds for food, clothing, and housing for
the needy. This is clearly a legitimate and reasonable area of
concern and must be examined with caution.It appears that, in the
case of some heroin users, availability of noncontingent financial
support contributes to sustaining an illicit life style. Since the
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life style of a heroin user is often characterized by isolation
from the culture at large and the absence of dignity, providing
funds without concern or attention to the consequences of doing so
is irresponsible. Noncontingent funds not only produce food and
shelter, they also maintain an addictive lifestyle, and Society
cannot be absolved of this responsibility. Appropriate contingent
provision of money, housing, and food can generate behavioral
change for the benefit of the client. It may be reasonable,
therefore, to link multiple drug-related legal encounters to
further access to public assistance based on participation in a
meaningful rehabilitative program. Some portion of the public
assistance (e.g., housing and food) might be provided with minimal
requirements, while all funds above and beyond these amounts would
be provided only in the context of rehabilitation.
Overall, the various aspects of the system discussed would provide
a reasonable mix of government and private endeavor. The brokers
and case managers would be employees of licensed nonprofit
organizations that would compete for contracts to deliver services
for which they would be reimbursed. Oversight and sampling of the
accuracy of the brokerage reporting and administration of funding
would entail a neutral government agency. The design of this
system is a reasonable outgrowth of experience in the provision of
diverse health care services with a focus on the desired outcome.
CONCLUSION
The problems in treatment of drug use are numerous and arise from
pharmacological, behavioral, and environmental determinants. In
the case of the typical heroin-dependent individual who enters
methadone treatment, it is clear that multiple social and economic
problems exist concurrently. Skillful scientists and clinicians
have investigated and addressed various aspects of these problems
and in many cases have generated impressive solutions. It is
becoming increasingly clear, however, that specific treatment of
one or another component will not provide resolution to a
multifaceted problem. This is true because heroin dependence does
not involve a predominantly biological illness amenable to
treatment in the conventional sense. In addition, despite efforts
to broaden the scope of treatment, an applied behavioral systems
analysis of the contingencies governing provision of treatment
suggests that even if the component strategies were optimal,
considerable difficulty would emerge in their application.
Models from other human services domains suggest an objective
accountability-oriented system of services coordinated and
administered by skilled brokers may be an excellent alternative.
Such a system assures that decisions concerning financial
incentives to service providers are based on objective measures of
progress. It further assures that from the perspective of the
client the rewards resemble those which are required for
maintaining a licit life style. While some difficult decisions are
demanded of communities, the resultant rehabilitation strategy is
one incorporating all the resources of the community rather than
relying heavily on that portion least able to provide support of a
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licit behavioral repertoire. Furthermore, inherent in the system
is the fact that clients learn under supervised conditions how to
live in the broader community rather than spending time loitering
or consorting with former peers and heroin-using cohorts.
Conceptually and practically it is clear that a procedure based on
contingencies and reinforcers anchored in progress and emphasizing
outcome rather than process could offer significant advantages for
drug abuse treatment and rehabilitation.
FOOTNOTE
1. "Operant," shorthand for "operant behavior," or behavior which
operates on the environment, denotes a behavioral unit defined at a
level appropriate for purposes of analysis. Self-injection of the
opiate could be the operant of interest, reinforced by drug effect,
in a microanalysis of self-administration behavior. Alternatively,
drug-seeking through drug-taking behavior could be viewed as an
operant of interest in analysis of a more global character. In the
present case, large behavioral chains are being defined as
behavioral units for purposes of exposition.
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Behavioral Intervention Tech-
niques in Drug Abuse Treatment:
Summary of Discussion
Maxine L. Stitzer, Ph.D., John Grabowski, Ph.D., and
Jack E. Henningfield, Ph.D.
A lengthy discussion concluded the technical review at which the
papers in this monograph were presented. The meeting participants
considered both general and specific advantages that might accrue
to making fundamental changes in the extant treatment delivery
system. Specific suggestions arose from that discussion on how to
improve the delivery of treatment services to drug-dependent
persons. While there was not complete agreement among all
participants, there was striking unanimity on many issues.
The comments that follow are divided into four major categories in
an attempt to reflect the tenor and emphasis of the discussion
without providing a verbatim reconstruction. The discussion points
include consideration of (1) improving treatment for specific drug
abuse problems, (2) improving delivery of ancillary treatment
services to drug abusers, (3) strengthening nondrug reinforcers,
and (4) establishing a long-term prophylactic environment for drug
users. Since some pharmacological treatments such as methadone
maintenance otter unique opportunities for behavioral management
interventions, much of the discussion centered on suggestions
specifically applicable to improving this treatment modality; many
innovations discussed can, however, be more generally applied to
treatments involving other pharmacological adjuncts as Well as to
nanpharmacological treatment approaches.
IMPROVING TREATMENT FOR SPECIFIC DRUG ABUSE PROBLEMS
Reduction of illicit drug use is the first goal of drug abuse
treatment. One model for achieving this goal is exemplified by
chronic methadone administration, which is currently the best
available treatment for accomplishing this goal for opiate drug
dependence. In particular, this treatment modality dramatically
reduces the ongoing use of illicit opiate drugs and is assumed
concomitantly to reduce the criminal activity associated with
obtaining funds to support illicit drug purchases. In terms of
this model it is desirable to attract as many opiate users as
possible, into treatment so as to maximize the beneficial effects of
treatment not only for the clients but also for the community.
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Although methadone is used primarily as a pharmacological adjunct 
for treatment of chronic opiate use and dependence, an important
property from a behavioral point of view is that it is a reinforcer
which can be used to establish and maintain treatment-oriented
behavior. In the initial stage of treatment, when methadone is
established as a reinforcer for heroin users, improvement in
treatment enrollment and retention might be established by more
effective introduction of the drug to patients.
One specific strategy suggested for improving the introduction of
methadone to opiate users was to begin treatment by pairing
methadone with intravenous administration of an opiate drug. In
this model, clients would initially be given both oral methadone
and intravenous opiate drugs at the clinic in an attempt to enhance
the reinforcing potency of the oral maintenance drug through
repeated pairings. Although it is unlikely that opiate abusers
would ever prefer oral methadone to intravenous opiate drugs, more
opiate users might find oral methadone an acceptable substitute for
street drugs under an improved system of introduction.
Aside from this specific introduction strategy, it is also probable
that higher rather than lower maintenance doses of methadone, as
well as a nonpunitive attitude on the part of the staff, are likely
to bring dependent individuals more effectively into treatment and
to maintain treatment participation. It should be apparent as well
that in those cases where other agents with a degree of reinforcing
effectiveness are used as adjuncts (e.g., benzodiazepines,
methylphenidate), contingencies governing their dispensing can be
established.
Methadone treatment does not eliminate all concurrent drug use, and
a considerable amount of supplementation with both opiate and
nonopiate drugs is observed among maintenance patients. Once oral
methadone is serving as a reinforcer to maintain treatment
participation, its reinforcing properties can be utilized to
influence ongoing supplemental drug use by judicious manipulation
of contingencies for daily methadone dose delivery based on the
results of onsite urine testing. For example, dose delivery hours
might be Utilized. Patients who provide a drug-free specimen in
the morning might receive their daily dose immediately, while those
whose urines indicate recent drug use would be required to return
in the afternoon for their methadone dose.
Additionally, the frequency of required attendance at the drug
clinic can be manipulated. Clinics generally grant take-home
privileges to patients who adhere to rules and consistently deliver
drug-free urines. Take-home privileges can be used explicitly to
produce marked improvement in poor performers when delivered
contingent on drug-free urinalysis results. The privilege of
take-home doses as well as the total number of such doses could be
made contingent on adherence with clinic requirements.
Finally, dosage level can be utilized in contingent arrangements:
dosage could be decreased for patients who provide drug-positive
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samples, while those delivering drug-free samples receive dosage
increases or have the option of changing dose. In one procedure
based on this approach, patients using illicit opiates are offered
the chance to choose an increased methadone dose each day they
deliver a urine sample that is free of illicit opiates, while they
receive only their regular dose if an opiate-positive sample is
delivered. This is effective because it offers the pharmacological
benefits of an increased methadone dose while utilizing the
reinforcing potential of extra methadone to motivate
discontinuation of illicit drug use. Contingent delivery of other
therapeutic medications, when their prescription is clinically
indicated, should also be considered.
The foregoing examples are based on the concept of a two-stage
treatment process in which methadone is first established as a
reinforcer and then its reinforcing power utilized to effect
behavioral change. The important point is that drugs commonly used
for treatment of behavioral disorders do have reinforcing effects
which can be used in contingent arrangements to influence
concurrent drug use as well as other therapeutically important
behaviors. Clinics often have rules which mimic clear
contingencies for reinforcement of adaptive behavior, but these may
be vaguely and unsystematically formulated and applied. It is
evident that explicit development of precisely defined
contingencies may better serve both the overall program and
individual patients. It is essential that the contingencies
applied to drug delivery not be so aversive or punitive as to
interfere with patient retention 'in treatment and should, in fact,
be couched in the terms of a positive reinforcement approach.
There has been considerable discussion over the years concerning
optimal techniques for dispensing drugs such as methadone. The
present system in which drug abuse patients receive all treatment
services in a segregated treatment system may appear to have
advantages from society's point of view; however, it also has clear
disadvantages' from a treatment or rehabilitation viewpoint.
Segregated treatment tends to isolate patients, to maintain the
social stigma which surrounds them, and to perpetuate friendships,
associations, and activities based on drug use. In addition, the
present methadone distribution system promotes loitering and
related behaviors which are the antithesis of desirable treatment
outcomes. Finally, the use of take-home medication for
well-behaved clients results in some illicit drug diversion. One
method suggested for improving this situation was to disperse
medication delivery more widely in the community, for example by
dispensing prescribed drugs at local pharmacies or mental health
centers.
While several practical problems would be raised with such a
system, it is likely that they could be minimized or circumvented.
For example, some drug abuse patients would attempt to secure
multiple rescriptions at different dispensing sites. This could
be prevented if medication dispensing were coordinated with
telephone or computer verification (Via a computerized prescription
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file) of patients' status and prescription. Interestingly,
computer-linked pharmacies are being developed for economic
advantage and the prescription "tracking" is one consequence. The
resistance of physicians and pharmacists in the community
concerning illicit activity would have to be overcome through
effective information programs, and satisfactory measures to meet
their objections would be essential. With community dispensing, it
would also be necessary to rely more consistently on reinforcers
other than methadone itself, since it might be difficult to arrange
contingencies between dose delivery and behavior or to arrange
convenient contact between patients and counselors offering
ancillary treatment services. Many of the problems could be
overcome or be precluded if appropriate preliminary efforts were
made in development of the "new" distribution system.
Agreement exists that community dispensing could at minimum replace
take-home privileges for a subgroup of well-adjusted patients who
do not need continual drug abuse surveillance and ancillary
treatment services, and this would have a positive impact on drug
diversion. For the pharmacists' purposes it would, of course, be
critical that drug dosage decisions be made elsewhere than at the
dispensing site, as is typically the case with all other
prescription drugs.
Drug clinic and community dispensing might profitably be combined
in a sequential approach. Thus, treatment could begin at a central
drug abuse clinic where intravenous as well as oral methadone was
available. Patients who continued to show illicit drug
supplementation, would be retained at this clinic and put under a
contingency management program based on methadone availability.
Other patients who showed little or no illicit drug use could be
recommended as candidates for convenient community dispensary
sites, a privilege which would depend upon continuing to provide
drug-free urine specimens. It would also be important to give
clinics credit for successfully graduating their patients into
community dispensary programs, since prevailing funding policies
tend to promote long-term retention of well-adjusted patients in
treatment at the drug abuse clinic. All patients would, of course,
be referred to other agencies for appropriate services.
IMPROVING DELIVERY OF ANCILLARY TREATMENT SERVICES
While the initial goal of drug abuse treatment is the reduction or
elimination of illicit drug use, it is also generally agreed that a
specific focus on drug use is Often not sufficient, since many drug
abuse patients exhibit a variety of psychiatric, behavioral, and
psychosocial deficits in addition to drug abuse. Although there is
disagreement as to the relationship between drug use and the other
behavioral disorders that drug abusers may exhibit, the most
reasonable approach is to advocate treatment interventions in all
appropriate areas based on assessment of individual needs. Several
suggestions were discussed for improving delivery of ancillary
treatment services to drug-using patients and for utilizing
behavioral principles to improve treatment outcome in areas other
than drug use.
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The ancillary problems presented by patients often are not
adequately addressed at the drug abuse clinic. In part the fact
that services are limited occurs because the skills and resources
of the paraprofessional counselors are limited when it comes to
providing treatment for ancillary problems and correlated
disorders. Yet there exist in the community expert providers of
services such as vocational training and psychological counseling,
from which many drug-dependent patients could greatly benefit. It
was suggested that treatment of patients' ancillary problems could
be addressed more effectively by reintegrating the treatment of
drug abuse patients into the existing network of mental health and
vocational training services, utilizing either drug abuse
counselors or a group of independent treatment brokers to arrange
for provision of services by appropriate professionals.
Numerous objections to this strategy may exist, but clear
advantages could emerge. Some may argue that since the population
in need of treatment is concentrated in urban settings, it may
overwhelm existing resources. However, redirection of drug
treatment resources would benefit all users of the communities'
resources and eliminate multiple administrative systems. It may be
feasible for some patients to move their residence to other
localities where more services are available. Indeed this step
could be encouraged by offering benefits or subsidies, thereby
further diminishing the problems which evolve from the
concentrations of patients at sites such as methadone clinics.
Alternatively, if available treatment services are inadequate to
deal with the demand, then money should be spent to develop more
services by well-trained professionals in specific areas of need
rather than simply providing a subsistence level of treatment
services by paraprofessional counselors who have not been trained
in these ancillary problem areas.
In addition to ensuring that adequate treatment resources exist, a
better system is needed for encouraging utilization of appropriate
ancillary treatment services by drug abusers. In theory, drug
abuse patients have all existing community resources at their
disposal, but, in fact, these resources are virtually never
utilized since these patients may be referred by these agencies to
special "drug abuse treatment clinics." This can be attributed in
part to the lack of appropriate contingencies Within the existing
treatment system. To take better advantage of existing services
and to improve delivery of ancillary treatment services, providers
must be motivated to deliver treatment to drug abuse patients, who
must in turn have incentives to take advantage of treatment
services from which they could benefit.
A brokerage system proposed at this meeting [see Thompson et al.,
this volume) would incorporate motivational features for both the
drug user and service providers. Each patient would be monitored
by a broker who would act as an intermediary or liaison between the
patient and community service providers. Brokers would use
monetary incentives to encourage appropriate behavior both on the
part of the drug user and on the part of treatment providers. For
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example, the drug treatment broker might establish a contract with
the county vocational training institute to accept a specified
number of urban drug abuse patients per year, pay the institute for
training the patients, and pay the patients for attendance and
success. Brokers might receive the money they need to perform
their service directly from drug abuse clinic treatment funds.
Alternatively, they might work by contract with employers of
persons with drug dependency problems, or with social welfare
agencies or medical insurance companies that are interested in
securing an effective range of treatment services for
drug-dependent clients. Quality control is also built into this
system, since experienced brokers would become selective in their
utilization of referral sources based on the-effectiveness of those
treatment facilities. Thus, a job training program that did not
consistently produce employable clients would find its enrollment
falling off as brokers took their business elsewhere.
Money is a universal reinforcer which can be used in contingent
arrangements to promote utilization of ancillary treatment services
within the context of the existing system as well as any improved
system that may be developed. As discussed in connection with the
brokerage system, patients can be paid explicitly for attending job
training workshops or psychological counseling sessions. Another
approach, which could be coordinated by either a broker or drug
abuse counselor, is to offer access to preferred activities as a
contingent reinforcer for engaging in some specified therapeutic
activity. A survey can be used to determine the kinds of
activities that individual patients would find desirable. These
may be, for example, specific educational opportunities such as
child care classes, recreational or social activities, access to
legal services, or altered levels of participation in the existing
treatment program. Social reinforcers available at the treatment
clinic can also be utilized as contingent reinforcers. For
example, the job-seeking client can be granted an interview with
the counselor only when he or she provides specific evidence of
job-seeking activities. Care must be taken, however, to preclude
the clinic's becoming the primary source of reinforcers for
patients.
Whether or not benefits would derive from any proposed new system
is an empirical question. Both short- and long-term cost-benefit
analysis would be essential for evaluating procedures which attempt
to better utilize community services for drug abusers. Possible
secondary benefits, such as improvement in services for persons
other than drug abusers, would have to be factored into the
analysis, as would any potential risks. Small-scale efforts in a
single geographic area or city would provide an opportunity to
further evaluate the brokerage system. An alternative approach to
improving delivery of ancillary services might be to bring
additional expertise to the drug abuse clinic and focus on
motivating patients to take advantage of services offered, although
this perpetuates the problem of segregation of one category of
behavioral disorder, i.e., drug use. In addition, this sort of
"patch up" approach leaves intact all of the difficulties inherent
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in the current system. It appears that due to current fiscal and
social issues this may be a propitious time to modify the treatment
system.
STRENGTHENING NONDRUG REINFORCERS
The dominant positive reinforcers for the chronic user of
illicit-illegal drugs are typically closely linked to acquisition
of drugs, interaction with dealers and others engaged in peripheral
illegal activities, and, of course, interaction with other drug
users. In some cases, drug-using patients have jobs and families
which can provide a source of external motivation for initial
behavioral change and continued good performance. Drug-using
health professionals, for example, may be motivated to seek and
continue treatment by the threat of losing their jobs or
professional licensure. Frequently, however, these external
motivators are absent or weak in drug abuse patients of lower
socioeconomic status. Since work and social relations are perhaps
the two most important sources of nondrug reinforcement available,
it is important to take steps which build these sources of
reinforcement into patients' lives whenever possible. Professional
job training and psychological services may be needed to accomplish
these goals.
In addition to establishing employment and social relationships as
potential sources of reinforcement for drug abuse patients, it
might be desirable also to establish more complex nondrug
activities such as sports, hobbies, or cultural events as .
reinforcers. In contrast to drugs and money, which can serve as
powerful reinforcers in the absence of complex learned behavioral
repertoires, these other nondrug activites generally can function
as reinforcers only after prolonged exposure and after some
competence has been developed in performing the activity. Some
drug abuse patients have never been particularly competent in
socially acceptable areas of activity unrelated to obtaining drugs,
and may, therefore, have few alternative reinforcers available to
them. In this situation, a technique called reinforcer priming can
be utilized which consists of exposing people to new activities and
continuing exposure for a sufficient time for them to gain interest
and some competence.
New activities might profitably be introduced at the methadone
clinic to take advantage of pairing with an existing reinforcer.
Alternatively, methadone delivery might be made specifically
contingent upon engaging in new activities. For example, it may be
considered therapeutically beneficial to help patients to routinize
a daily schedule of activities which are more socially adaptive
than those in which they normally engage. Divided ingestion of the
methadone dose at intervals throughout the day following the
completion of specified activities might be arranged. A similar
system could be set up using token reinforcers rather than
methadone dose, if dosage fractionation proved impractical.
Alternatively, patients might be required to engage in one new
activity per week from a list provided in order to continue
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treatment participation with full privileges. Presumably, if
patients continue to sample new activities, some will be
established as reinforcers and will continue independently of
contingencies at the clinic related to drug dispensing.
Overall it should be recognized that the approach of strengthening
nondrug reinforcers is one component (albeit an important one) of a
more thorough behavioral intervention program. It clearly serves
as an important feature in the more general approach of structuring
or restructuring environmental conditions which will maintain
adaptive behavior.
ESTABLISHING A PROPHYLACTIC ENVIRONMENT
The success of behavior therapy depends greatly on the number and
effectiveness of reinforcers which the therapist can control for
use in contingent arrangements to promote behavior change. In the
previous section, consideration was given to development of new
nondrug reinforcers for drug-dependent patients. Once a repertoire
of reinforcing activities and social relationships has been
established, the next step in therapy would be to transfer
behavioral control from the treatment clinic to the nonclinic
environment. The optimal administrative system would permit the
broker or therapist to build a prophylactic environment for the
patient which would contain appropriate contingencies to discourage
reinitiation of drug use. In addition, the optimal program, unlike
a traditional "drug clinic," would provide an environment and
structuring of contingencies which would preclude evolution of a
new maladaptive repertoire.
A recurrent theme in the discussion was that drug 'abuse treatment
is necessarily a long-term rather than a short-term undertaking
although this is clearly related to the experience of the
individual patient and pattern of use. For some patients, return
to drug use may occur months or even years after an apparently
successful treatment episode. Because return to use may be a
critical feature of substance abuse, the time frame for drug abuse
treatment should be reevaluated to assure the continuing dominance
of nondrug reinforcers. Instead of short-term interventions,
attention-should be devoted to treatment commitments lasting for
several years, during which a prophylactic environment is built for
the dependent patient. Urine monitoring on at least an occasional
basis should continue to be a part of treatment for an extended
period of time, since this provides an objective source of
information about drug use as well as a target for prophylactic
contingencies.
Family, employers, and agents of the legal system should be
considered to be the best sources of natural environment control
for former drug abuse patients.
(1966), while studying the long-term outcomes of drug abusers
A number of years ago Vaillant
incarcerated at the Public Health Service Hospital in Lexington,
Kentucky, noted that enforced abstinence during incarceration was
insufficient. Rather, it was observed that long-term legal
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supervision in the community was associated with the best outcome
for narcotic-dependent individuals. It is particularly important
to emphasize that incarceration itself has no apparent value as a
treatment mode; rather, it is the continued natural environment
intervention which increases probability of success. Contingencies
which require active participation in drug abuse and ancillary
treatment services can be built into legal supervision systems when
appropriate. Effective contingency programs can be utilized with
drug abuse probationers, and specific contingencies can also be
based on evidence of good performance in a drug treatment program.
For example, specified periods of probation time (e.g., 1 week)
may be subtracted for each treatment week in which drug-free urines
are provided.
Employers can also be an excellent source of longer-term
prophylactic supervision, although this issue of exposing an
individual's problem to public view must be approached cautiously
for obvious ethical reasons. Many employers are becoming
increasingly aware of the financial benefits to be gained from
reducing drug and alcohol use among their employees. It might be
particularly useful if contingencies, such as loss of wages and
mandatory reenrollment in treatment, were attached to any detected
drug use episodes of former drug abusers and bonuses were
associated with drug-free periods. At the same time caution to
assure protection of civil rights and the individual's integrity is
essential. Although it is unlikely that the existing welfare
system will be dramatically changed, creative contingencies could
be attached to the receipt of welfare payments to promote improved
functioning among indigent drug abuse patients.
Finally, the family should be considered as an important source of
natural environment contingencies. Families have control over many
reinforcers, both social and material, which they routinely
dispense to the drug-using family member. The family would be an
important source of behavioral control, especially if they could be
taught to dispense these reinforcers more effectively contingent
upon desirable rather than disruptive behaviors. Surrogate
families could serve a comparable function for drug abusers who
lack contact with their own families. Given the recent reports of
success with family therapy treatment of drug addicts, referral to
an experienced family therapist should be considered as an
important step in drug abuse treatment for some patients.
Hunt and Azrin (1973), working with chronic alcoholics in a rural
Illinois community, showed that it is possible to improve outcomes
for chronic alcoholics dramatically by establishing a prophylactic
environment in which access to jobs, social relations, and social
activities is contingent upon sobriety. Jobs were found for the
alcoholics, but they would lose wages if they came to work drunk.
Marital therapy was offered and spouses were taught special
techniques and skills for dealing with both specific behavioral
events and long-term behavioral goals. In addition, a nonalcoholic
social club was established, admission to which depended on
sobriety. These efforts, along with others, demonstrated the
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effectiveness of behavioral intervention techniques. There can be
little doubt that contingencies appropriately arranged in the
environment can have a large impact on substance abuse behavior. A
cost-benefit analysis would be needed to determine whether
individualized behavioral interventions with drug abuse patients
would have a sufficient payoff in improved outcomes to warrant
investment in such an approach.
CONCLUSION
Consideration has been given to four general areas where the
existing treatment of drug abuse patients might benefit from
changes based on behavioral analysis and behavioral management
approaches: (1) improving treatment for specific drug abuse
problems, (2) improving delivery of ancillary treatment services to
drug users, (3) strengthening nondrug reinforcers, and (4)
establishing a long-term prophylactic environment for drug users.
Major changes and specific approaches that might be desirable in
each of these areas were discussed. The overall point to be made,
however, is that a behavioral approach may offer advantages both
for assessing problems within the existing treatment delivery
system and for suggesting changes which might lead to more
effective treatment delivery systems for drug abusers. One of the
main advantages of behaviorally oriented treatment approaches is
that they specify objective therapeutic goals and evaluate the
outcome of treatment empirically. Further, behavioral techniques
are compatible with many other approaches such as family therapy or
worksite interventions.
Actual implementation of any changes in existing treatment services
would best be achieved by a gradual rather than a dramatic shift
and should be subject to cost-benefit analysis on a small scale
before large scale implementation is considered. It is hoped that
this monograph and discussion will encourage treatment planners and
evaluators to adopt a flexible approach in considering the
application of behavioral technology to the treatment of drug abuse
patients.
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researchers, assessing the problem of PCP abuse.
GPO Stock #017-024-00785-4 $7.00 NTIS PB #288 472/AS $25
22 QUASAR: QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS OF
ANALGESICS, NARCOTIC ANTAGONISTS, AND HALLUCINOGENS. Gene
Barnett, Ph.D.; Milan Trsic, Ph.D.; and Robert Willette, Ph.D.;
eds. Reports from an interdisciplinary conference on molecular
drug-receptor interactions.
GPO Stock #017-024-00786-2 $8.00 NTIS PB #292 265/AS 935.50
23 CIGARETTE SMOKING AS A DEPENDENCE PROCESS. Norman A.
Krasnegor, Ph.D., ed. Discusses factors involved in the onset,
maintenance, and cessation of the cigarette smoking habit.
Includes an agenda for future research.
GPO Stock #017-024-00895-8 $6.00 NTIS PB #297 721/AS $19
24 SYNTHETIC ESTIMATES FOR SMALL AREAS: STATISTICAL WORKSHOP
PAPERS AND DISCUSSION. Jos. Steinberg, ed. Papers from a work-
shop on statistical approaches that yield needed estimates of
data for States and local areas. Not available from NCDAI.
GPO Stock #017-024-00911-3 $8.00 NTIS P8 #299 009/AS $23.50
25 BEHAVIORAL ANALYSIS AND TREATMENT OF SUBSTANCE ABUSE. Norman
A. Krasnegor, Ph.D., ed. Papers on commonalities and
implications for treatment of dependency on drugs, ethanol, Food,
and tobacco.
GPO Stock #017-024-00939-3 35.00 NTIS PB #80-112428 $22
160
26 THE BEHAVIORAL ASPECTS OF SMOKING. Norman A. Krasnegor, Ph.D.,
ed. Reprint of the behavioral section of the 1979 Report of the
Surgeon General on Smoking and Health; introduction by editor.
GPO out of stock NTIS PB #80-118755 $17.50
27 PROBLEMS OF DRUG DEPENDENCE, 1979: PROCEEDINGS OF THE 41ST
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG DE-
PENDENCE, INC. L.S. Harris, Ph.D., ed. Not available from NCDAI.
GPO Stock #017-024-00981-4 $9.00 NTIS PB #80-175482 337
28 NARCOTIC ANTAGONISTS: NALTREXONE PHARMACOCHEMISTRY AND
SUSTAINED-RELEASE PREPARATIONS. Robert Willette, Ph.D., and
Gene Barnett, Ph.D., eds. Papers report research on sustained-
release and long-acting devices for use with the narcotic antag-
onist naltrexone.
GPO Stock #017-024-01081-2 37.00 NTIS PB 881-238875 $23.50
29 DRUG ABUSE DEATHS IN NINE CITIES: A SURVEY REPORT. Louis A.
Gottschalk, M.D., et al. Epioemiologic study providing data on
drug-involved deaths and procedures for their investigations.
Not available from NCDAI.
GPO Stock #D17-024-00982-2 $6.50 NTIS PB #80-178882 $17.50
30 THEORIES ON DRUG ABUSE: SELECTED CONTEMPORARY PERSPECTIVES.
Dan J. Lettieri, Ph.D.; Mollie Sayers; and Helen Wallenstein
Pearson, eds. Volume presents summaries of the major contem-
porary theories of drug abuse by each of 43 leading theorists.
GPO Stock #017-024-00997-l $10.00 Not available from NTIS
31 MARIJUANA RESEARCH FINDINGS: 1980. Robert C. Petersen, Ph.D.,
ed. The text of the 8th Marijuana and Health report to Congress
and the background scientific papers on which it was based.
GPO out of stock NTIS PB #80-215171 $20.50
32 GC/MS ASSAYS FOR ABUSED DRUGS IN BODY FLUIDS. Rodger L. Foltz,
Ph.D.; Allison F. Fentiman, Jr., Ph.D.; and Ruth B. Foltz. A
collection of methods For quantitative analysis Of several
important drugs of abuse by gas chromatography- mass spectrometry.
GPO Stock #017-024-01015-4 $6.00 NTIS PB #81-133746 $19
33 BENZODIAZEPINES: A REVIEW OF RESEARCH RESULTS, 1980. Stephen
I. Szara, M.D., D.Sc., and Jacqueline P. Ludfora, M.S., eds.
A RAUS (Research Analysis and Utilization System) Review Report
on the abuse liability of the benzodiazepine "tranquilizers."
GPO Stock #017-024-01108-8 $5.00 NTIS PB #82-139106 $13
34 PROBLEMS OF DRUG DEPENDENCE, 1980: PROCEEDINGS OF THE 42ND
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG
DEPENDENCE, INC. Louis S. Harris, Ph.D., ed.
GPO Stock #017-024-01061-8 $8.00 NTIS PB #81-194847 $34
161
35 DEMOGRAPHIC TRENDS AND DRUG ABUSE, 1980-1995. Louise G.
Richards, Ph.D., ed. Estimates of probable extent and nature Of
nonmedical drug use, 1980-1995, based on age structure and other
characteristics of U.S. population.
GPO Stock #017-024-01087-l $4.50. NTIS PB 182-103417 $13
36 NEW APPROACHES TO TREATMENT OF CHRONIC PAIN: A REVIEW OF MULTI-
DISCIPLINARY PAIN CLINICS AND PAIN CENTERS. Lorenz K.Y. Ng, M.D.,
ed. A sharing of ideas among active practitioners in the treat-
ment Of pain.
GPO Stock #017-024-01082-l $5.50. NTIS Pa #81 -240913 $19
37 BEHAVIORAL PHARMACOLOGY OF HUMAN DRUG DEPENDENCE. Travis
Thompson, Ph.D., and Chris E. Johanson, Ph.D., eds. Presents a
growing body of data, systematically derived, on the behavioral
mechanisms involved in use and abuse of drugs.
GPO Stock #017-024-01109-6 $6.50 NTIS PB #82-136961 $25
38 DRUG ABUSE AND THE AMERICAN ADOLESCENT. Dan J. Lettieri,
Ph.D., and Jacqueline ?. Ludford, M.S., eds. A RAUS Review
'Report, emphasizing use of marijuana: epidemiology, socio-
demographic and personality factors, family and peer influence,
delinquency, and biomedical consequences.
GPO Stock #017-024-01107-O $4.50 NTIS PB #82-148198 $14.50
39 YOUNG MEN AND DRUGS IN MANHATTAN: A CAUSAL ANALYSIS.
Richard R. Clayton, Ph.D., and Harwin L. Voss, Ph.D. Examines
the etiology and natural history of drug use, with special focus
on heroin. Includes a Lifetime Drug Use Index.
GPO Stock #017-024-01097-9 $5.50 NTIS PB #82-147372 $19
40 ADOLESCENT MARIJUANA ABUSERS AND THEIR FAMILIES. Herbert
Hendin, M.D., Ann Pollinger, Ph.D., Richard Ulman, Ph.D., and
Arthur Carr, Ph.D. A psychodynamic study of adolescents
involved in heavy marijuana use, to determine what inter-
action between family and adolescent gives rise to drug abuse.
GPO Stock #017-024-01098-7 $4.50 NTIS P8 #82-133117 $13
41 PROBLEMS OF DRUG DEPENDENCE, 1981: PROCEEDINGS OF THE 43RD
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG
DEPENDENCE, INC. Louis S. Harris, Ph.D., ed. A broad review Of
current research. Includes treatment issues; chemistry and
pharmacology of abused drugs; efficacy and dependence liability
of new compounds.
Not available from GPO NTIS PB #82-190760 941.50
42 THE ANALYSIS OF CANNABINOIDS IN BIOLOGICAL FLUIDS. Richard L.
Hawks, Ph.D., ed. Presents varied approaches to sensitive,
reliable, and accessible quantitative assays for the chemical
constituents of marijuana, For basic researchers in biomedical
and forensic science.
GPO Stock # 017-024-01151-7 35 NTIS PB #83-136044 $16
162
43 PROBLEMS OF DRUG DEPENDENCE, 1982: PROCEEDINGS OF THE 44TH
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG
DEPENDENCE, INC. Louis S. Harris, Ph.D., ed. A collection of
papers which together record a year's advances in drug abuse
research; also includes reports on tests of new compounds for
efficacy and dependence liability.
GPO Stock #017-024-01162-2 $8.50 NTIS PB 83-252-692 $40
47 PREVENTING ADOLESCENT DRUG ABUSE: INTERVENTION STRATEGIES.
Thomas J. Glynn, Ph.D.; Carl G. Leukefeld, D.S.W..; and
Jacqueline P. Ludford, M.S., eds. A RAUS Review Report on a
variety of approaches to prevention of adolescent drug abuse, how
they can be applied, their chances for success, and needed Future
research.
Not available from GPO NTIS PB to be assigned
48 MEASUREMENT IN THE ANALYSIS AND TREATMENT OF SMOKING
BEHAVIOR. John Grabowski, Ph.D., and Catherine S. Bell, M.S.,
eds. Based upon a meeting cosponsored by NIDA and the National
Cancer Institute to delineate necessary and sufficient measures
for analysis of smoking behavior in research and treatment
settings.
GPO Stock #017-024-01181-9 $4.50 NTIS PB to be assigned
IN PREPARATION
44 MARIJUANA EFFECTS ON THE ENDOCRINE AND REPRODUCTIVE SYSTEMS.
Monique C. Braude, Ph.D., and Jacqueline P. Ludford, M.S., eds.
A RAUS Review Report of animal studies and preclinical and
clinical studies of effects of cannabinoids on human endocrine
and reproductive functions.
45 CONTEMPORARY RESEARCH IN PAIN AND ANALGESIA, 1983. Roger M.
Brown, Ph.D.; Theodore M. Pinkert, M.D., J.D.; and Jacqueline P.
Ludford, M.S., eds. A RAUS Review Report on the anatomy,
physiology, and neurochemistry of pain and its management.
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